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The microtubule network is the central framework in multiple cellular processes.  
The microtubule array undergoes dramatic changes as cells progress through the cell 
cycle.  In mitosis the interphase microtubule array is reorganised into the dynamic 
mitotic spindle which mediates chromosome segregation.  This reorganisation is co-
ordinated by microtubule associated proteins (MAPs).  However, little is known 
about the cell cycle regulation of MAPs and how it plays a role in mitotic spindle 
formation. 
 In this thesis, I describe the development of a method to determine the 
profiles and relative quantities of MAPs purified from mitotic and interphase 
Drosophila culture cells.  This method utilises mass spectrometry combined with 
stable isotope labelling by amino acids in cell culture (SILAC) for protein 
quantification.  This study identified MAPs whose association with microtubules 
increased during mitosis and revealed a new mitotic MAP, which I have named 
NuMAP. 
 NuMAP localises to the nucleus in interphase and to microtubules only in 
mitosis, covering the entire spindle.  Truncation analysis identified two protein 
domains sufficient but not essential for nuclear localisation and one C-terminal 
domain vital for microtubule localisation.  Interestingly, creation of an interphase 
cytoplasmic pool indicated that the interphase form of NuMAP has low affinity for 
microtubules, suggesting a cell cycle-related post-translational modification.  A 
deletion mutant of the NuMAP gene was generated by P element excision and will 
be valuable to define the role of NuMAP in fly development. 
1. Introduction 
 
1.1 Microtubule structure and polymerisation 
Microtubules are essential cytoskeletal components in all eukaryotic cells.  The 
microtubule network functions as the central framework of a number of different 
cellular processes such as cell division, morphogenesis and migration (Valiron et al., 
2001).  The diversity of microtubule function is possible due to the number of 
different arrays that microtubules form in cells: parallel, staggered linear arrays or 
radial arrays.  This depends on cell type.  One of the most remarkable structures 
formed by microtubules is the mitotic spindle.  The mitotic spindle is a very dynamic 
structure and is crucial to segregate chromosomes correctly during cell division. 
 
1.1.1 Microtubule structure 
Microtubules are composed of α- and β-tubulin heterodimers (Weisenberg et al., 
1968).  This subunit was first purified using its affinity for colchicine, a strong 
mitotic inhibitor (Weisenberg et al., 1968).  The dimer bound one mole of colchicine 
and two moles of nucleotide, guanosine triphosphate (GTP).  It was identified that 
there were two nucleotide binding sites.  The first site allowed rapid exchange of 
bound and free GTP.  Nucleotide exchange at the second site proceeds very slowly.  
By measuring the binding activity of colchicine, Weisenberg et al (1968) found that 
GTP was necessary to maintain the native protein configuration. 
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Further biochemical studies showed that the β-subunit hydrolyses GTP 
during polymerisation (Weisenberg et al., 1968).  Hydrolys takes place in the fast 
exchanging site (the E-site) and occurs when the tubulin subunit becomes integrated 
into the microtubule lattice.  Following hydrolysis, the E-site contains guanosine 
diphosphate (GDP), which is not exchangeable while the β-tubulin remains within 
the microtubule (David-Pfeuty et al., 1977).  When the microtubule is 
depolymerised, this GDP-containing dimer becomes free and GDP-GTP exchange 
can take place.  The resulting GTP dimer is then free to undergo another round of 
polymerization.  The α-tubulin subunit also binds GTP (Spiegelman et al., 1977) the 
second site identified by Weisenberg et al (1968).  GTP in this site is non-
exchangeable and is not hydrolysed during microtubule polymerisation (Spiegelman 
et al., 1977).  
The amino acid sequence of these two globular proteins, α- and β-tubulin, is 
approximately 45 % identical (Burns, 1991) and each has a molecular mass of about 
50 kDa.  This remarkable similarity in primary structure suggests similar tertiary 
structures.  The few differences between the proteins are thought to lie on the 
exterior of the protein, with the GTP binding sites remaining highly conserved 
(Burns, 1991).  Tubulin heterodimers associate in a head to tail arrangement, 
interacting through hydrophobic and polar contacts (Nogales et al., 1999).  This 
head-to-tail association has been shown to be the structural basis of the protofilament 
(Figure 1.1a) (Amos and Klug, 1974).  Protofilaments come together in a lateral 
arrangement to form a 25 nm wide hollow cylindrical structure; the microtubule 
(Amos and Klug, 1974).  Purified tubulin polymerised spontaneously in vitro 


















Figure 1.1  The microtubule structure, the protofilament and their
subunit.  (A)  A schematic representation of the tubulin heterodimer and the
protofilament.  The heterodimers composed of α- and β- tubulin proteins
associate in a head-to-tail arrangement to form the protofilament.  
(B)  A schematic representation of the A lattice.  Lateral associations form 
between the α-monomers of one protofilament and the β-monomers of the
adjacent protofilment. (C) A schematic representation of the B lattice.  
Lateral interactions are between α- and β-monomers (a dimer) of adjacent
protofilaments.  13 protofilaments aligned in parallel create a hollow







staining of microtubules polymerised in vivo or nucleated in vitro from centrosomes, 
showed that 13 protofilaments form the microtubule structure.  It is thought that the 
pericentriolar material of the centrosome nucleates microtubules, creating a uniform 
polarity and favouring this specific structure.  (Amos and Klug, 1974; Evans et al., 
1985),  
The head-to-tail association of the tubulin dimer leads to structural 
polarization of the protofilament (Amos and Klug, 1974).  Parallel alignment of 
protofilaments to form the microtubule structure establishes this polarity within the 
microtubule (Amos and Klug, 1974).  This integrated polarity results in distinct 
microtubule ends with structural and kinetic differences.  The two ends of the 
microtubule have different polymerisation rates, with the faster-growing end known 
as the plus end and the slower-growing end as the minus end (Allen and Borisy, 
1974).  The α-tubulin subunit is exposed at the minus end of the microtubule (Fan et 
al., 1996), which is associated with microtubule organising centres (MTOCs) usually 
located towards the centre of the cell.  In contrast, the faster growing plus end of the 
microtubule is not anchored and the β-tubulin subunit exposed (Mitchison, 1993).  
This orientation of the tubulin dimer in the protofilament is also supported by studies 
of kinesin motor domain binding.  A microtubule coated with the kinesin head, the 
motor domain, a region of kinesin known to bind β-tubulin was examined.  Electron 
microscopy of the decorated microtubule showed the main mass of kinesin head to 
be associated with the tubulin subunit closer to the plus end.  This confirmed the 
dimer orientation to be α-tubulin to the minus end and β-tubulin to the plus end.  In 
vivo the plus end of the microtubule is peripheral and selectively interacts with 
cellular components such as kinetochores and the cell cortex (Hayden et al., 1990).  
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The polarity within the microtubule is also critical to the function of motor proteins 
such as kinesin. 
There are two possible arrangements of protofilaments with regard to the 
lateral interactions, the A-lattice and the B-lattice.  For the A-lattice it is proposed 
that lateral associations are between α-monomers of one protofilament and β-
monomers of adjacent protofilaments (Figure 1.1b).  In comparison, the lateral 
interactions of the B-lattice are proposed to be between α- and β-monomers (dimer) 
of adjacent protofilaments (Figure 1.1c).  Structural analysis of a kinesin decorated 
microtubule confirmed the correct structure to be that of the B-lattice (Kikkawa et 
al., 1994).  The bonds between tubulin monomers do not lie horizontally, they in fact 
have a 10 angle.  This creates a helical path of monomers which travels along the 
microtubule in a 3-start helix formation.  With this arrangement the adjoining 
monomers in the helix are both either β- or α-subunits for a single helical turn.  At 
this point the change in monomer creates a seam where an α- and β-tubulin are 
neighbouring (Figure 1.1c) (Kikkawa et al., 1994). 
 
1.1.2 Microtubule polymerisation 
The microtubule is formed by the head-to-tail association of the tubulin dimer.  
However, although the microtubule is described as a helical structure, it does not 
have to assemble by the classical helical formation.  Tubulin dimers often first form a 
curved sheet like lattice of protofilaments (Detrich and Jordan, 1986).  Multiple 
studies have observed the presence of jagged/C-shaped protofilament sheets at the 
distal end of microtubules (Detrich and Jordan, 1986; McIntosh et al., 1985; Simon 
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and Salmon, 1990).  This morphology has been seen in vivo and in vitro and is 
believed to represent an intermediate structure of microtubule assembly and not 
disassembly.  Erickson (1974) polymerised purified tubulin and took samples for 
analysis at regular time points during assembly.  At early time points he observed 
these large sheets containing up to 13 protofilaments.  However, they rarely saw 
those sheets containing 13 protofilaments.  Closer analysis showed the frequency of 
protofilament sheets to decrease as microtubule assembly progressed.  They therefore 
hypothesised that microtubule assembly begins with a small aggregate of filaments.  
This then elongates with the addition of more tubulin dimers to existing filaments, 
along with the slower addition of protofilaments to the side.  This curving structure, 
with the addition of a 13
th
 filament, will close and form bonds creating the intact 
cylindrical structure of the microtubule (Erickson, 1974).   
The formation of sheets of parallel protofilaments has been observed in 
conditions lacking associating proteins.  This therefore suggests their formation to be 
an intrinsic property of microtubule assembly (Simon and Salmon, 1990).  The 
presence of these protofilament sheets has been suggested to stabilise microtubules, 
and when closed the microtubule is more likely to undergo a catastrophe. (Chretien 
et al., 1995). 
 
1.2 Microtubule dynamics 
Microtubules are dynamic structures and undergo significant changes through the 
cell cycle.  It has long been established that the dynamic properties of microtubules 
are essential for their function, specifically during mitosis (Inoue and Sato, 1967).  
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Therefore the characterisation of microtubule dynamics and their function has been 
thoroughly studied.  Here I will summarise four main features of microtubule 
dynamics: treadmilling, dynamic instability, the GTP cap and the importance of 
microtubule dynamics in vivo. 
 
1.2.1 Treadmilling 
Microtubules were primarily analysed with respect to treadmilling, a process which 
had been observed in actin filaments (Wegner, 1976).  The idea of treadmilling in 
microtubules was introduced after Margolis et al (1978) observed the continuous 
incorporation of tubulin into the steady state microtubule using 
3
HGTP as a tubulin 
marker.  The microtubule poison podophyllotoxin, which interferes with microtubule 
function in cells, prevented the incorporation of tubulin into the microtubule matrix, 
but not its loss.  Furthermore, pulse labelling of microtubules at steady state showed 
little loss of label over a significant period of time.  These results indicated that 
microtubule assembly and disassembly occur at different sites of the microtubule 
(Margolis and Wilson, 1978).  An increase in the disassembly rate of microtubules 
when sheared showed tubulin loss to be end dependent, identifying the assembly and 
disassembly to occur at opposite ends of the microtubule (Margolis and Wilson, 
1978).  The plus end of the microtubule incorporates tubulin dimers containing GTP 
and the minus end loses tubulin dimers containing GDP during treadmilling (Figure 
1.2).  When microtubule minus ends are fixed in structures such as MTOCs, 
treadmilling results in the appearance of a flux of tubulin dimer through the 
microtubule.  When microtubule ends are free, treadmilling results in an apparent 
7
GTP-Tubulin Labelled GTP-Tubulin Unlabelled
Figure 1.2  A schematic representation of microtubule treadmilling.  
The plus end of the microtubule incorporates tubulin dimers containing GTP
and the minus end loses tubulin dimers containing GDP.  When microtubule
minus ends are fixed in cell structures, treadmilling results in the appearance
of a flux of tubulin dimer through the microtubule.
Plus endMinus end
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migration of the microtubule within the cell (Margolis and Wilson, 1981; Rodionov 
and Borisy, 1997).   
 
1.2.2 Dynamic instability 
Dynamic instability is a behaviour whereby microtubules are proposed to alternate 
stochastically between polymerisation and depolymerisation.  This mechanism was 
first put forward by Mitchison and Kirschner in 1984.  The shearing of steady state 
microtubules and depolymerisation in the absence of re-nucleation decreased the 
number of microtubules, but created monomers available for incorporation, and 
resulted in longer microtubules.  This indicated that the steady state microtubule 
network results from the existence of two phases; the majority of microtubules 
polymerising slowly at equilibrium and a minority of microtubules depolymerising 
rapidly (Mitchison and Kirschner, 1984).  If transition between these phases is 
frequent, little elongation or number loss would be observed.  Mitchison et al (1984) 
concluded that the phase transition occurs infrequently.  This was also observed by 
Horio and Hotani (1986) and was later confirmed by Walker et al (1988) with 
analysis of individual microtubules by video light microscopy.  Transitions were not 
only infrequent but also abrupt and random. 
 The transition from elongation to rapid shortening is known as a ‘catastrophe’ 
and the transition from shortening to elongation as ‘rescue’.  Walker et al (1988) also 
observed microtubules to ‘pause’, a period of time when the microtubule length 
remained constant.  However, this occurred very rarely.  Observations of individual 
microtubules have led to the description of dynamic instability by four parameters: 
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the rates of polymerisation and depolymerisation and the occurrence of catastrophes 
and rescues (Walker et al., 1988).  The microtubule plus end polymerises 
approximately three times faster than the minus end and undergoes a higher rate of 
‘catastrophe’.  In contrast, the minus end of the microtubule undergoes faster 
depolymerisation and an increase in the frequency of ‘rescue’(Horio and Hotani, 
1986).  These significant differences of dynamic instability at microtubule ends 
contribute to the previously described treadmilling effect (Hotani and Horio, 1988).  
The mechanism of dynamic instability appears to be unique to microtubules and has 
become established as the main mechanism for the regulation of microtubule 
dynamics (Desai and Mitchison, 1997). 
 The hydrolysis of GTP by β-tubulin during polymerisation is thought to be 
the source of energy for dynamic instability.  Kinetic data has shown GTP hydrolysis 
to be two successive reactions (Carlier and Pantaloni, 1981): chemical cleavage of 
the γ-phosphate group, followed by the release of phosphate.  Although hydrolysis of 
GTP is thought to provide energy, microtubule polymerisation does not require GTP 
hydrolysis to occur (Caplow et al., 1994).  GTP hydrolysis is also independent of free 
tubulin concentration, unlike polymerisation, and, when present within the 
microtubule, GTP is still able to be exchanged.  Upon hydrolysis the remaining 
product, GDP, is locked into the E site of tubulin (Carlier and Pantaloni, 1981).  The 
replacement of GTP with GDP causes a tubulin conformational change, resulting in a 
more ordered structure (Howard and Timasheff, 1986).   
Tubulin-GDP has a stronger tendency to form a double ring structure than 
tubulin-GTP.  Analysis of this structure shows it to be equivalent to pairs of curved 
protofilaments coiled sideways which are tensioned within the microtubule.  This 
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structure causes functional instability within the microtubule and increases the 
possibility of depolymerisation (Diaz et al., 1994).  Structural analysis of dynamic 
microtubules revealed structural differences between polymerising and 
depolymerising microtubule ends.  Cryo-electron microscopy showed growing 
microtubule ends to have straight protofilaments, whereas those undergoing 
depolymerisation had protofilaments coiled inside-out (Mandelkow et al., 1991).   
Caplow et al (1994) identified conditions in which guanylyl-(a,b)-
methylenediphosphonate (GMPCPP), a GTP analogue, was hydrolysed upon 
integration into the microtubule lattice.  Comparison of the disassociation of 
GMPCPP and its hydrolysed product GMPCP, showed GMPCP to dissociate faster 
than its counterpart.  They also observed that the energy release upon GMPCPP 
hydrolysis was close to zero, indicating that the potential energy produced by 
hydrolysis is stored within the microtubule (Caplow et al., 1994).  This system is 
thought to apply to GTP hydrolysis and potentially regulates microtubule dynamics.  
Within the cell, the energy stored in microtubules could be utilized to move 
structures in the cell such as chromosomes during anaphase. 
The use of GTP-hydrolysis is proposed to function as the main regulator of 
microtubule dynamics.  Evidence shows that the hydrolysis of GTP induces 
weakening of the microtubule lattice, increasing the probability of catastrophes.  
However, the mechanism for prolonged microtubule polymerisation is not addressed 
here.  There are multiple models for the maintenance of microtubule stability, with 
the key mechanism suggested to be a GTP cap at the plus end of the microtubule. 
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1.2.3 The GTP cap 
Free tubulin has a slow rate of GTP hydrolysis.  Integration into the microtubule 
lattice increases the rate of this reaction (Caplow and Shanks, 1990; David-Pfeuty et 
al., 1977).  As the hydrolysis of GTP is thought to be a main regulator of microtubule 
dynamics, it was suggested by Mitchison et al (1984) that microtubules were 
stabilised by a cap of tubulin-GTP.  This hypothesis was supported by the earlier 
observation that tubulin is integrated into the microtubule lattice before GTP 
hydrolysis (Carlier and Pantaloni, 1981).  However some studies have indicated that 
there is little, if any, lag between polymerisation and hydrolysis (Caplow, 1992).  
The GTP cap could be made up of either GTP-tubulin or GDP.Pi-tubulin.  It 
is not always the cleavage of GTP that induces a conformational change in protein 
structures.  It can also be the release of phosphate (Pi).  Melki et al (1990) observed 
direct evidence for GTP and GDP-Pi intermediates in microtubule assembly.  It was 
found that microtubules composed of GDP.Pi-tublin were very stable, losing 
subunits at a very slow rate.  This led to the conclusion that the release of Pi and not 
the cleavage of GTP induced a conformational change in tubulin and subsequent 
destabilisation of the microtubule lattice (Melki et al., 1990).  These results 
supported evidence showing little lag time between microtubule polymerisation and 
GTP hydrolysis (Caplow and Shanks, 1990).  It is therefore proposed that 
microtubules growing at rates relevant to dynamic instability have terminal GTP 
subunits and sub-terminal GDP.Pi subunits (Melki et al., 1990).  The release of Pi 
from polymerising microtubules was addressed in later years.  Again a lag between 
microtubule polymerisation and Pi release was observed using rapid taxol-driven 
microtubule polymerisation (Melki et al., 1996).  The presence of this lag was not 
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confirmed under the conditions of dynamic instability, but clearly supports the model 
of a GTP/GDP.Pi cap. 
 The size of the GTP/GDP.Pi cap has also been previously investigated by 
Walker et al (1991).  Polymerising microtubules were rapidly diluted and the time it 
took for microtubules to undergo a catastrophe was measured.  Individual 
microtubules were observed to undergo a catastrophe only seconds after dilution, 
even at high rates of microtubule elongation.  It was therefore concluded that the size 
of the stabilising cap was small, ≈ 200 tubulin dimers or less, and was independent of 
microtubule polymerisation rates (Walker et al., 1991).  By labelling subunits with 
rhodamine, Drechsel et al (1994) measured the size of the cap to be as few as 40 
subunits in order to stabilise the microtubule plus end.  This supports a model in 
which at least one tubulin subunit at the end of all 13 protofilaments of a microtubule 
is bound with GTP (Drechsel and Kirschner, 1994). 
 
1.2.4 Microtubule dynamics in vivo 
Several biological functions in the cell have been suggested to gain the benefit of 
dynamic instability.  Firstly it has been proposed that dynamic instability allows the 
rapid filling of newly formed cytoplasm with microtubules.  Imaging of fluorescently 
tagged microtubules in frog embryonic neurons showed that microtubules change 
rapidly between configurations during growth cone extension.  However, no net 
growth within the microtubule system was observed, with little change in the growth, 
shrinkage and catastrophe rates.  This suggested the colonisation of newly formed 
cytoplasm was regulated by a high rescue frequency of microtubules.  Translocation 
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of polymer from the axon also appeared to be a major mechanism in generating new 
polymer in the growth cone (Tanaka and Kirschner, 1991). 
 Interestingly, dynamic instability is thought to be the mechanism by which 
microtubules search three-dimensional space effectively to find specific target sites, 
this is known as the search-capture model.  Quantitative modelling showed dynamic 
instability reduces the time needed for microtubules to find a target; and clearly 
demonstrated the importance of dynamic instability in the search and capture model 
(Holy and Leibler, 1994).  The search-capture model was formulated to account for 
the capture of kinetochores by microtubule plus ends during the formation of the 
mitotic spindle.  Using interference-contrast light microscopy this process was 
visualised in prometaphase newt lung cells.  Microtubules emanating from polar 
regions continuously probed chromosomes until they contacted chromosome 
kinetochores (Hayden et al., 1990).  Captured microtubules are then thought to be 
stabilised, resulting in the detyrosination of α-tubulin (Bulinski and Gundersen, 
1991). 
 The parameters of dynamic instability in vitro differ from those observed in 
vivo.  Microtubules assembled from purified tubulin in vitro show reduced dynamic 
behaviour when compared to those polymerised in vivo.  Microtubule elongation in 
sea urchin interphase extract is approximately six times faster than that observed 
with purified sea urchin egg tubulin.  The occurrence of catastrophes and rescues 
were 20 times and 2 times more frequent respectively.  However, the rate of 
shortening was equivalent between in vitro and in vivo samples (Simon et al., 1992).  
Therefore, sea urchin extract must contain factors that stimulate elongation velocity 
and induce microtubule catastrophe (Simon et al., 1992). 
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 The parameters of microtubule dynamics also change extensively through the 
cell cycle, specifically at the interphase-mitosis transition.  Incorporation of labelled 
bovine tubulin into cultured mammalian cells occurs in a matter of seconds during 
mitosis.  However, in interphase cells, fluorescent microtubules are only obtained 
after minutes.  Photo-bleaching has also confirmed this difference in microtubule 
dynamics (Saxton et al., 1984).  Analysis of microtubule dynamics in interphase and 
mitotic Xenopus extracts showed a significant difference in microtubule dynamics 
between the two cell states.  Quantitative analysis determined polymerisation and 
depolymerisation rates to be similar, with an increase in the frequency of catastrophe 
(Belmont et al., 1990).  Cell differentiation also induces different microtubule 
dynamics.  Microtubules are selectively stabilised during cell differentiation, 
becoming labelled by post-translational modifications of phosphorylation and 
acetylation (Baas et al., 1991; Bulinski and Gundersen, 1991). 
The control of microtubule dynamic instability appears to be achieved 
through regulatory molecules targeted to control the frequency of microtubule 
transition between phases.  Activation of Xenopus extracts with cyclin B results in 
shortening of centrosome-nucleated microtubules with increased catastrophe rates 
(Verde et al., 1992).  Computational simulation demonstrated that an increase in 
catastrophe and a decrease in rescue frequencies could reproduce microtubule 
dynamic changes observed in vivo between interphase and mitosis (Gliksman et al., 
1993). 
Evidence that microtubules are also regulated by signal transduction 
pathways has been observed.  Cell stimulation of macrophages with phorbol esters 
results in an increase in the level of microtubule polymer and number (Robinson and 
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Vandre, 1995).  Studies on the regulation of microtubule dynamics have suggested 
that phosphorylation and transcriptional regulation play significant roles.  Treatment 
of sea urchin egg extract with a potent phosphatase inhibitor resulted in the 
elimination of microtubule rescue and the production of short dynamic microtubules, 
typical of mitosis (Gliksman et al., 1992).  In neurite growth, nerve growth factor has 
been suggested to promote microtubule assembly through the synthesis of 
microtubule regulating factors (Drubin et al., 1985). 
To understand fully the dynamics of microtubules in vivo, significant work 
has been carried out to identify the proteins regulating microtubules.  A large number 
of these proteins are known to associate with microtubules.  This group of proteins 
are collectively called microtubule-associated proteins, (MAPs).  Below I discuss a 
number of MAPs, how they regulate microtubules, and the roles they play in cellular 
processes. 
 
1.3 Microtubule-associated proteins 
Microtubule-associated proteins are the main regulators of microtubule dynamics and 
organisation and are defined as proteins which associate with microtubules (Solomon 
et al., 1979).  They were first identified as proteins which fractionate with 
microtubules after cycles of assembly and disassembly (Borisy et al., 1975) with the 
more prominent proteins having high molecular weights. 
MAPs are classified into 2 groups, motor and non-motor MAPs.  Motor 
MAPs generate force through adenosine-triphosphate (ATP) hydrolysis and move 
along the microtubule, often carrying cargo (Amos and Cross, 1997).  Non-motor 
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MAPs are a varied group of proteins and do not contain any force-generating 
domains.  These proteins regulate microtubules by binding directly and through their 
associating proteins. 
The movement of motor MAPs along the microtubule is directional due to the 
polymer’s polarised structure and are classified by their direction of translocation.  
There are two families of motor MAPs; dynein and kinesin, which are defined by 
their motor domain structure.  One form of dynein, cytoplasmic dynein 1, is a minus 
end-directed complex with a range of functions, including spindle positioning and 
organisation during mitosis (Eshel et al., 1993).  Dynein is regulated through its 
interaction with accessory proteins such as dynactin (Gonczy et al., 1999; Goshima 
et al., 2005; Morales-Mulia and Scholey, 2005).  The kinesin family of motors are 
classified into 14 groups and are mostly plus end-directed motors (Amos and Cross, 
1997; Lawrence et al., 2004; Miki et al., 2005).  One exception is kinesin-14 which is 
a minus end-directed kinesin (Miki et al., 2005).  Like dynein, kinesins play essential 
roles in a number of cellular processes, including organelle transport (Brady et al., 
1990), nuclear movement (Holzinger and Lutz-Meindl, 2002), chromosome 
segregation and bipolar spindle formation (Enos and Morris, 1990). 
 Non-motor MAPs are a diverse group of proteins with no common structural 
or functional motifs.  They are classified by the roles they play in microtubule 
regulation and can be divided into two main groups.  Firstly there are those that 
stabilise microtubules, for example the key neuronal protein tau.  Tau increases the 
polymerisation rates of individual microtubules and in vitro enhances a reduction in 
the rate of microtubule transition to the depolymerisation (Drechsel et al., 1992).  In 
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neurons, tau influences net microtubule assembly, increasing neurite extension and 
stability (Esmaeli-Azad et al., 1994). 
Secondly there are MAPs that destabilise microtubules.  These proteins are 
important for the rapid change of microtubule organisation through the cell cycle.  
Microtubule destabilisation is induced through multiple mechanisms.  For example, 
the protein Katanin induces rapid depolymerisation by removal of the GTP cap 
through microtubule severing.  This leaves the microtubule prone to rapid 
disassembly (Hartman et al., 1998; McNally et al., 1996; McNally and Vale, 1993).  
In contrast the protein stathmin prevents microtubule polymerisation by sequestering 
the tubulin dimer inhibiting microtubules polymerisation (Belmont and Mitchison, 
1996) and inducing catastrophes. 
 
1.4 Biochemical identification of microtubule-associated proteins 
Microtubule-associated proteins regulate microtubule organisation, dynamics and, in 
turn, their function in the cell.  Due to their key roles in microtubule cytoskeletal 
function, the identification of MAPs has become an important goal in research.  
 MAPs were first identified in porcine brain tissue as high molecular weight 
proteins which co-purify with microtubules in assembly/disassembly cycles (Borisy 
et al., 1975), however this identified very few proteins.  The conditions of 
microtubule assembly/disassembly cycles excluded the isolation of specific groups of 
MAPs such as microtubule destabilising proteins.  Further improved microtubule 
purification methods have therefore been developed. 
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In 1982, Vallee investigated the use of taxol, a microtubule stabilising drug, 
in the purification of MAPs.  Using taxol, microtubules were assembled and purified 
in conditions for rapid and high yield of MAPs which were previously unsuitable for 
microtubule polymerisation (Vallee, 1982).  MAPs were shown to disassociate from 
microtubules when exposed to elevated concentrations of NaCl, providing a method 
for the separation of MAPs from microtubules (Vallee, 1982; Vallee and Bloom, 
1983).  Using this new taxol dependent method, Vallee and Bloom (1983) identified 
several mitotic spindle MAPs by generating monoclonal antibodies.  This approach 
provided a rapid and conclusive method for the identification of MAPs in various 
cell systems (Vallee and Bloom, 1983).  Although sedimentation of taxol-stabilised 
microtubules with their associating proteins is rapid, only proteins which tightly bind 
the entire microtubule length are identified. 
In 1989 an affinity chromatography method for the identification of less-
abundant MAPs was developed by Kellogg et al (1989).  Affinity chromatography 
allowed the isolation of minor MAPs with weak microtubule binding and identified 
proteins that localised to the centrosome and kinetochores (Kellogg et al., 1989).  
Comparison of microtubule co-sedimentation and affinity chromatography showed 
these methods to be complementary to each other.  Affinity chromatography 
identifies a larger variety of proteins with a higher protein yield.  However, although 
a broader range of MAPs are identified using affinity chromatography, co-
sedimentation still isolates unique proteins.  Neither method obtains complete MAP 
coverage and each approach has its advantages; affinity chromatography allows close 
regulation of elution conditions, while co-sedimentation is rapid and robust (Kellogg 
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et al., 1989).  Therefore these methods used in parallel could obtain a more 
comprehensive list of MAPs. 
The above studies confirmed isolated proteins to be MAPs by a variety of 
methods.  Borisy et al (1975) examined the sedimentation of the high molecular 
weight proteins in conditions in which microtubule assembly was prohibited.  Both 
the Vallee and Bloom (1983) and the Kellogg et al (1989) studies produced 
antibodies against isolated proteins.  Immunofluorescence microscopy confirmed 
protein localisation to microtubules and immunoblot confirmed protein enrichment in 
microtubule fractions (Kellogg et al., 1989; Vallee and Bloom, 1983). 
 In recent years mass spectrometry and biochemical screens have also been 
used in combination for the identification of MAPs.  Microtubule co-sedimentation 
has been used to isolate MAPs from extracts of various organisms and mass 
spectrometry used for protein identification (Hughes et al., 2008; Mack and 
Compton, 2001; Sisson et al., 2000).  Together these screens identified 303 MAPs, 
17 of which were primarily isolated to interact with actin and therefore also bind 
microfilaments.  Mack and Compton’s (2001) use of mammalian mitotic cell extract 
to identify spindle-associated proteins was complemented by the isolation of 
structures such as the centrosome which revealed more mitotic proteins (Andersen et 
al., 2003; Muller et al., ; Ozlu et al., 2010; Sauer et al., 2005; Skop et al., 2004).  
Further proteomic analysis of human spindles confirmed the high complexity of the 
spindle apparatus and showed it to contain more proteins than previously predicted 
or identified (Sauer et al., 2005).  Together these numerous screens have provided 
hundreds of candidate MAPs. 
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1.5 The regulation of microtubule associated proteins 
Although significant research has been carried out to identify MAPs, little is known 
about their regulation.  Due to the essential role MAPs play in the regulation of 
microtubules and the formation of the mitotic spindle, it is likely that they 
themselves are under tight regulation.  At present, only three mechanisms have been 
identified to regulate MAPs: protein phosphorylation, ubiquitination and the Ran 
pathway. 
 
1.5.1 The regulation of microtubule associated proteins by phosphorylation 
Structural MAPs have been shown to be in vitro substrates of several protein kinases 
suggesting a major role of MAP regulation is the post translation modification of 
phosphorylation.  However precise mechanisms have been identified and studied in 
very few cases. 
 
Tau 
Hyper-phosphorylated forms of the microtubule stabilising protein tau are the 
components of paired helical filaments.  The presence of these filaments is a major 
hallmark of Alzheimers disease (Morishima-Kawashima et al., 1995).  Due to its 
implication in the pathology of neurodegeneration, most published data regarding 
MAP phosphorylation concerns tau and its effect on microtubule binding and 
regulation.  Tau can be phosphorylated by multiple kinases at many different sites 
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which effect its ability to promote the assembly of microtubules (Lindwall and Cole, 
1984). 
Two types of tau phosphorylation have been distinguished; phosphorylation 
at KXGS motifs in repeat sites and TP/SP motifs in domains flanking the repeats.  
Phosphorylation of TP/SP motifs accounts for approximately 80 % of tau 
phosphorylated residues.  However, using site directed mutagenesis the 
phosphorylation of Ser
262
 within a KXGS motif in the first repeat has been identified 
to be dominant in reducing the affinity of tau for microtubules (Biernat et al., 1993; 
Morishima-Kawashima et al., 1995).  This phosphorylation of tau specifically at 
Ser
262
 is essential for microtubule destabilisation and reorganisation during neuronal 
differentiation (Biernat and Mandelkow, 1999). 
Previous studies showed C-kinase and CaM Kinase II can phosphorylate tau 
at Ser
262
 but it only partially reduces the microtubule binding of tau (Sengupta et al., 
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262
 
gave the maximum inhibition of the microtubule binding of tau.  (Sengupta et al., 
2006) that the phosphorylation of tau by cyclin dependent kinase-5 (Cdk5) at Ser
235
 




 by glycogen synthase kinase-3 
(GSK3).  This induction of GSK activity is proposed to be regulated by inhibitory 
cross-talk of Cdk5 and GSK3 via phosphatases (Plattner et al., 2006). 
 
Kinesin-5 
Kinesin-5 is a key regulator of spindle assembly and has also been reported to be 
phosphorylated.  The tail region of Kinesin-5 contains a conserved motif which in 
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Xenopus was shown to be phosphorylated by Cdk1 during mitosis (Cahu et al., 2008; 
Heck et al., 1993; Sawin and Mitchison, 1995).  In Drosophila, the non-
phosphorylated kinesin-5 protein does not localise to the mitotic spindle nor does it 
rescue the mutant monopolar phenotype.  Kinesin-5 localisation and function are 
therefore phosphorylation-dependent (Goshima and Vale, 2005; Sharp et al., 1999).  
During interphase kinesin-5 remains diffuse and does not associate with 
microtubules.  As cells progresses into mitosis kinesin-5 is phosphorylated by Cdk1 
and associates with microtubules, regulating the formation of the bipolar mitotic 
spindle (Goshima and Vale, 2005). 
 In HeLa cells, the microinjection of antibodies against human kinesin-5 
blocked centrosome migration and resulted in cell arrest in mitosis with monoastral 
microtubule arrays.  Blangy et al (1995) also showed that the conserved 
phosphorylation site Thr
927
 was phosphorylated exclusively in mitosis and was 
readily phosphorylated by p34
cdc2
/cyclin B in vitro.  The microtubule association of 
human kinesin-5 was inhibited by the mutation of Thr
927
 to a nonphosphorylatable 





 protein kinase is essential to promote its microtubule association. 
 
CLIP-170 
Recently the phosphorylation of the MAP CLIP-170 has been shown to be important 
for the formation of focal adhesions and lamellipodium created during cell polarity 
and migration processes.  Nakano et al (2010) identified the majority of endogenous 
CLIP-170 protein to be phosphorylated at Ser
311
 by the AMP-activated protein kinase 
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(AMPK).  Both the inhibition of AMPK and the transient expression of the non-
phosphorylatable form of CLIP-170 resulted in an accumulation of CLIP-170 at 
slower growing microtubule tips.  It was also noted that microtubule 
depolymerisation was reduced and the number of stable microtubules was increased 
(Nakano et al., 2010).  Collectively the data suggests that AMPK phosphorylation of 
CLIP-170 is needed for the effective disassociation of CLIP-170 from microtubules 
and is essential for efficient microtubule polymerisation and depolymerisation.  
Interestingly, Nakano et al (2010) also demonstrated that CLIP-170 is the most 
important protein substrate of AMPK as phenotypes produced by AMPK depletion 
of inhibition could be rescued by the expression of phosphomimetic CLIP-170. 
 
1.5.2 The regulation of microtubule associated proteins by Ran- a central 
player in mitosis 
Ran is an abundant nuclear GTPase which was first characterised to regulate protein 
nuclear transport during interphase.  In 1999 it was demonstrated that Ran plays a 
significant role in the assembly of the mitotic apparatus.  The addition of RanGTP to 
Xenopus M phase extracts induced the nucleation and assembly of spindle like 
structures (Carazo-Salas et al., 1999).  Further studies confirmed this and identified 
RCC1 (the Ran nucleotide exchange factor), RanBP1 (a guanine nucleotide 
dissociation inhibitor) and RanGAP (an activator of Ran GTPase activity) to be 
involved in the spindle assembly process (Kalab et al., 1999; Ohba et al., 1999).  A 
generally accepted model is that RCC1, a chromosomal associated protein, generates 
a high concentration of RanGTP is the region of the chromosomes. 
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In the cytoplasm the protein RanGAP is thought to stimulate Ran GTPase 
activity.  From this a RanGTP gradient is formed; a high RanGTP concentration 
surrounding the chromosomes reducing to a low cytoplasmic RanGTP concentration.  
Therefore a favourable environment for microtubule nucleation and spindle assembly 
is created in the vicinity of chromosomes.  The existence of this gradient has been 
demonstrated in Xenopus egg extract and cells.  Using fluorescence energy transfer 
based biosensors, RanGTP was shown to have a steep nuclear cytoplasm 
concentration gradient in interphase and a steep chromosome cytoplasm gradient in 
mitosis (Kalab et al., 2002).  Long range gradients were later demonstrated and 
predicted to result from the RanGTP importin-β complex preventing RanGAP 
induced GTP hydrolysis until the association of importin-α (Caudron et al., 2005).  In 
cells, this long range gradient kinetically promotes spindle formation (Kalab et al., 
2006). 
 Ran is known to associate with the nuclear import receptors importin-β and 
importin-α.  Analysis of Ran’s role in spindle assembly showed these receptors to 
play significant roles.  Investigation into protein regulation by Ran and the nuclear 
import receptors, revealed the protein NuMA (nuclear mitotic apparatus protein) as a 
target.  Alongside this, the purification of Ran-dependent nucleation activity from 
HeLa cells using Xenopus egg extract depleted of importin-α, identified the protein 
TPX2 (Gruss et al., 2001). 
From this work it was proposed that in low RanGTP concentrations the cargo, 
such as MAPs regulating spindle assembly, bind importin-α and -β.  In high RanGTP 
concentrations, for example surrounding chromosomes, importin-β dissociates from 
the complex and binds RanGTP.  This dissociation weakens the binding between 
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importin-α and its cargo.  Spindle assembly factors are released and activate 
microtubule nucleation and spindle formation.  Away from the chromosomes, Ran 
GTPase activity is activated by the RanGAP/RanBP1 complex and importin-β is 
released, allowing it to re-establish inhibition of spindle assembly factors distant 
from the chromosomes (Dasso, 2002; Gruss et al., 2001).  Therefore spindle 
assembly factors will be predominantly released in the vicinity of the chromosomes.  
This model is illustrated in Figure 1.3. 
During interphase, Ran and the importin proteins regulate the import of 
proteins into the nucleus.  Therefore from this model, Ran regulated spindle 
assembly factors are localised to the nucleus during interphase.  Indeed the spindle 
factors NuMA and TPX2 are located in the nucleus during interphase. 
 
1.5.3 Mitotic Ran regulated importin cargos 
Multiple proteins have been identified to be regulated directly by Ran or are related 
to Ran regulated factors.  Here I will describe key spindle assembly factors which are 
regulated by the Ran pathway. 
 
TPX2 
Targeting protein for Xklp2 (TPX2) is an 82.4 kDa protein first identified as being 
required for the microtubule localisation of the kinesin like protein Xklp2.  A point 
mutation of Xklp2 suggested TPX2 to be a receptor for the Xklp2 leucine zipper and 



















Figure 1.3  Model of Ran regulation of spindle assembly factors.  
At low RanGTP concentrations importin-α and -β form a complex with their 
cargo.  In high RanGTP concentrations, for example around chromosomes, 
importin-β dissociates from the complex and binds RanGTP.  The interaction
of importin-α and its cargo is weakened and the active cargo is released.
In the cytoplasm the RanGAP/RanBP1 complex activates Ran’s GTPase 
activity releasing importin-β, allowing the re-estabilshment of cargo inhibition.
GDP
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al., 1998).  During interphase TPX2 is localised in the nucleus and during mitosis 
becomes localised to the spindle poles.  This pole localisation requires activity of the 
dynein-dynactin complex.  In late anaphase TPX2 is relocated to the spindle 
midbody(Wittmann et al., 2000).  Immunodepletion of TPX2 in mitotic Xenopus egg 
extract induced bipolar spindle structures with disintegrating poles and a decreased 
microtubule density.  In contrast, excess TPX2 created monopolar spindle structures 
with large poles (Wittmann et al., 2000).  In HeLa cells TPX2 depletion arrested cells 
in mitosis with multipolar spindles (Garrett et al., 2002), or no spindle formation 
even in the presence of duplicated centrosomes (Gruss et al., 2002).  Later work has 
shown that depletion of TPX2 in mammalian cells blocks kinetochore associated 
microtubule polymerisation but does not affect chromosome capture by centrosomal 
microtubules (Tulu et al., 2006).  However, co-depletion of TPX2 with MCAK, or 
the addition of excess XMAP215 can rescue spindle formation (Groen et al., 2009). 
As described earlier, TPX2 is regulated by RanGTP and is required for 
spindle formation through the RanGTP pathway.  TPX2 is inactivated by importin-α 
binding which is displaced by RanGTP (Gruss et al., 2001).  A TPX2 mutant that 
shows reduced affinity for importin-α is constitutively active and induces the 
formation of microtubule containing aster-like structures in Xenopus egg extracts.  
However, although importin-α inhibits TPX2 induced microtubule formation, it does 
not inhibit TPX2 tubulin interaction or its ability to bundle microtubules (Schatz et 
al., 2003).  TPX2 has also been identified to activate the mitotic kinase Aurora A.  
RanGTP stimulates an interaction between TPX2 and Aurora A resulting in the 
phosphorylation of both proteins in a microtubule dependent manner (Tsai et al., 
2003).  TPX2 and microtubules induce Aurora A phosphorylation by prevention of 
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protein phosphatase I.  This de-phosphorylation results in a kinase gradient on the 
microtubules and regulates spindle assembly and dynamics (Tsai et al., 2003).  The 
interaction of these two proteins is inhibited by importin-α resulting in no Aurora A 
activity or recruitment to microtubules (Trieselmann et al., 2003). 
 
NuMA 
Nuclear mitotic apparatus protein (NuMA) is a 236 kDa coiled-coil protein which is 
a component of the nuclear matrix and the aster promoting activity complex (Sun and 
Schatten, 2006).  The localisation of the NuMA protein is cell cycle-regulated.  In 
interphase NuMA is restricted to the nucleus of the cell.  Indirect 
immunofluorescence in human cells showed NuMA to concentrate to the polar 
regions of the mitotic apparatus during mitosis (Lydersen and Pettijohn, 1980).  This 
localisation is dependent on the integrity of the mitotic spindle.  Closer analysis 
identified more specific cell-cycle localisation; in prophase NuMA localises in the 
vicinity of centrosomes.  It becomes localised to the poles in metaphase, with a 
crescent shape localisation at poles in anaphase.  Lastly in telophase, NuMA is 
localised to the newly formed sister nuclei (Kallajoki et al., 1991).  Again these 
specific localisations are dependent on the presence of functional microtubules. 
NuMA is essential for the formation and early function of the mitotic spindle.  
In a cell free system for the assembly of mitotic asters the depletion of NuMA results 
in the formation of dispersed microtubules instead of organised asters (Gaglio et al., 
1995).  In Xenopus egg extracts, depletion results in chromatin associated with 
irregular microtubule arrays which lack characteristic spindle poles (Gaglio et al., 
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1995; Merdes et al., 1996).  The injection of monoclonal NuMA antibody into 
interphase and prophase HeLa cells showed inhibition of the mitotic spindle 
formation.  Cells remained in a prometaphase state (Kallajoki et al., 1991).  Antibody 
injection during metaphase shows spindle collapse into monopolar spindles (Yang 
and Snyder, 1992).  In contrast, antibody microinjection during anaphase resulted in 
fewer defects, suggesting NuMA is required early in mitosis (Kallajoki et al., 1993). 
The cell cycle localisation and function of NuMA is regulated by 
phosphorylation.  Mutation of a predicted p34
cdc2
 phosphorylation site abolishes 
NuMA association with spindle microtubules and poles.  This results in spindles that 
are disorganised and micronuclei are formed as seen with NuMA depletion 
(Compton and Luo, 1995).  However this mutation does not affect NuMA 
localisation to the nucleus.  NuMA associates with the dynein/dynactin complex 
(Merdes et al., 1996), which is thought to translocate NuMA to the spindle poles 
(Sun and Schatten, 2006).  In anaphase NuMA is de-phosphorylated and dissociates 
from the dynein/dynactin complex and the spindle poles.  NuMA dissociation from 
the poles, allowing spindle disassembly and the reorganisation of the microtubule 
network into an interphase array (Gehmlich et al., 2004). 
NuMA is also thought to be regulated by RanGTP although the details of this 
regulation are not yet established.  NuMA interacts with the nuclear transport 
receptor protein importin-β which inhibits microtubule aster formation in Xenopus 
egg extracts (Wiese et al., 2001).  NuMA is released from importin-β by the 




Nucleolar spindle associated protein (NuSAP) is a 48 kDa protein which was first 
identified in a screen of cDNA expression patterns during proliferation of mouse 
MCSTSE1 oseteoblasts (Raemaekers et al., 2003).  NuSAP is similar to other Ran 
regulated proteins and is localised in the nucleus during interphase and on the spindle 
during mitosis.  Specifically, NuSAP localises to microtubules in the vicinity of the 
chromosomes during metaphase and early anaphase.  This chromosomal localisation 
is not dependent on microtubule integrity.  NuSAP was identified to directly bind 
DNA and it is therefore thought that NuSAP links chromosomes and microtubules 
(Ribbeck et al., 2007).  Depletion of NuSAP protein by siRNA in HeLa results in a 
number of mitotic phenotypes.  Prometaphase spindles are disorganised and 
frequently show abnormal chromosome condensation patterns.  Metaphase spindles 
are also less dense with disorganised microtubules and misaligned chromosomes 
(Raemaekers et al., 2003). 
 NuSAP is regulated by rapid degradation and the Ran pathway.  Importin-α 
and importin-β have been shown to associate with NuSAP and inhibit protein 
activity.  RanGTP releases NuSAP from importin-α and importin-β allowing NuSAP 
to regulate spindle function, microtubule bundling and stabilisation (Ribbeck et al., 
2006).  The protein NuSAP is described in further detail in 4.7.2. 
 
HURP 
Hepatoma upregulated protein (HURP) is a microtubule binding protein which was 
first identified in 2003 due to its differential expression in human hepatocellular 
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carcinoma (HCC).  HURP mRNA levels are regulated closely through the cell cycle 
and peak at the G2/M phase transition (Tsou et al., 2003).  In a functional genomic 
screen in HeLa cells, HURP was identified to be required for chromosome 
congression and alignment.  In HeLa cells HURP co-localises with the mitotic 
spindle with an increased concentration in the vicinity of the chromosomes (Wong 
and Fang, 2006).  The depletion of HURP results in the persistence of unaligned 
chromosomes and a reduced tension in inter sister kinetochore tension in HeLa cells 
(Koffa et al., 2006; Wong and Fang, 2006).  In vivo, HURP stabilises microtubules, 
promotes polymerisation, supports bipolar spindle formation and reduces spindle 
turnover.  As a result HURP plays an important role in spindle stability and dynamics 
(Wong and Fang, 2006).   
HURP was also identified to be a target of the Ran pathway.  HURP protein 
was determined to be a direct cargo of the nuclear transport protein importin-β.  The 
overexpression of a RanGTP mimic (RanQ69L) in COS7 cells resulted in increased 
association of HURP with the mitotic spindle.  In addition HURP is phosphorylated 
by the Ran regulate kinase Aurora A.  This phosphorylation increases the stability of 
the HURP protein (Yu et al., 2005). 
 
1.5.4 Regulation of MAPs by ubiquitination 
The ubiquitin ligase anaphase-promoting complex/cyclosome (APC/C) is essential 
for correct formation of the mitotic spindle.  Recently it was identified that the 
APC/C promotes the ubiquitination and degradation of four proteins required for 
spindle formation; Bard1, Hmmr, HURP and NuSAP (Song and Rape).  Similar to 
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other known APC/C substrates, all four proteins accumulate in HeLa cells arrested in 
mitosis and are degraded upon mitotic exit.  All proteins are absent from quiescent 
cells and co-expressed on cell cycle re-entry.  As described previously, HURP and 
NuSAP are also regulated by RanGTP and the importin proteins.  Interestingly 
HURP and NuSAP proteins are not degraded in HeLa cell extracts containing high 
levels of importin proteins.  In contrast Bard1 and Hmmr are effectively degraded in 
these conditions.  It is proposed that the degradation of NuSAP and HURP requires 
their release from importin-β by RanGTP.  The inhibition of APC/C-dependent 
degradation of NuSAP and HURP by importin-β during prometaphase is essential for 
spindle formation.   Equally, the degradation of excess HURP and NuSAP proteins 
by the APC/C is important to achieve accurate spindle formation (Song and Rape, 
2010).  The co-regulation of these proteins is therefore essential for cell cycle 
progression and spindle formation. 
 
1.6 Project aims and objectives. 
The microtubule network functions as a central framework in a number of different 
cellular processes and changes dramatically as cells progress through the cell cycle.  
In mitosis the interphase microtubule array is reorganised into the dynamic mitotic 
spindle which is crucial for the correct segregation of chromosomes during cell 
division.  This reorganisation is regulated by a group of proteins collectively called 
microtubule-associated proteins (MAPs).  However, little is known about the 
regulation of MAPs. 
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My hypothesis is that there are distinct groups of MAPs which associate and 
regulate microtubules at specific times during the cell cycle.  For example, as cells 
progress from interphase to mitosis, an interphase group of MAPs will disassociate 
and a mitotic group of MAPs will associate with microtubules (Figure 1.4).  This 
group of mitotic MAPs will be important for the correct formation and function of 
the mitotic spindle.  The aim of this study was to identify those MAPs which 
associate with microtubules specifically during mitosis and to understand their 
regulation and function. 
To fulfil this aim, I began the study with two specific objectives:   
1)  The development of a method for the identification of MAPs which associate 
with microtubules specifically during mitosis. 
2)  The characterisation of those proteins identified to associate with microtubules 
specifically during mitosis. 
 In this thesis I describe the work carried out to achieve these objectives and 











Both interphase and mitosis
Figure 1.4  Proposed model of microtubule associated protein regulation
from interphase to mitosis.  There are three distinct groups of microtubule 
associated proteins (MAPs) which associate with microtubules at specific 
times during the cell cycle.  As cells progress from interphase to mitosis, the 
interphase group of MAPs dissociate from microtubules and a group of 
mitotic MAPs associate with microtubules.  The third group of MAPs remain 
associated with microtubules in both interphase and mitosis.
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2. Materials and methods 
 
2.1 Supplier information 
All oligonucleotides used in this study were supplied by MWG-Biotech.  All 
chemical reagents (if not stated otherwise) were supplied by Invitrogen, Sigma-
Aldrich and Gibco.  All chemicals used were analytical grade.  Other kits and 
equipment used are stated below. 
 
2.2 Standard buffers and stock solutions 
Standard stock solutions and buffers were used throughout the study (Sambrook, 
1989).  Compositions of commonly used buffers were:  Protein sample buffer (50 
mM Tris pH6.8, 2 % SDS, 10 % Glycerol, 0.1 % Bromophenol blue); PBS (1.4 mM 
KH2PO4, pH 7.5, 4.3 mM Na2HPO4, 2.7 mM KCl, 137 mM NaCl); DEPC water 
(0.01 % DEPC added to water and stirred overnight); TBS (50 mM Tris HCl pH 7.4, 




The working dilutions of all primary and secondary antibodies used are shown in 
Table 2.1.   
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Table 2.1 Antibodies used in this study. 
Antibodies Dilution Blocking solution Company 
Primary antibodies    
Western blot    
MPM2 1:500 3 % milk, 0.05 % 




1:1000 3 % milk, 0.05 % 
Tween in TBS 
Upstate 
Rabbit anti-GFP 1:1000 3 % milk, 0.05 % 
Tween in PBS 
Molecular probes 
Immunofluorescence    
Mouse anti-tubulin 
(dm1a) 
1:250 10 % FBS in 0.1 % 
Triton X 100-PBS 
Sigma 
Rabbit anti-histone H3 
phosphate 
1:500 10 % FBS in 0.1 % 
Triton X 100-PBS 
Upstate 
Mouse anti-γ tubulin 
(GTU-88) 
1:1000 10 % FBS in 0.1 % 
Triton X 100-PBS 
Sigma 
Rat YOL 1/34 1:10 10 % FBS in 0.1 % 
Triton X 100-PBS 
Sigma 
Rabbit anti-GFP 1:500 10 % FBS in 0.1 % 
Triton X 100-PBS 
Molecular probes 
Secondary antibodies    








Anti-rabbit alexa flour 
488 
1:1000 10 % FBS in 0.1 % 
Triton X 100-PBS 
Molecular probes 
Anti-mouse alexa flour 
488 
1:250 10 % FBS in 0.1 % 
Triton X 100-PBS 
Molecular probes 
Anti-rat Cy3 1:500 10 % FBS in 0.1 % 
Triton X 100-PBS 
Jackson immuno 
research 
Anti-mouse Cy5 1:125 10 % FBS in 0.1 % 





2.4 DNA techniques 
2.4.1 Generation of NuMAP entry clone 
Gateway molecular cloning technology was used to generate entry clones.   The 
NuMAP coding sequence was amplified from NuMAP cDNA (LD43724) using Exl 
polymerase. The primers used are listed in Table 2.2.  The sequence highlighted in 
red corresponds to the specific sequences (attB sites) needed for recombination.  The 
PCR products were purified using the PCR cleanup kit (Qiagen) following the 
manufacturer’s instructions and used as a DNA template for a second PCR using 
attB1/attB2 primers shown in Table 2.2.  These primers encompass the remaining 
attB site sequence needed for recombination.  The PCR product was purified from 
agarose gel and BP recombination reactions were carried out following the 
manufacturer’s instructions (Invitrogen), using purified PCR product and 
pDONR221 plasmid.  Transformation was carried out using TOP10 cells 
(Invitrogen) as described by the bacteria manufacturer.  2.5 µl of BP reaction was 
used for 25 µl TOP10 cells.  Bacteria were plated on LB-plates, supplemented with 
the appropriate antibiotic and incubated at 37 C overnight.  Correct clones were 
identified from transformants by colony PCR and restriction digest.  Positive 
colonies were then confirmed by sequencing. 
 
2.4.2 Generation of NuMAP expression plasmids 
Expression plasmids were generated by LR recombination reactions using NuMAP 
entry clones and destination vectors (pAWG, pAGW, pPWG, pPGW obtained from 
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Table 2.2 Primers used for gene cloning. 

































Table 2.3 Expression plasmids generated using the gateway cloning 
system. 
Plasmid Number  
pHS18 MBP-CG11120 
pHS19 GST-CG11120 
pHS20 Ap GFP-CG11120 
pHS21 Ap CG11120-GFP 
pHS25 pUASp CG11120-GFP 
pHS26 pUASp GFP-CG11120 
pHS48 MBP-CG11120(548-754) 
pHS49 GST-CG11120(623-754) 
pHS50 Ap GFP-CG11120(548-754) 
pHS51 Ap GFP-CG11120(623-754) 




Drosophila Genomics Research Centre; pMAL-gateway and pGEX-4T-1-gateway 
previously generated in the lab).  LR reactions were carried out following the 
manufacturer’s instructions.  All expression plasmids created are shown in Table 2.3. 
 
2.4.3 Generation of plasmids to express NuMAP truncation 
NuMAP truncations were created using 4 different methods.  Green fluorescent 
protein (GFP)-NuMAP(548-754) and GFP-NuMAP(623-754) were created using the 
Gateway cloning system with primers suitable to amplify the corresponding region of 
protein.  The primers used are shown in Table 2.2.  GFP-NuMAP(0-44), (0-109), (0-
171), (0-227) and (0-404) were created by site-directed mutagnesis using the Quick 
change Kit (Invitrogen) to introduce premature stop codons.  All Quick change 
reactions were carried out using GFP-NuMAP plasmid as the template DNA 
following the manufacturer’s instructions.  Truncations GFP-NuMAP(623-729), 
(623-693) and (623-718) were also created by the introduction of premature stop 
codons from the GFP-NuMAP(623-754) expression plasmid.  The primers used for 
site directed mutagenesis are shown in Table 2.4.  GFP-NuMAP(0-57/232-754), (0-
57/537-754) and (0-57/609-754) were created using EcoRI endonuclease.  The GFP-
NuMAP plasmid contains a single EcoRI cleavage site 57bp from the start of 
NuMAP’s coding sequence.  Additional sites were firstly introduced by Quick 
change reactions at approximately 100 bp intervals in the NuMAP coding sequence.  
The resulting plasmids were digested and the DNA purified using the QIAquick Gel 
Extraction Kit (Qiagen) without actually running DNA on agarose gels.  The purified 





Table 2.4 Primers used to create CG11120 truncations. 























































































volume of 40 µl.  5 µl of ligation was transformed using 50 µl of TOP10 cells 
(Invitrogen) as described by the manufacturer.  Bacteria were then plated on LB-
plates supplemented with the correct antibiotic.  Positive transformants were 
identified by plasmid DNA purification using the QIAprep spin Miniprep kit 
(Qiagen) followed by plasmid digestion with appropriate restriction endonucleases.   
 
2.4.4 Generation of plasmid containing NuMAP NES fusion 
Full length NuMAP coupled to a nuclear export signal (NES) was created using two 
methods.  The NES coding sequence used was from the human protein PKI alpha.  
Firstly the Gateway cloning system was used to create an entry clone containing the 
NES-NuMAP fusion.  The forward primer used for the amplification of NuMAP 
coding sequence contained three specific sequences, one specific to the NuMAP 
gene, the NES coding sequence and attB1 sequence needed for the recombination 
reaction.  Primers used here are shown in Table 2.5.  An entry clone and the GFP 
expression plasmids were created using this amplified DNA fragment as described 
previously. 
Secondly, full length NuMAP coupled with an NES was also created using 
PCR and XhoI endonuclease.  PCR was used to amplify the NuMAP entry clone 
plasmid using primers which annealed to the beginning of the NuMAP coding 
sequence.  Both primers contained XhoI cleavage sites and the forwards primer also 
contained the NES coding sequence.  The PCR product was digested using XhoI and 
re-ligated using T4 ligase, to generate a new plasmid containing the NES-NuMAP 








Table 2.5 Primers used to create CG11120/nuclear export signal fusion. 
Construct Forwards Reverse 












































2.5 Techniques used for Drosophila cell line culture 
2.5.1 Drosophila cell culture 
The Drosophila Schneider 2 (S2) cell line was used for all RNA interference (RNAi) 
experiments, MAP purification and NuMAP localisation analysis.  The cells used for 
RNAi and NuMAP localisation analysis were cultured in Schneider media (Sigma) 
supplemented with 10 % heat-inactivated foetal bovine serum (Gibco) at 27 ºC in a 
humidified incubator.  Small cultures, less than 20 ml, were grown in 25 cm
2
 and 75 
cm
2
 flasks (Iwaki), and cultures over 20 ml were cultured in a spinner flask (Sigma). 
The cells used for microtubule co-sedimentation were cultured in stable 
isotope labelling by amino acids in cell culture (SILAC) conditions.  Media was 
made following the recipe for Schneider media (Sigma) omitting Arginine, Lysine 
and yeast extract.  Yeast extract at 200 mg/ml (Sigma) was dialysed overnight using 
dialysis tubing with a pore size of 1200 MW in a solution of 0.9 % NaCl.  Media was 
supplemented with 10 % heat inactivated dialysed foetal bovine serum (Gibco) and 
dialysed yeast extract to a final concentration of 2 mg/ml.  For ‘heavy’ culture 
conditions, 
13
C arginine and 
13
C lysine were added to 3.4 mM and 2.8 mM.  For 
‘light’ culture conditions 
12
C arginine and 
12
C lysine were used at the same 
concentrations.  All S2 cell cultures were kept at a cell density between 0.5 x 10
6
 







2.5.2 S2 cell transfection 
3.5 x 10
6
 cells were transfected with 0.4 µg DNA of interest using the Effectene 
transfection reagent (Qiagen) following the manufacturer’s instructions.  Healthy 
growing cells at a density of 6 x 10
6
 cells/ml were diluted to a density of 2.5-3 x 10
6
 
cells/ml.  After 24 hours, 3.5 x 10
6
 cells were seeded with fresh media in a 6-well 
plate at a final volume of 1.6 ml.  0.4 µg DNA of interest was diluted to a final 
volume of 100 µl with DNA condensation buffer (Buffer EC), 3.2 µl of Enhancer 
was added and the mixture incubated at room temperature for 5 min.  10 µl of 
Effectene solution was then added to coat DNA molecules with cationic lipids, 
mixed by pipetting and then incubated at room temperature for 10 min to allow 
transfection-complex formation.  After transfection-complex formation, 600 µl of 
growth media was then added and the mixture added drop wise to the seeded cells.  
The cells and transfection complex were mixed by pipetting and swirling to ensure 
even distribution of DNA complexes.  The cells were then cultured at 27 C for 24-
48 hours and examined by immunofluorescence. 
 
2.5.3 Generation of a stable S2 cell line expressing GFP-NuMAP 
To generate a cell line stably expressing GFP tagged NuMAP, S2 cells were 
transfected with 800 ng of GFP-NuMAP expression plasmid and 200 ng of vector 
containing blastidicin resistance gene using Effectene.  The transfected cells were 
then cultured under normal conditions for 2 days.  The culture was then diluted 2:1 
with fresh media containing 25 µg/ml blastidicin for selection.  Cells were cultured 
for a further 3 weeks in the presence of blastidicin.  After this period the blastidicin 
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was removed and cells cultured under normal conditions.  No clones were isolated 
resulting in a diverse population with varying expression levels between cells. 
 
2.5.4 Mitotic arrest of S2 cells 
To obtain cell cultures enriched in mitotic cells, confluent S2 cell cultures (6 x 10
6
 
cells/ml) were diluted with fresh media to a concentration of 0.5 x 10
6
 cells/ml and 
colchicine added to a final concentration of 12 µg/ml. Cultures were incubated with 
colchicine for approximately 24 hours to obtain mitotically enriched cell populations.  
Longer incubations with colchicine resulted in increased frequency of cell death and 
unhealthy cell populations.  Therefore colchicine incubation was not increased in 
SILAC cultures with longer generation times. 
 
2.5.5 RNA interference in S2 cells 
Double stranded RNA (dsRNA) used for silencing in S2 cells was produced by two 
rounds of PCR followed by in vitro transcription.  In the first round of PCR, 
approximately 600 bp of the largest exon of the target gene was amplified from 
genomic DNA.  For the preparation of genomic DNA for PCR, 1 male fly was 
homogenised in 40 µl of fly homogenising buffer (10 mM Tris, 1 mM EDTA pH8, 
25 mM NaCl, 200 µg/ml freshly added Proteinase K, (Roche)) and incubated at 37 
C for 30 min, followed by 5 min at 95 C.  1 µl of genomic DNA was used for a 
single PCR.   
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 The primers used for the first round of PCR began with 18 nucleotides 
corresponding to the minimal T7 promoter sequence (27 bp) followed by 18 gene-
specific nucleotides, as shown in Table 2.6.  The first round PCR product therefore 
carried an 18 bp inverted sequence at both ends.  This PCR product was then run on 
an agarose gel, purified using the QIAquick gel extraction kit (Qiagen) and used as 
template DNA in a second round of PCR.  For the second round of PCR, the minimal 
T7 promoter sequence (27 nt) was used as the primer for both sides.  This resulted in 
the addition of the rest of the promoter sequence at either end of the product. 
The second PCR product was purified using the PCR purification kit 
(Qiagen), quantified by spectrophotometry at 260 nm and used as template DNA in 
an in vitro transcription of both sense and antisense strands.  The transcription was 
performed using the MEGAscript T7 Kit (Ambion) following the manufacturer’s 
instructions.  The RNA was ethanol precipitated, re suspended in DEPC-treated 
water (RNase free) and the formation of dsRNA was induced by heating to 65 C for 
30 min and slowly cooling to 0 C.  dsRNA was run on an agarose gel, quantified by 
spectrophotometry and stored at -20 C. 
 To induce gene silencing, dsRNA was transfected into cells by adding it to 
culture medium.  Healthy cells at a density of 5-7 x 10
6
 cells/ml were diluted to 1 x 
10
6
 cells/ml with serum free culture medium and 15 µg of dsRNA was added to 1 ml 
of diluted cells.  After 1 hour of serum starvation, 2 ml of serum-containing media 
was added.  Cells were then incubated with dsRNA for 5 days and examined by 
immunofluorescene.  To obtain 8 days of gene silencing, cells were incubated with 
dsRNA for 5 days and then diluted back to 1 x 10
6






Table 2.6 Primers used for generation of dsRNA. 








































containing 15 µg of new dsRNA.  Again after 1 hour of serum starvation 2 ml of 
serum-containing media was added and cells cultured for a further 3 days and then 
examined by immunostaining. 
 
2.5.6 Immunostaining of S2 cells 
To prepare for immunostaining analysis, S2 cells were plated onto concanavalin A 
(Con A) coated coverslips.  Con A coated coverslips were prepared as follows; 
Coverslips (thickness 1mm, VWR International) were washed three times for 5 min 
in dH2O.  Coverslips were then treated with 0.5 M HCl for 30 min, washed three 
more times with dH2O (5 min each) and once with 100 % ethanol for 30 min.  
Coverslips were then air dried, dipped in 0.5 mg/ml con A (Calbiochem) solution, 
allowed to air dry again and stored at 4 C. 
 The cells were diluted to 5 x 10
6
 cells/ml with serum-containing media and 
plated onto Con A coated coverslips for 2 hours (Rogers et al., 2002).  Excess media 
was removed and adhered cells were fixed in cold methanol fix (90 % methanol, 3.5 
% paraformaldehyde, 5 mM Na2CO3 pH 9, prechilled on dry ice for 30 min) or 
paraformaldehyde fix (6.4 % paraformaldehyde in PBS).  For methanol fixation, 
cells were incubated in fix for 15 min on dry ice, 15 min at room temperature and 
washed twice in washing buffer (0.1 % Triton X 100 in PBS).  For paraformaldehyde 
fixation, cells were incubated in fix for 15 min at room temperature, in SDS solution 
(0.5 % SDS in PBS) for 15 min and finally washed in PBS.  Fixed cells were then 
stored at 4 C in PBS. 
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 For immunostaining, fixed cells were blocked for 1 hour in blocking solution 
(10 % Foetal bovine serum (FBS) in washing buffer), and incubated with primary 
antibodies diluted in blocking solution for 1 hour.  After three 5 min washes in 
washing buffer, cells were incubated for 1 hour with secondary antibodies diluted in 
blocking solution.  Again the cells were washed three times for 5 min followed by a 
10 min incubation with 0.4 µg/µl DAPI diluted in washing buffer.  Coverslips were 
finally washed twice with washing solution and once with PBS and mounted onto 
slides with mounting medium (85 % glycerol, 2.5 % propyl gallate).  Cells were then 
visualised using an Axioplan-2 fluorescent microscope (Zeiss) using x40 and x100 
magnification.  Images were obtained with a CCD camera (Hamamatsu) attached to 
the microscope controlled by Openlab 2.2.1 software (Improvision).  Exposure times 
were varied depending on signal quantity and image quality.  The images obtained 
were finally cropped and contrasted (if required) using Adobe Photoshop. 
 
2.6 Bacterial and fly strains 
2.6.1 Bacterial strains and culture 
The following bacterial strains were used for DNA cloning and protein expression:  
One shot TOP10 cells; Invitrogen, F-mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 
ΔlacX74 recA1 araD139 Δ(araleu) 7697 galU galK rpsL (StrR) endA1 nupG.  
XL1Blue;  recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F´ proAB 
lacIqZΔM15 Tn10 (Tetr)].   
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.  Bacteria were cultured in Luria-Bertani (LB) medium, or LB-agar plates 
supplemented with the appropriate antibiotic at 37 ºC or 18 ºC (Sambrook, 1989). 
 
2.6.2 Drosophila melanogaster culture 
Flies were grown on yeast cornmeal agar medium at 25 ºC or 18 ºC and standard 
techniques for Drosophila handling were used (Ashburner, 2005).  All fly lines used 
are shown in Table 2.7. 
 
2.7 Protein techniques 
2.7.1 SDS- polyacrylamide gel electrophoresis 
Throughout the study, standard protein techniques were used (Sambrook, 1989).  
Proteins were analysed by standard SDS-polyacrylamide gel electrophoresis (SDS-
PAGE).  Resolving gels (10 % acrylamide concentration) and stacking gels (5 % 
acrylamide concentrations) were made using the Mini-PROTEAN II (Biorad) 
System.  Electrophoresis was carried out in standard running buffer (250 mM 
glycine, 25 mM Tris, 0.1 % SDS).  For estimation of protein molecular weight, a 
standard protein marker was used (New England Biolabs, Prestained protein marker, 
Broad range).  Proteins were visualised in gel by Bio-Safe Coomassie (BioRad) 
following the manufacturer’s instructions, or by the use of an adapted silver staining 
technique adapted from Blum et al., 1987.  The gel was fixed for 1 hour in fix 







Table 2.7 Fly strains used in this study. 
Fly strain genotype Reference 
w
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and once in water for 20 min.  The gel was then sensitized in 0.02 % Na2S2O3 for 1 
min, washed three times for 20 seconds in water and incubated in silver solution (0.2 
% AgNO3, 0.02% formaldehyde) for 20 min at 4 C.  After three 20 second washes 
in water, proteins were visualised using developing solution (3 % NaCO3, 0.05 % 
formaldehyde).  When this was sufficient, development was stopped by washing the 
gel in 5 % acetic acid and finally stored in 1 % acetic acid at 4 C. 
Protein samples were prepared for mass spectrometry analysis by separation 
on Novex NuPAGE 1.5 mm 4-12 % Tris-glycine gels (Invitrogen) using MOPS 
buffer (Invitrogen).  To visualise protein bands, gels were fixed in 50 % methanol, 5 




For immunoblotting, proteins were transferred to nitrocellulose membrane in transfer 
buffer (25 mM Tris, 250 mM glycine) using the Mini-Trans Blot system (BioRad) 
following the manufacturer’s instructions.  To confirm homogenous transfer of 
proteins, the membrane was stained using the reversible protein stain MemCode Blue 
(Pierce).  Nitrocellulose membranes were then blocked for up to 2 hours (minimum 
of 1 hour) in either PBS or TBS containing 3 % skimmed milk and 0.05 % Tween 
20.  After blocking, membranes were incubated with the appropriate concentration of 
primary antibody diluted in suitable blocking solution.  Table 2.1 shows antibody 
dilutions used and appropriate blocking solutions.  The membranes were washed for 
a minimum of 1 hour in either PBS or TBS containing 0.05 % Tween 20 and then 
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incubated for 1 hour with the secondary antibody conjugated to horseradish-
peroxidase which was diluted in blocking solution.  Extensive washing was again 
carried out.  Secondary antibodies were then detected using an 
electrochemiluminescence (ECL) kit (Amersham) with exposure to Hyperfilm ECL 
(GE Healthcare). 
 
2.7.3 Protein expression and purification 
NuMAP fused to maltose binding protein (MBP) was expressed in the BL21 strain of 
Escherichia coli.  Bacteria containing expression plasmids were cultured in LB 
medium supplemented with 50 µg/ml ampicillin at 37 ºC overnight with constant 
shaking.  Cultures were diluted 1:100 in fresh LB medium and cultured at 37 ºC until 
an OD600 of 0.5 was achieved.  Protein expression was induced by the addition of 
isopropyl β-D-1-thiogalactopyranoside (IPTG) to 1 mM and cells were incubated at 
37 ºC for 3 hours.  After this 3 hour induction, cultures were centrifugated at 4000 
rpm for 15 min to pellet the cells and the supernatant was removed.  The cells were 
either processed directly or stored at -20 ºC. 
 Expressed maltose binding protein (MBP) fusion protein (MBP-NuMAP) 
was insoluble, therefore protein was purified from gel.  Cell pellets were re-
suspended in inclusion body (IB) buffer (100 mM NaCl, 1 mM EDTA, 50 mM Tris 
(pH8), 1 mM PMSF), and lysozyme was added to a final concentration of 1 mg/ml.  
Suspended cells were incubated on ice for 30 min and subjected to five rounds of 
freeze/thaw cycles, freezing in a dry ice ethanol bath and thawing in a 37 ºC water 
bath.  To break down DNA, the lysed suspension was sonicated on ice (1 min of 
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pulses of 5 s on 10 s off at 38 % amplitude using a Vibra-Cell Ultrasonic Processor, 
CV33 converter and 3 mm probe (Sonics)).  Insoluble material was obtained by three 
rounds of centrifugation at 8000 rpm for 10 min followed by re-suspension in IB 
buffer containing 0.1 % sodium deoxycholate.  The final insoluble pellet was re-
suspended in 1 ml of IB buffer.  The sample was boiled for 5 min after the addition 
of SDS sample buffer containing 5 % β-mercaptoethanol. 
 The insoluble material was separated by SDS-PAGE.  The expressed protein 
band was cut from gel and divided into 8 pieces.  Each piece was crushed and 
suspended in 700 µl of 0.2 M NaHCO3, 0.02 % SDS solution and the suspension was 
incubated at 37 ºC overnight with constant shaking to elute the protein.  The 
supernatant was collected and the protein concentration estimated by comparison of 
SDS-PAGE of sample and with a known amount of bovine serum albumin (BSA).  
The protein solution was then concentrated to a concentration of 1 µg/µl by 
evaporation using a Concentrator 5301 (Eppendorf). 
 
2.7.4 Peptide antibody production 
Peptide antibodies were produced and purified by Eurogentec.  Eurogentec identified 
regions likely to be exposed on the protein surface and chose two peptides suitable 
for antibody production.  These peptides were; Peptide 1, QNEETPRRSCRKSVR 
and Peptide 2, EVGKNSRKRGRKSKR.  Both peptide sequences lie close to the N-
terminus of the NuMAP (CG11120) protein.  Peptides were synthesised and a 
mixture used to inoculate two rabbits.  Antibodies were purified from crude serum 
using affinity purification with the above peptides.  Each peptide was bound to AF-
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amino TOYOPEARL 650M matrix and used to extract sequence specific antibodies 
from crude serum.  Eurogentec purified each peptide separately producing two 
antibodies.  The purity of the antibodies was analysed using a bioanalyser. 
 
2.7.5 Immunoprecipitation from S2 cells 
Stable cell lines expressing GFP-NuMAP and NuMAP-GFP were used to obtain cell 
extract for immunoprecipitation using rabbit anti-GFP antibody.  Cells not 
expressing the GFP fusion protein were used for a control extract.  4 x 10
8
 cells of 
each cell type were suspended in 4 ml of cold lysis buffer (100 mM NaCl, 20 mM 
Tris pH7.5, 5 mM EGTA, 1 mM DTT, 1 mM PMSF and Complete EDTA free 
protease inhibitor cocktail tablet (Roche)).  Cells were lysed by pulse sonication on 
ice (1 min of  pulses of 5 s on 10 s off at 38 % amplitude using a Vibra-Cell 
Ultrasonic Processor, CV33 converter and 3 mm probe (Sonics)).  After sonication 
Triton X-100 was added to a final concentration of 0.3 % and the lysate incubated on 
ice for 10 min.  To clear the lysate of insoluble material it was centrifugated at 13 
krpm for 10 min.  The pellet was discarded and centrifugation repeated.  The cleared 
lysate was then added to 20 µl (solid mass) of protein A agarose beads coated in 
rabbit anti-GFP antibody.  The beads were prepared by protein A agarose bead 
incubation with rabbit anti-GFP antibody (1/100 dilution) in 300 µl of PBS 
containing 0.5 % Triton X-100. 
After immunoprecipitation reactions were incubated for 30 min at 4C with 
rotation, beads were pelleted by centrifugation at 13K rpm in a bench- top centrifuge 
for 10 s.  Protein A agarose beads were washed 3 times for 5 min in lysis buffer with 
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0.3 % Triton X-100.  To elute the protein, immunoprecipitated beads were 
resuspended in SDS-PAGE protein sample buffer and analysed by SDS-PAGE 
followed by immunobloting with anti-GFP antibody or mass spectrometry. 
 
2.8 Microtubule co-sedimentation from S2 cell and embryonic extracts 
2.8.1 Microtubule co-sedimentation from S2 cell extract 
Cells were lysed in BRB80x buffer (80 mM Pipes-KOH(pH6.8), 1 mM MgCl2, 1 
mM Na3EGTA, 1 mM DTT, 1mM PMSF, Complete EDTA-free protease inhibitor 
cocktail tablets (Roche Applied sciences)).  Cells were lysed by sonication in 1 ml of 
buffer for every 1 x 10
8
 cells (1 min of pulses of 5 s on 10 s off at 38 % amplitude 
using a Vibra-Cell Ultrasonic Processor, CV33 converter and 3 mm probe (Sonics)).  
Following sonication, Triton X-100 was added to a concentration of 0.1 % and the 
lysate chilled on ice for 30 min.  The extract was cleared of debris using multiple 
steps.  Firstly the lysate was centrifuged at 55 krpm for 10 min at 4 C using a 
Optima TLX personal bench top ultracentrifuge with a TLA120.20 rotor.  The 
supernatant was removed and incubated at 30 C in a water bath for 20 min and 
again centrifuged at 55 krpm for 10 min at 4 C.  The supernatant was removed and 
repeated centrifugation carried out until no pellet was obtained.  From the final 
supernatant a sample of extract was taken. 
In parallel to extract preparation, 7.58 µg of porcine tubulin (from 
Cytoskeleton inc) was polymerised for every 1 x 10
8
 cells used to obtain protein 
extract.  The appropriate quantity of tubulin was diluted to a concentration of 5 µM 
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with BRB80x buffer supplemented with 1 mM GTP.  Stepwise addition of taxol to 
the final concentration of 20 µM was used to induce polymerisation and was then 
incubated at room temperature for 30 min.  Following polymerisation, microtubules 
were pelleted at 13 krpm in a bench-top centrifuge for 15 min and re-suspended in 
100 µl of taxol washing buffer (BRB80x supplemented with 20 µM taxol). 
DTT (to 0.1 mM), GTP (to 1 mM) and latrunculin A and B (2 µg/ml) were 
added to cleared extract and the extract split into two; the sample and the extract.  To 
the sample, taxol was added to a final concentration of 20 µM along with the 100 µl 
of washing buffer containing microtubules.  To the control, colchicine was added to a 
final concentration of 10 µg/ml and 100 µl of colchicine washing buffer (BRB80x 
supplemented with colchicine to 10 µg/ml).  The sample and control were then 
incubated at room temperature for 1 hour to allow for the binding of microtubule-
associated proteins.  After incubation, the sample and control were loaded on top of a 
300 µl 50 % sucrose cushion (50 % sucrose in BRB80x buffer with taxol for the 
sample and 50 % sucrose in BRB80x buffer with colchicine for the control) and 
microtubules pelleted through the sucrose cushion by centrifugation at 27 krpm for 
35 min at 20 C using a TLS-55 spinning bucket rotor.  Samples of the supernatants 
were taken, sucrose cushions removed and the pellets re-suspended in 300 µl of 
appropriate washing buffers (BRB80x supplemented with taxol or colchicine).  
Again microtubules were pelleted through a 50 % sucrose cushion.  Finally, the 
sample and control pellets were re-suspended in 50 µl of BRB80x buffer and stored 
at -20 C. 
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2.8.2 Microtubule co-sedimentation in Drosophila melanogaster embryonic 
extract 
Drosophila embryos were collected and aged according to standard techniques 
(Ashburner, 2005).  Adult flies were allowed to lay eggs on grape-juice agar plates at 
25 C for 4 hours.  Embryos (0-4 hrs) were first washed with 0.1 % Triton X 100 in 
water 3 times and then dechorionated in 100 % bleach for 3-5 min.  They were then 
washed thoroughly with 0.1 % Triton X 100 in water four times, followed by 
washing in water alone.  Any residual water was removed from the embryo 
collection and the collection frozen at -80 C.  Approximately 5 ml of embryos were 
used for one microtubule co-sedimentation experiment.   
For microtubule co-sedimentation, embryos were homogenised in 5 ml 
BRB80x buffer supplemented with 0.2 % Triton X 100 using a dounce homogenizer.  
The extract was incubated on ice for 30 min and then cleared of debris as follows.  
Firstly, large debris was removed by centrifugation at 20 krpm for 10 min at 0 C 
using the Beckman Avnati J25 centrifuge with the JA-25.50 rotor.  The pellet was 
then discarded and the supernatant was filtered through 0.2 µm MiniSart filters.  
Following filtration, the supernatant was centrifuged again at 20 krpm for 15 min and 
the pellet discarded.  To remove small debris, the supernatant was next centrifuged at 
55 krpm for 10 min at 4 C, as described with S2 cell extract.  The pellet was 
discarded and the supernatant incubated at 30 C for 20 min in a water bath.  Finally, 
the extract was then centrifuged repeatedly at 55 krpm for 10 min at 4 C until 
minimal pellet was obtained and a sample of extract was taken at this point.  Using 
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this cleared embryonic extract; microtubule co-sedimentation was carried out as 
previously described for S2 cell extract. 
 
2.8.3 Microtubule co-sedimentation in the presence of phosphatase 
inhibitors. 
Microtubule co-sedimentation in the presence of phosphatase inhibitors was carried 
out as described above, depending on cell type used.  However, all buffers used were 
supplemented with 15 mM NaVO4, 10 mM p-nitrophenyl phosphate and 1 µM 
okadaic acid to maintain cellular phosphorylation. 
 
2.9 Proteomic techniques 
2.9.1 Protein in gel digestion 
Protein samples were electrophoresed through Novex NuPAGE 1.5 mm 4-12 % Tris-
glycine gels (Invitrogen) using MOPS buffer (Invitrogen).  The gels were then fixed 
in 50 % methanol, 5 % acetic acid and proteins visualised using the colloidal blue kit 
(Invitrogen).  The protein lane of interest was sectioned, excised and processed 
following a standard trypsin digestion procedure (Shevchenko et al., 1996).  Proteins 
present in each gel section were reduced using 100 mM DTT in 50 mM ammonium 
bicarbonate for 30 min at 37 C, followed by alkylation with 55 mM iodoacetamide 
50 mM ammonium bicarbonate for 30 min at room temperature in the dark.  Proteins 
were then digested overnight at 37 C using 12.5 ng/µl trypsin (proteomics grade, 
Sigma).  Following digestion, the supernatant (digest) was acidified using 
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trifluoroacetic acid and desalted using StageTips (Rappsilber et al., 2003).  For mass 
spectrometry analysis, peptides were eluted from StageTips using 20 µl elution 
buffer (80 % acetonitrile, 0.1 % trifluoroacetic acid).  To ensure maximum peptide 
binding to the C18 material packed into the column needle, acetonitrile was 
evaporated off using a Concentrator 5301 (Eppendorf) and the volume of peptide 
solution adjusted to 5 µl with 0.1 % trifluoroacetic acid.  Each gel section was then 
analysed individually, with all 5 µl being used for liquid chromatography mass 
spectrometry/mass spectrometry (LC-MS/MS) analysis. 
 
2.9.2 Nano-LC-MS/MS analysis 
Following protein digestion using trypsin, the resulting peptides were analysed using 
an Orbitrap system (Finnigan LTQ-Orbitrap, Thermo electron), 1200 series nanoflow 
LC system (Aligent technologies) and a HTC PAL auto sampler (CTC analytics).  
Peptides were loaded onto a column needle  which had been prepared by packing 3 
µm Reprosil C18 materials (Germany) into Pico Tip Emitter silica tips (8±1 µm) 
under the pressure of nitrogen at a flow rate of 0.7 µm/min.  Mobile phases were (A) 
5 % acetonitrile, 0.5 % acetic acid and (B) 99.5 % acetonitrile, 0.5 % acetic acid.  A 
flow rate of 300 ml/min was used with a spray voltage of 1.8 kV.  Analysis was 
performed using either a two-step linear gradient of 0-20 % B in 35 min, 20-80 % B 
in 4 min and 80 % for 2 min or a two-step linear gradient of 0-20 % B in 75 min, 20-
80 % B in 13 min and 80 % B for 10 min.  The gradient used was determined by 
protein sample quantity and complexity estimated by colloidal blue staining.  Each 
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MS cycle consisted of one full MS scan acquired on the Orbitrap, followed by 
MS/MS scans of the six most abundant peptides in the ion trap.   
 
2.9.3 Database searching 
Peak lists were extracted from MS raw files using the MaxQuant Quant module (Cox 
and Mann 2008) or DTAsupercharge (V1.18).  Peaks lists extracted using 
DTAsupercharge were used in Mascot daemon (V2.2.0) to conduct an automated 
database search against the UniProt/SwissProt Drosophila melanogaster database.  
Search parameters were precursor mass tolerance of 10 ppm, fragmentation ion mass 
tolerance to 0.8 Da enzyme trypsin and allowance of 3 missed cleavages.  Peptide 
charge was set to 1+, 2+ and 3+.  Carboamidomethylation of cysteine was set as a 
fixed modification, with oxidation of methionines as a variable modification.  For 








) were also set as 
variable modifications.  Quantification of SILAC samples processed by 
DTAsupercharge and Mascot daemon were obtained using MSQuant followed by 
manual verification. 
 Peaks lists extracted using the MaxQuant Quant module, were also submitted 
to the Mascot search engine for an MS/MS ion search.  The search engine results 
were next processed using the MaxQuant Identify module which integrates and 
statistically validates peptides, assembling them into proteins.  The proteins were 
then quantified for a second time and results tables produced (Cox et al., 2009). 
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2.10 Drosophila techniques 
2.10.1 Imprecise excision of P-element 
The remobilisation of a P-element was used to create a NuMAP deletion mutant as 
described in the crossing scheme in Figure 2.1.  The P{EPgy2}Trf4-2
EY05585
 line was 
crossed to the ∆2-3 fly strain carrying the transposase gene and individual jump-
starter males where identified by their mosaic eye colour and the stubble (Sb) 
marker.  These jump-starter males from F1 were crossed with virgin females from 
the P{w
+
}/TM6B,Hu line (a source of balancer chromosome).  In F2, individual 
males showing P-element loss (eye colour revertant; white eye) were crossed to 





.  Male F3 flies carrying the excised P-element 
chromosome and deficiency chromosome were identified by their lack of Sb and 
humeral (Hu) marker chromosomes and were analysed by PCR for imprecise P-
element excision removing the NuMAP coding sequence.  The primer pair 
oHS90/oHS92 (shown in Table 2.8) was used to amplify a region of the NuMAP 
coding sequence.  The lack of amplification of this region indicated removal of the 3’ 
end of the NuMAP coding sequence.  Further PCR analysis was carried out to 
determine the full extent of NuMAP coding sequence removal.  All primers used to 
determine the extent of P-element excision are shown in Table 2.8 and Figure 2.2.  
From 115 successful crosses, 8 events removing part of the NuMAP coding sequence 













TM6B X Df (3R)BSC318TM6C ♀♀
Red eyes Orange eyes
Mosaic eyes Orange eyes
White eyes White eyes






Figure 2.1 Crossing scheme for NuMAP deletion by P-element excision.
The diagram shows the crossing scheme used to generate a NuMAP 
deletion by P element excision.  The transposase gene was introduced into the fly 
strain P{EPgy2}Trf4-2EY05585 containing the P element P{EY05585}.  Males 
containing both transposase (Δ2-3)  and P{EY05585} were crossed
with virgin females containing a balancer chromosome (P{w+}/TM6B).  Male
flies which had lost P{EY05585} and contained the balancer chromosome (TM6B)
were crossed with virgin females of a fly strain with a deficiency in which the
NuMAP gene is deleted.  Males containing the deficiency chromosome and 










Table 2.8 Primers used to detect P-element imprecise excision events. 

















































Figure 2.2 Characterisation of imprecise excision events.  
Genomic localisation of primers used for imprecise excision events.  Primers
oHS90 and oHS92 were used to screen for deletion of NuMAP coding 
sequence.  Other primers were used to assess the size of NuMAP deletion.
These are not shown for simplicity.Further analysis is needed to ensure no 
deletion of gene upstream of NuMAP.  
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2.10.2 Fly transformation 
Transgenic flies carrying GFP-NuMAP or NuMAP-GFP were generated by the 
company Genetic Services Inc using P-element transformation.  w
-
 pre-blastoderm 
embryos were injected with plasmids containing GFP-NuMAP and NuMAP-GFP 
along with a helper plasmid which encodes transposase and enables P-element 
insertion into the genome.  Both transgenes were cloned in the pUASp vector which 
carries the mini-w
+
 marker and therefore transformants were identified by their 
orange eye colour.G0 adults were crossed with w
1118
 flies. 
The insertion sites of the transgenes were mapped to specific chromosomes 
by each transgeneic fly line being crossed with a fly line carrying a marked 
chromosome II balancer (CyO) and a marked chromosome III balancer (TM6C, Sb).  
Flies from F1 carrying the transgene and both markers were then crossed with w
1118
 
virgin females and chromosome segregation followed using chromosome markers.  
The chromosomal locations of the transgenes were identified by the chromosomal 
segregation patterns observed.  For example, if the transgene was inserted on the II 
chromosome, no flies with orange eyes would be seen to carry the chromosome 2nd 
marker (CyO). 
 
2.10.3 Live imaging of NuMAP in Drosophila embryos  
Drosophila embryos were collected and aged according to standard techniques 
(Ashburner, 1989).  To obtain early embryonic stages, transgenic flies (GFP-NuMAP 
and NuMAP-GFP) were allowed to lay eggs on grape-agar plates for 1 hour at 25 C 
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and aged for another hour at 25 C.  To enable clear visualisation, embryos were 
dechorionated by dissection, adhered to the coverslip surface and covered with 
halocarbon oil (700).  Mitotic division in the syncytial embryo was then observed 
using an Axiovert (Ziess) microscope with a spinning disc confocal head 
(Yokogawa) with an Apochromat 63x lens and movies were acquired using the 
Volocity software.  A series of z-sections (15 x 0.5µm slices) which covered an 
entire spindle were acquired.  Due to the rapid progression of mitosis in the embryo, 
no delay between acquiring Z stacks was used. 
 
2.10.4 Live imaging of NuMAP in Drosophila meiosis I spindle 
Oocytes from homozygote transgenic matured adult females were dissected in 
halocarbon oil (700).  The meiotic I spindle was observed by using the Axiovert 
microscope with spinning disc confocal head.  A series of z-sections (separated by 
0.5 µm) which covered the entire spindle were taken every 20-35 s. 
 
2.11 Bioinformatics techniques 
Homology analysis of the NuMAP protein sequence was carried out using the Basic 
Local Alignment Search Tool (BLAST) at http://blast.ncbi.nlm.nih.gov/Blast.cgi.  
Further domain analysis was carried out using protein sequence analysis tools at 
http://bioweb.pasteur.fr/protein/intro-en.html and 
http://www.ch.embnet.org/software/COILS_form.html to predict coiled-coil protein 
regions. 
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3. Identification of microtubule associated proteins which associate 
with microtubules specifically during mitosis 
 
3.1 Background 
Microtubules are key components of all eukaryotic cells and play a major role in the 
segregation of chromosomes during mitosis.  The organisation and dynamics of 
microtubules change dramatically from interphase to mitosis and it is thought that 
these changes are regulated by a number of proteins which bind microtubules.  These 
proteins are collectively called microtubule-associated proteins (MAPs).  I 
hypothesised that there are a set of MAPs which associate with microtubules solely 
in mitosis, and play crucial roles in regulating the mitotic spindle.  Prior to this study 
a number of MAPs had been identified through different screening methods (Gatti 
and Baker, 1989; Kellogg et al., 1989), but few have been shown to exclusively 
associate with microtubules only in mitosis. 
In order to better understand the formation and regulation of the mitotic 
spindle, I decided to identify MAPs which show association to microtubules 
specifically during mitosis (mitotic-specific MAPs).  This chapter describes the 
development of a method for the identification of mitotic-specific MAPs.  It also 
discusses the subsequent identification of a mitotic-specific MAP, Nuclear 
microtubule associated protein (NuMAP), which is described further in chapter 4. 
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3.2 Development of a method for the identification mitotic-specific 
MAPs 
To identify mitotic-specific MAPs, a comparison of MAPs associated to 
microtubules during interphase and in mitosis was needed.  To accomplish this I 
isolated, identified and quantified MAPs from both cellular states. 
 
3.2.1 Optimisation of microtubule co-sedimentation in Schneider 2 cells 
As the first step, microtubule binding proteins from interphase and mitotic extracts 
needed to be purified and identified.  Microtubule co-sedimentation using 
Drosophila embryonic extract is a common and effective method for the isolation of 
MAPs (Hughes et al., 2008; Kellogg et al., 1989).  Embryonic extract has a high 
tubulin content and enables the polymerisation of endogenous tubulin in the presence 
of taxol.  However, Drosophila embryos were not suitable for obtaining a 
synchronised population for stable isotope labelling by amino acids in cell culture 
(SILAC, described in 3.2.2) and therefore I chose to perform microtubule co-
sedimentation using the Drosophila Schneider 2 (S2) cell line. 
For the identification of isolated MAPs, I decided to use mass spectrometry.  
Mass spectrometry is both a fast and sensitive method for the identification of 
proteins and also allows their relative quantification when in combination with 
SILAC (Bauer and Kuster, 2003).  As there was only one previous publication 
describing the purification of MAPs from S2 cells (Goldstein et al., 1986), my first 
aim was the optimisation of microtubule co-sedimentation in S2 cells. 
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S2 cell extract has a significantly lower quantity of tubulin compared to 
embryonic extract.  This lower tubulin content is supposed to be below the critical 
level for microtubule polymerisation, even in the presence of taxol.  Therefore 
microtubule co-sedimentation was first tried using the addition of microtubules 
polymerised from purified porcine tubulin.  This approach is illustrated in Figure 3.1.  
Briefly, S2 cell extract was obtained by sonication of S2 cells in BRB80, a buffer 
previously used for microtubule co-sedimentation.  This extract was cleared of 
insoluble material by repeated high speed centrifugation.  The cleared extract was 
divided into two, the sample and negative control.  Porcine tubulin was separately 
polymerised in BRB80 using GTP and taxol and added to the sample extract.  
BRB80 buffer containing colchicine was then added to the control.  Colchicine is a 
microtubule depolymerising drug and therefore was used to ensure the control would 
contain no microtubules.  Both the sample and control extract were then incubated at 
room temperature for 1 hour.  The incubation time allowed for proteins from the 
extract to bind microtubules.  The microtubules were then twice pelleted through a 
sucrose cushion, pulling down any associated proteins (Figure 3.1).   
Sample and control protein pellets were analysed by SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE) and silver staining.  Silver staining showed a number 
of proteins in the sample pellet.  In contrast, the control pellet contained no 
microtubules and showed less protein, but still contained a significant amount.  This 
result demonstrated that the use of exogenous microtubules could co-sediment 
MAPs.  However, this procedure also sedimented non-specific proteins which is 
most likely due to protein aggregation during co-sedimentation (Figure 3.2a). 
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S2 cells










Microtubule pellet and 
associated proteins
Sucrose cushion
Figure 3.1 Microtubule co-sedimentation protocol.  Schematic
representation of microtubule co-sedimentation from Drosophila 
S2 cells.  Cell extract is incubated with microtubules and then centrifuged
through a 50% sucrose cushion.  Only microtubules and their associated
proteins are able to pellet; all other proteins remain in the supernatant.
Sedimentation with colchicine is performed in parallel as a control.
 










Figure 3.2 Microtubule co-sedimentation in Drosophila S2 cells.  
(A)  Silver stain analysis of sample (S) and control (C) protein pellets.  The
control pellet, without microtubules, contains a significant number of 
aggregating proteins.  (B)  Silver stain analysis of sample and 
control protein pellets.  Cell extract was prepared differently than that used
to obtain pellets in (A).  During extract preparation, extract was warmed
at 30 °C for 20 min.  The extract was then repeatedly centrifuged to
remove all aggregating proteins. The control pellet showed that few proteins 
















To remove all aggregating proteins before co-sedimentation, the S2 extract 
was warmed during extract clearance.  The extract was first centrifuged to remove 
insoluble material and then was next warmed to 30 C for 20 min.  This allowed for 
any protein aggregates to form rapidly.  The extract was then centrifuged repeatedly 
until no pellet was visible and this cleared extract used for microtubule co-
sedimentation.  Silver staining of the control pellet showed minimal protein content, 
indicating that after warming, few proteins aggregated during co-sedimentation 
(Figure 3.2b).  Therefore the remaining proteins in the sample pellet were most likely 
microtubule binding proteins. 
If proteins associate with microtubules at precise times during the cell cycle, 
they are most likely regulated by a post-translational modification.  Therefore to 
identify proteins whose microtubule associations are regulated, it is crucial to 
maintain major post-translational modifications during MAP purification.  
Phosphorylation is a key post-translational modification and is known to play a 
significant role in cell cycle regulation of multiple proteins (Suryadinata et al., 2010).  
Therefore it is likely that phosphorylation will play a role in regulating MAPs and 
must be maintained during MAP purification.   
To maintain phosphorylation, phosphatase inhibitors can be used.  However 
when adding phosphatase inhibitors there were a number of factors which I needed to 
consider.  Firstly the phosphatase inhibitors used needed to maintain phosphorylation 
in S2 cell extract.  They also needed to be compatible with microtubule co-
sedimentation. Phosphatase inhibitors are often highly charged molecules and salt 
containing chemicals and therefore may affect the polymerisation of microtubules 
and the association of proteins.  Therefore I needed to identify a combination of 
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phosphatase inhibitors which maintained polymerised microtubules and did not 
affect the co-sedimentation of microtubule-associated proteins. 
Firstly, a mixture of common phosphatase inhibitors was assessed for their 
ability to maintain phosphorylation.  S2 cells were lysed in the presence of NaVO4, 
NaF, p-nitrophenyl phosphate and β-glycerophosphate (Mixture 1, Table 3.1).  The 
level of phosphorylation was assayed by western blot using MPM2, a monoclonal 
antibody identified to detect many mitosis-specific phosphorylations (Davis et al., 
1983) at serine and threonine (Zhao et al., 1989) Western blotting analysis showed 
significantly more MPM2 signal from cells lysed in the presence of phosphatase 
inhibitors than those lysed without.  This indicated phosphorylation within the S2 
cell extract was maintained by this mixture of phosphatase inhibitors (Figure 3.3).   
Next, the compatibility of this phosphatase inhibitor mixture with MAP 
purification was examined.  Microtubule co-sedimentation was carried out in the 
presence of the above phosphatase inhibitor mixture.  SDS-PAGE analysis followed 
by coomassie blue staining showed a lower amount of tubulin in the pellet when 
phosphatase inhibitors were used.  This suggested that microtubules were 
depolymerised under these conditions (Figure 3.4a). 
To overcome this problem, various combinations of phosphatase inhibitors 
were tested for the maintenance of phosphorylation and polymerised microtubules 
(Table 3.1).  One additional phosphatase inhibitor, Okadaic acid was introduced to 
the mixture.  Okadaic acid is a potent phosphatase inhibitor and thus enabled the use 
of lower concentrations of other phosphatase inhibitors.  Phosphatase inhibitor 
combinations were first tested for their capability to maintain phosphorylation by 
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Phosphatase inhibitor Mixture 
 1 2 3 4 5 6 7 8 
NaVO4 (mM) 20 20 20 20  20 15 10 
NaF (mM) 100 100 100  100    
p-nitrophenyl phosphate (mM) 15 15  15 15 10 10 10 
β-glycerophosphate (mM) 100  100 100 100    
Okadiac acid (as shown)  2 µM 2µM 2µM 2µM 1 µM 1µM 1µM 
         
Maintain phosphorylation YES YES NO YES YES YES YES NO 
Maintained polymerised 
microtubules 
























Table 3.1 Table of phosphatase inhibitor combinations.  This table shows the mixtures and concentrations of phosphatase 
inhibitors tested for the maintenance of phosphorylation and compatibility with microtubule (MT) co-sedimentation.  Some 





Figure 3.3  Maintenance of phosphorylation by phophatase 
inhibitor mixture (PI).  Drosophila S2 cells were lysed in the 
presence of a phosphatase inhibitor mixture 1 containing, NaVO4, 
NaF, p-nitrophenyl phosphate and β-glycerophosphate.  
Maintenance of phosphorylation was assayed using MPM2, an 
anti-phosphoserine/threonine antibody.  Phosphorylation was 










Coomassie Silver stain Silver stain
A B
Figure 3.4  Microtubule co-sedimentation with various phosphatase
inhibitor mixtures (PI).  (A)  Microtubule co-sedimentation sample pellet 
with mixture 1 (NaVO4,  p-nitrophenyl phosphate, β-glycerophosphate and NaF).  
Microtubules depolymerise in these conditions.  
(B)  Microtubule pellets with and without phosphatase inhibitor mixtures 5 
and 2.  Mixture 5:  NaF, p-Nitorphenyl phosphate, β-glycerophosphate and 
Okadiac acid (OA).  Mixture 2:  NaVO4, NaF, OA and p-Nitorphenyl phosphate.  
Microtubules remained intact in both phosphatase inhibitor mixtures.  The 
number of proteins which bound microtubules was higher in mixture 5.  
However, the number of proteins co-sedimented when no phosphatase inhibitors
were used was still significantly higher.
















western blot using MPM2.  Each combination which maintained phosphorylation 
was then further assessed for the maintenance of polymerised microtubules and co-
sedimentation.  Microtubule co-sedimentation was performed with the various 
combinations.  Each microtubule pellet was analysed using SDS-PAGE and silver 
staining (Figure 3.4b).  The pellet obtained in the presence of mixture 5 (NaF, p-
nitrophenyl phosphate, β-glycerophosphate and Okadaic acid) contained a significant 
quantity of tubulin and the largest number and quantity of other proteins. 
In addition to microtubule depolymerisation I also noticed that the presence 
of phosphatase inhibitors did reduce the quantity and number of proteins which co-
sedimented with microtubules (Figure 3.4b).  There were two possible reasons for 
this reduction.  Firstly, phosphorylation significantly reduces the number of proteins 
which bind microtubules.  Alternatively, independently of maintaining 
phosphorylation, phosphatase inhibitors chemically affect the binding of proteins to 
microtubules.  To distinguish between these two possibilities, microtubule co-
sedimentation was carried out in the absence of phosphorylation but in the presence 
of phosphatase inhibitors.  S2 cell extract was prepared in the absence of phosphatase 
inhibitors, allowing phosphorylation to be removed by active phosphatases.  
Phosphatase inhibitors were then added to the extract and co-sedimentation carried 
out.  In parallel co-sedimentation was carried out without the addition of phosphatase 
inhibitors.  Analysis of microtubule pellets by silver stain showed the pellet 
containing phosphatase inhibitors had fewer associated proteins (Figure 3.5a).  This 
result showed that the reduction in the binding of proteins to microtubules is due to 



















Figure 3.5  Optimisation of phosphatase inhibitor mixture for 
microtubule co-sedimentation.  (A)  The presence of phosphatase inhibitors
reduces the number of proteins which bind microtubules.  Microtubule 
co-sedimentation in the absence of phosphorylation but in the presence of 
phosphatase inhibitors, mixture 5 (NaF, p-nitrophenyl phosphate, β-glycerophosphate 
and okadaic acid).  Microtubule pellets were analysed by silver stain.  
(B)  Drosophila S2 cells were lysed in the presence of decreasing 
concentrations of NaVO4.  The maintenance of tyrosine phosphorylation was 
assessed by immunoblot with anti-phosphotyrosine.  Two bands (indicated by
arrowheads) showed reduced signal in extract obtained with a NaVO4 
concentration of 10 mM and 5 mM.  (C)  Microtubule pellets obtained in the 
presence and absence of final concentration of phosphatase inibitor 
mixture 7; 15 mM NaVO4, 10 mM p-nitrophenyl phosphate and 1 uM 
okadaic acid.  Co-sedimentation with this phosphatase inhibitor combination 
purified a comparable number of MAPs to those purified in the absence of 

















As I mentioned earlier phosphatase inhibitors are often salt based chemicals.   
Three of the phosphatase inhibitors used here were sodium salts, β-glycerophosphate, 
p-nitrophenyl phosphate and NaF.  Therefore, the phosphatase inhibitor mixture 
probably contained a high concentration of sodium ions (Na
+
).  High sodium ion 
concentrations can disrupt protein-protein interactions, suggesting that high Na
+
 was 
the reason for the reduction in protein binding to microtubules.  I also observed that 
the phosphatase inhibitor that inhibits tyrosine phosphatase (NaVO4) had been 
inadvertently omitted for the mixture.  Although tyrosine phosphorylation is less 
common than serine and threonine phosphorylation, NaVO4 was reintroduced to 
maintain tyrosine phosphorylation.  This raised the Na
+
 concentration of the mixture 
even further.  Therefore, to reduce the Na
+
 concentration, both β-glycerophosphate 
and NaF were removed from the mixture.   
To reduce the Na
+
 concentration further, the concentration of NaVO4 was 
decreased.  S2 cell extracts were obtained using gradually reducing concentrations of 
NaVO4 in combination with other phosphatase inhibitors (Table 3.1).  The lowest 
concentration to maintain tyrosine phosphorylation was assessed by western blot 
using an anti-phosphotyrosine antibody (Figure 3.5b).  Cell extract obtained using 15 
mM NaVO4 showed significant signal with anti-phospho tyrosine antibody.  
However, the signal was reduced when a concentration of 10 mM was used (Figure 
3.5b).  This result showed that 15 mM was the minimum concentration of NaVO4 
needed to maintain tyrosine phosphorylation. 
This final combination of phosphatase inhibitors, shown to maintain 
phosphorylation (15 mM NaVO4 10 mM p-nitrophenyl phosphate and 1µM Okadaic 
acid), was next tested further for its compatibility with co-sedimentation.  
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Microtubule co-sedimentation was performed with and without the phosphatase 
inhibitors and the pellets analysed by SDS-PAGE and silver stain.  Both microtubule 
pellets showed a similar amount of protein and band pattern.  This result showed that 
co-sedimentation with this phosphatase inhibitor mixture purified a comparable 
number and quantity of MAPs to co-sedimentation in the absence of phosphatase 
inhibitors (Figure 3.5c).  From this work the final phosphatase inhibitor mixture 
chosen for further use was:  15 mM NaVO4, 10 mM p-nitrophenyl phosphate and 1 
µM okadaic acid. 
 
3.2.2 Optimisation of Stable isotope labelling by amino acids in cell culture in 
Schneider 2 cells 
To identify mitotic-specific MAPs isolated from interphase and mitosis needed to be 
quantitatively compared.  As mass spectrometry was the chosen method of MAP 
identification, it was decided to couple this method with stable isotope labelling by 
amino acids in cell culture (SILAC).  SILAC was chosen as it is a simple and 
accurate procedure which has been used in a variety of cell types to obtain relative 
protein quantities (Ong et al., 2002; Ong et al., 2003). 
SILAC relies on the incorporation of a ‘heavy’ (
13
C) or ‘light’ (
12
C) form of 
certain amino acids into cellular proteins.  Two populations of cells are cultured in 
identical media, with the exception that one contains ‘heavy’ and the other contains 
‘light’ (normal) forms of certain amino acids.  For example, cells can be cultured 
with arginine labelled with six 
13
C atoms, instead of the normal 
12
C.   The ‘heavy’ 
amino acid isotopes are incorporated into all newly synthesised proteins.  After a 
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number of cell divisions all instances of the amino acid, are replaced by their 
analogue.  Next, the two cell populations are mixed in an equal ratio and after 
protease digestion are analysed by mass spectrometry.  Chemically identical peptides 
containing different isotopes can be differentiated in the mass spectrometer by their 
mass shift.  For example, those peptides containing a single arginine 
13
C will have a 
mass shift of 6 Da compared to the 
12
C counterpart.  The ratio of peak intensities of 
such peptides reflects the relative quantities of the protein in the two cell populations 
(Figure 3.6).  Although SILAC is a powerful and widely used method, at this stage 
its use in S2 cells had not been published.  Therefore the establishment of SILAC in 
S2 cells was necessary for this study. 
To gain full incorporation of the isotope labelled amino acid, all other sources 
of amino acids must be removed from the culture media.  As standard S2 cells are 
cultured with 10 % foetal bovine serum (FBS), this is an alternative source of amino 
acids in the media.  Therefore, SILAC cells were cultured in media containing 
dialysed FBS.  S2 cells grew in these conditions however their doubling time 
increased two-fold. 
Trypsin digestion is commonly used to create peptides for mass spectrometry 
analysis.  Trypsin is a protease which cleaves polypeptide sequences after arginine 
and lysine.  By using arginine and lysine for isotope-labelled culture coupled with 
trypsin digestion all peptides will be labelled.  I therefore decided isotope labelled 
arginine and lysine were most suitable for use in this experiment. 
However, arginine can be converted to proline in the cell.  This conversion 
results in ‘heavy’ proline in cells cultured in isotope labelled arginine media.  The 
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Ratio = Relative quantities
Figure 3.6  Schematic representation of Stable isotope labelling by 
amino acids in cell culture (SILAC).  Cells are cultured in ‘Heavy’ or ‘Light’
arginine media.  Cells are mixed and protein purification carried out.  
Chemically identical peptides containing different isotopes are differentiated 
by the their mass shift in the mass spectrometer.  The ratio of peak intensities




production of ‘heavy’ proline creates an additional peptide signal affecting the ability 
to quantify peptides containing proline.  To prevent this conversion the arginine 
concentrations in the media needs to be optimised.  By reducing the concentration of 
arginine, the conversion and the quantity of ‘heavy’ proline is reduced, however this 
must be balanced with cell growth.  In order to optimise the arginine concentration, 
cells were cultured in media with 3.4 mM (standard media concentration), 1.7 mM, 
1.1 mM and 0.84 mM arginine.  Lysine concentrations were also reduced to enable 
minimal use of isotope-labelled amino acids.  S2 cells grew normally in all culture 
conditions.  To measure the degree of conversion to proline, extracts from each 
culture condition were analysed by mass spectrometry.  The spectrum of proline 
containing peptides showed a minimal intensity of ‘heavy’ proline labelled peaks at 
all arginine concentrations (Figure 3.7a).  I therefore concluded that the conversion 
of arginine to proline was negligible in S2 cells and decided to continue with SILAC 
culture using standard amino acid concentrations. 
 When analysing the spectrum I noticed that there was still an 8.9 % ‘light’ 
peak for each peptide, indicating that full incorporation of the ‘heavy’ isotope was 
not obtained (Figure 3.7a).  This was likely due to the one remaining source of ‘light’ 
arginine and lysine in the media, which was yeast extract.  To overcome this, I first 
tried to culture cells without any yeast extract, however S2 cells failed to grow in 
these conditions.  The yeast extract was therefore dialysed overnight and added to 
SILAC media.  These conditions supported cell growth and to assess for full 
incorporation, the cell extract was analysed by mass spectrometry.  Although a 2.9 % 
‘light’ peptide signal was still present, it was not significant and was acceptable to 




Figure 3.7  Analysis of isotope incorporation and conversion.  Cell 
extract from cells cultured with 3.4 mM ‘heavy’ arginine were analysed by 
mass spectrometry.  (A)  MS spectrum showing mass/charge ratio for 
pepide of interest.  A  ‘heavy’ peptide peak was identified at 491.74 (blue),
with the charge state of the peptide determined to be 2 +.  There is a 
minimal peak (green) for the peptide containing ‘heavy’ proline.  A ‘light’ 
peptide peak was also identified at 488.73 (red).  (B)  MS spectrum 
obtained when cells cultured with dialysed yeast extract.  The ‘heavy’ 
peptide peak was present, with a smaller ‘light’ peptide peak.
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dialysed FBS and yeast extract, S2 cells showed normal microtubule arrays.  I could 
therefore assume cells cultured in these conditions to be wild-type. 
 
3.2.3 Optimisation of SILAC and microtubule co-sedimentation for MAP 
quantification 
The next step was to test the protocol for the quantification of MAPs.  Although from 
previous analysis of co-sedimentation from S2 cells I had identified multiple MAPs, 
it was still unknown if the protocol was able to quantify a sufficient number of MAPs 
by mass spectrometry.  The population of cells cultured within ‘light’ media were 
enriched in mitosis by treatment with colchicine, a microtubule depolymerising drug.  
Those cultured in ‘heavy’ media were left untreated and taken to be ‘interphase’ 
cells.   
To identify those proteins that bind microtubules specifically in mitosis, I 
needed to ensure that the two cell populations had significantly different mitotic 
indices.  Drosophila culture cells, including S2 cells, do not arrest efficiently in 
mitosis in the presence of microtubule poisons, including colchicine.  Therefore for 
each experiment, the mitotic index of both the interphase and mitotic enriched cells 
needed to be confirmed.  To measure the mitotic index, a sample of cells was taken 
and adhered to concanavalin A coated coverslips.  The cells were then fixed and 
immunostained with anti phospho-H3.  Histone H3 is phosphorylated at serine 10 
(H3P) during mitosis (Hans and Dimitrov, 2001) and therefore was used to identify 
mitotic cells.  The mitotic index was calculated by dividing the number of anti 
phospho-H3 positive cells by the total number of cells counted.  The mitotic indices 
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were 0.5 % and 22 % for the interphase and mitotic cells respectively.  Although the 
mitotic index of the arrested cells was not very high, the difference between the 
interphase and mitotic enriched population was significant.  This difference was 
sufficient for the identification of mitotic-specific MAPs, although it was not 
possible to identify any interphase specific MAPs from this experiment.  The two 
cell populations were then mixed in equal numbers and used for co-sedimentation 
with phosphatase inhibitors.   
Next, each element of co-sedimentation was analysed individually.  Firstly, 
the sample and control pellets were analysed by silver staining after SDS-PAGE.  
The sample pellet contained a significant number of proteins and in contrast the 
control pellet contained minimal, if any proteins (Figure 3.8a).  This result showed 
that those proteins within the sample pellet were proteins that bound specifically to 
the microtubules. 
Secondly, the maintenance of phosphorylation was assessed by western blot 
using MPM2 antibody.  To monitor the level of phosphorylation throughout the 
experiment, samples were obtained during co-sedimentation.  A sample of the total 
extract was taken before it was split into experimental sample and control.  Samples 
of the supernatants after microtubules had been pelleted, were taken from both the 
experimental sample and control.  All three samples were then analysed by western 
blot using MPM2 and the signal obtained was compared to that of an S2 cell extract 
obtained by cell lysis in SDS sample buffer.  Direct denaturation of proteins by SDS 
sample buffer should have maintained cellular phosphorylation in this extract.  
Supernatants showed significant signal, confirming that phosphorylation was 














































Figure 3.8  Microtubule co-sedimentation analysis.  Analysis of first
quantification of MAPs (A)  Silver stain analysis of microtubule pellets from
sample (S) and control (C) using SILAC cultured cells.  Sample pellet contains
tubulin and MAPs.  The control pellet contains minimal protein.
(B)  Immunoblot with MPM2 of samples during microtubule co-sedimentation
in the presence of phosphatase inhibitors (PI).  Phosphorylation was maintained










After experimental parameters had been confirmed as above, samples were 
analysed by mass spectrometry.  The microtubule pellet was run on SDS-PAGE and 
the gel was cut into sections. In-gel digestion by trypsin was then carried out on each 
section.  Each digest was desalted and concentrated using a C18 stage tip (Rappsilber 
et al., 2003) and run on an liquid chromatograpghy mass spectrometry/mass 
spectrometry (LC MS/MS) Orbitrap.  The spectrum was then processed using 
DTAsupercharge and Mascot.  DTAsupercharge processes the spectrum into peak 
lists which are then used by Mascot (Mortensen et al., 2010).  Mascot searches this 
peak list for a match to theoretical peptide masses calculated from a sequence 
database, identifying those proteins present in the sample (Perkins et al., 1999).  
Finally the data was processed using MSQuant, a program which extracts 
corresponding mass spectrum peaks and subsequently calculates each protein ratio 
(Mortensen et al., 2010).  From the data obtained, in total only 59 proteins were 
identified.  Moreover, of these, only 10 proteins were identified by three or more 
peptides and could be reliably quantified.  This indicated that the method needed to 
be improved in order to quantitate a significant number of MAPs. 
 Large quantities of a single peptides can mask other proteins in the mass 
spectrometer.  The co-sedimentation microtubule pellet contained a large amount of 
tubulin which will result in a large number of single peptides.  The high 
concentration of tubulin is therefore the likely cause of the low number of quantified 
MAPs.  To overcome this, I needed to identify the lowest quantity of exogenous 
tubulin that would co-sediment the maximum quantity of MAPs.   
Microtubule co-sedimentation was performed with varying quantities of 
polymerised tubulin.  For each co-sedimentation experiment, 1 x 10
8
 cells were used.  
90
The quantity of MAPs pulled down was monitored by silver stain and western blot 
after SDS-PAGE.  Silver staining showed that the quantity of MAPs which co-
sedimented decreased between the use of 7.5 µg and 5 µg of tubulin.  This was also 
confirmed by western blot using an antibody against the protein Mini spindles 
(Msps), a previously studied MAP (Figure 3.9).  The quantity of Msps present in the 
microtubule pellet was also reduced between the use of 7.5 µg and 5 µg of tubulin.  
The results showed collectively that the optimum ratio between the number of S2 
cells and the quantity of tubulin used was 1 x 10
8
 cells for 7.5 µg of tubulin.  This 
ratio was roughly comparable to that seen naturally in embryonic extract, further 
supporting the use of these proportions. 
 The protocol using reduced amounts of tubulin was next tested to determine 
the number of quantifiable MAPs.  The sample was processed as above.  For details 
of results see 3.3.1.  However, this time the resulting spectra were processed using 
the newer, more sophisticated MaxQuant.  MaxQuant is a quantitative software 
package designed for the quantitation of high resolution SILAC mass spectrometry 
data (Cox and Mann, 2008; Cox et al., 2009) and incorporates all the steps needed 
for computational proteomics processing.  However, it does use Mascot to generate 
peptide candidates for each peptide spectrum.  MaxQuant first identifies peaks by 
fitting a Gaussian curve to raw data points in each mass spectrum scan.  These are 
then assembled into 3D peak hills over the mass/charge-retention time plane.  SILAC 
pairs are identified by grouping those peaks at the correct distance for isotope 
labelling with correlated Gaussian curves.  Peptides are next identified by a database 
search using Mascot.  Peptide hits are assembled into proteins and the ratio median 












Figure 3.9  Optimisation of tubulin:cell extract ratio.  Microtubule 
co-sedimentation was carried out with various quantities of tubulin using
1 x 108 cells.  The quantity of MAPs purified was monitored by silver stain 
and immunoblot.  An antibody against the MAP Mini spindles (Msps) was
used for immunoblot.  The number of purified MAPs decreased with the use
of 5 µg tubulin.  The optimum ratio between cell number and tubulin was 
identified to be 7.5 µg tubulin : 1 x 108 cells.
µg Tubulin 10 7.5 2.55




normalised, correcting for any unequal protein loading assuming the majority of 
proteins show no difference.  From the data obtained, 271 proteins were quantified 
(see 3.3.1 for more details).  Using the minimum amount of tubulin to reduce 
masking of MAPs in the mass spectrometer and the use of a new data analysis 
procedure, the number of MAPs quantified was dramatically increased. 
 
3.3 Identification of mitotic-specific microtubule associated proteins 
To identify mitotic-specific MAPs relative quantification of MAPs from interphase 
and mitosis was carried out in duplicate.  Each experiment was analysed individually 
for mitotic arrest, the specificity of microtubule co-sedimentation and the 
maintenance of phosphorylation.  As each experiment had different mitotic 
enrichment levels, they were treated independently to identify mitotic-specific 
MAPs.  The final MAPs list was obtained by comparison of the results from both 
experiments. 
 For the first of the duplicate experiments as mentioned previously in 3.2.3, 
co-sedimentation using reduced amounts of tubulin was carried out and the sample 
processed.  The analysis showed that the percentages of H3P positive cells were 22 
% and 1.8 % of the mitotic enriched and interphase cells respectively.  The sample 
pellet contained a large number of proteins and the control pellet no detectable 
proteins (Figure 3.10a).  Western blot using MPM2 showed the supernatant to have a 
reduced but clear signal for phosphorylation (Figure 3.10b).  Together these results 
confirmed that MAPs had successfully been purified from a mixture of interphase 












































Figure 3.10  Microtubule co-sedimentation with SILAC exp 1.  (A)  
Microtubule co-sedimentation was carried out using cells cultured in 
SILAC conditions.  Silver stain analysis showed no detectable proteins in the
control (C) pellet identifying those in sample (S) pellet to be microtubule-
associated proteins.  (B)  Maintenance of phosphorylation in the presence 
of phosphatase inhibitors (PI) was assessed by immunoblot using MPM2.
Sample of supernantants were taken after microtubule co-sedimentation
and used for immunoblot.  Phosphorylation was reduced but maintained.
(C)  The sample microtubule pellet was fractioned by SDS-PAGE and





















microtubule pellet were next fractioned by SDS-PAGE and sectioned for trypsin in 
gel protein digestion (Figure 3.10c).  The peptide mixtures were analysed by mass 
spectrometry and the resulting data was processed using MaxQuant.   
In total 467 proteins were identified and ‘heavy’ / ‘light’ protein ratios were 
calculated for 271 of these (Table A2).  Figure 3.11 shows a functional classification 
of these 271 quantified proteins.  Protein ratios were then plotted against relative 
intensities and also the number of unique peptides (Figure 3.12).  If a protein 
associates with microtubules throughout the cell cycle, then ‘heavy’ / ‘light’ ratio 
will be equal to one.  Due to the use of the ‘light’ population as mitotic extract, any 
protein which binds to microtubules specifically in mitosis will show a small ratio, 
close to zero.  Taking into account the level of mitotic arrest, I calculated that if a 
protein bound exclusively to microtubules during mitosis its ‘heavy’ / ‘light’ ratio 
would be around 0.1.  I therefore applied a stringent cut off of 0.2 ‘heavy’ / ‘light’ 
protein ratio to the data (Table 3.2 and Figure 3.12).  This gave a shortlist of 15 
proteins whose ratio was below 0.2.  This list includes all exogenous proteins used 
during sample preparation as expected: tubulin, trypsin and bovine serum albumin 
(BSA).  Porcine tubulin was used during co-sedimentation.  Trypsin was used as the 
protease during in gel protein digestion and BSA was used as a standard protein for 
the assessment of the mass spectrometer performance.  Due to these proteins being 
exogenous, they were all composed of ‘light’ amino acids.  This results in them 
obtaining a low protein ratio during quantification.  These exogenous proteins were 
therefore removed from the ‘hit’ list.  This first experiment therefore results in a list 
of seven proteins which appear to associate with microtubules specifically in mitosis.  










Figure 3.11  Functional classification of 271 quantified proteins.  Pie 
chart representing the classification of quantified MAPs from experiment 1.
Classification was determined according to Gene ontology, supported by
manual data mining using Flybase.  This classification was carried out in
April 2010.  All proteins were grouped into five main categories
i) RNA/DNA associated, ii) Protein folding/degradation, iii) Other, 












































Figure 3.12  Graphic representation of SILAC data.  Protein ratios were
calculated by dividing peptide relative intensities, ‘heavy’/‘light’.  (A)  The 
protein ratio was plotted on a log scale against the relative intensity. 
(B)  The protein ratio was plotted on a log scale against the number of 
unique peptides.  A stringent cut off of 0.2 was applied to the data.  Those 
proteins to the left of this cut-off show increased binding to microtubules 



















































Table 3.2  Table of identified mitotic-specific MAPs.  Microtubule co-
sedimentation was used, with SILAC, to identify mitotic-specific MAPs.  The 
table shows those MAPs identified from experiment one with a H/L ratio 
below 0.55.  It also shows their protein ratios from experiment two if they 
were identified/quantified.  Those in red have protein ratios below the 
stringent cut-off of 0.2.  Those in blue have protein ratios below the less 
stringent cut-off of 0.55. 
CG 
Number 
Synonym Number of unique 
peptides 
Ratio ‘heavy’ / ‘light’ Identified 
but not 
quantified 
  Exp 1 Exp 2 Exp 1 Exp 2 in Exp 2 
CG2093 Vacuolar protein 
sorting 13 
1  0.0029  Not 
identified 
CG9359 β-Tubulin at 85D 16 14 0.0252 0.14124  
 
CG9476 α-Tubulin at 85E 13  0.0268  Not 
identified 
CG3401 β-Tubulin at 60D 13 11 0.0331 0.0113  
 
CG10390 Meiosis I arrest 1  0.0369  Not 
identified 
CG31315  1  0.0385   
 
CG2512 α-Tubulin at 84D 19  0.0578  Not 
identified 
CG3836 Stonewall 2  0.0651  Not 
Quantified 
CG9277 β-Tubulin at 56D 24 19 0.0809 0.0365  
 
 Porcine Trypsin 8 6 0.1070 0.224  
 
 Bovine Albumin 14  0.1883  Not 
identified 
CG9191 Kinesin-like protein 
at 61F 
8 12 0.1886 0.2492  
CG11120  6 5 0.1927 0.3030  
 
CG4869 β-Tubulin at 97EF 12 10 0.1949 0.1787  
 
CG4001 Phosphofructokinase 3  0.1981  Not 
Quantified 
CG13345 Tumbleweed 2 3 0.2796 0.8132  
 
CG10641  4  0.3419  Not 
identified 
CG1258 Pavarotti 18 9 0.3438 0.7808  
 








Synonym Number of unique 
peptides 
Ratio ‘heavy’ / ‘light’ Identified 
but not 
quantified 
  Exp 1 Exp 2 Exp 1 Exp 2 Exp 2 








2  0.4531  Not 
identified 
CG1977 α Spectrin 13 8 0.4625 1.345  
 
CG3902  6 3 0.4867 0.6139  
 




13 17 0.5048 0.9512  
CG18076 Short stop 31 42 0.5081 0.9902  
 
CG10236 Laminin A 1 4 0.5210 0.5632  
 
CG2238 Elongation factor 2b 10  0.5297  Not 
identified 
CG12165 Inner centromere 
protein 
5 2 0.5370 0.8567  
CG3415  2  0.53766  Not 
identified 
CG6647 Porin 7 5 0.5429 0.7525  
 
CG1782 Ubiquitin activating 
enzyme 1 




These seven proteins included KLP61F, also known as Kinesin-5, a kinesin 
like protein whose microtubule association is known to be cell cycle-regulated.  
During interphase, KLP61F is diffuse within the cytoplasm.  As the cell progresses 
through mitosis, KLP61F becomes phosphorylated.  Upon phosphorylation the 
protein associates with spindle microtubules and is essential for the formation of a 
bipolar spindle (Goshima and Vale, 2005).  The identification of a protein already 
known to associate with microtubules specifically during mitosis, gave confidence in 
my identification of the other proteins. 
On looking at the intensity graph (Figure 3.12), it appeared that there were a 
number of proteins which lay outside the main group, but did not make it through my 
stringent cut-off.  The very stringent cut-off took into account the level of mitotic 
arrest, but it did not take into account that microtubule association of proteins may 
not be a switch, an ‘all or nothing’ association, between interphase and mitosis.  For 
example, a protein may bind with 90 % and 10 % affinity in mitosis and interphase 
respectively and its ratio would therefore be 0.4.  This would be missed by the more 
stringent cut off and therefore to ensure no interesting protein had been missed, a less 
stringent cut off of 0.55 was also used.  It allowed the identification of an additional 
20 proteins whose binding potentially ‘increases’ in mitosis compared to interphase 
(Table 3.2 and Figure 3.12).  A number of these proteins have already been shown to 
play a role in microtubule regulation and spindle formation. 
For the second of the duplicate experiments, the mitotic index of mitotic and 
interphase extracts were 23 % and 2.8 % respectively.  The specificity of microtubule 
co-sedimentation and the maintenance of phosphorylation are shown in Figure 3.13.  















































Figure 3.13  Microtubule co-sedimentation with SILAC exp 2.  (A)  
Microtubule co-sedimentation was carried out using cells cultured in 
SILAC conditions.  Silver stain analysis showed little protein in the control 
(C) pellet identifying those in sample (S) pellet to be microtubule associating 
protiens.  (B)  Maintenance of phosphorylation was assessed by immunoblot 
using MPM2.  Phosphorylation was reduced but maintained.  (C)  The sample 






















number of proteins identified in this duplicate experiment was significantly lower 
than the previous experiment, with a number of proteins having considerable changes 
in their ratio.  Protein ratios were again plotted against intensities and also the 
number of unique peptides (Figure 3.14). 
To obtain the final list of mitotic-specific MAPs, those identified in the 
duplicate experiments were compared.  In total 326 individual proteins were 
quantified, however only four proteins were identified as mitotic-specific MAPs in 
both experiments.  Figure 3.15 shows a functional classification of these 326 
proteins.  These four proteins were KLP61F, Laminin A and two uncharacterised 
proteins, CG11120 and CG3902.  Laminin A is a non-essential protein which has 
been suggested to be involved in cell adhesion, migration and rearrangement during 
organogenesis.  It is extracellular and highly studied.  Therefore I chose not to pursue 
it further. 
Of the two uncharacterised proteins, CG11120 had a ratio of most 
significance.  It consistently gained a low ratio and in both experiments lay close to 

































Figure 3.14  Graphic representation of SILAC data.  Protein ratios were
calculated by dividing peptide relative intensities, ‘heavy’/‘light’.  (A) The 
protein ratio was plotted on log scale against the relative intensity.  
(B)  The protein ratio was also plotted on a log scale against the number of 
unique peptides.  A stringent cut-off of 0.2 was applied to the data.  Those 
proteins to the left of this cut-off show increased binding to microtubules 













































Figure 3.15  Functional classification of 326 quantified proteins.  Pie 
chart representing the classification of quantified MAPs of combined experiments.
Classification was determined according to Gene ontology, supported by manual
data mining using Flybase.  This classification was carried out in November 2010.
All proteins were grouped into five main categories i) RNA/DNA associated, ii) Protein
folding/degradation, iii) Other, iv) Expected MT functions and 






















3.4 Analysis and discussion of the developed protocol’s ability to 
identify mitotic-specific MAPs 
3.4.1 Possible reasons behind the small number of identified mitotic-specific 
MAPs  
In this chapter, I have described the development of a method for the systematic 
identification of proteins that bind to microtubules specifically during mitosis.  Using 
this method I have identified a new microtubule-associated protein which shows 
binding to microtubules specifically during mitosis which is discussed in detail in 
chapter 4. 
 However, the number of proteins identified to associate with microtubules 
specifically in mitosis was smaller than expected.  Although I hypothesised that only 
a small proportion of MAPs would bind microtubules specifically in mitosis, I had 
expected that more than four proteins would be replicated between the two 
experiments.  There are various reasons why a reduced number may have been 
identified and how this could be improved.   
Firstly, there may only be four MAPs that associate with microtubules 
specifically during mitosis in S2 cells.  However, the mitotic spindle is a complex 
structure and it is unlikely that only four proteins are needed to regulate is function 
during chromosome segregation.  I therefore suspect this study has not identified all 
potential mitotic-specific MAPs. 
Secondly, the amount of protein analysed may be insufficient for effective 
protein quantification.  The larger the quantity of protein injected into the mass 
spectrometer, the better the quality of the spectrum.  A better quality of spectrum 
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enables the sequencing of more peptides and therefore the identification and 
quantification of more proteins.  Consequently, if I had used a larger number of S2 
cells, and purified greater quantities of MAPs, I may have identified more mitotic-
specific MAPs. 
Not only the quantity but also the quality of the sample used may affect the 
identification of mitotic-specific MAPs.  To increase the number of identified MAPs, 
the method of their purification could also be improved.  The method of microtubule 
co-sedimentation is most often used, identifying abundant proteins which bind to the 
entire length of the microtubule.  In 1989, Kellogg et al developed a new method to 
identify less abundant MAPs.  Fifty Drosophila embryonic proteins which bind 
microtubules were identified using a microtubule affinity column (Kellogg et al., 
1989).  Embryonic extract was passed over columns containing taxol stabilised 
microtubules coupled to an agarose matrix, the column washed and MAPs eluted.  In 
parallel to affinity chromatography, Kellogg et al (1989) also performed microtubule 
co-sedimentation.  A comparison of the two sets of proteins identified in both 
experiments showed a greater variety of proteins identified by microtubule affinity 
chromatography (Kellogg et al., 1989).  With the use of identical buffers in both 
procedures, more similarities between the two sets of results were seen, although 
some differences still remained. 
Although microtubule co-sedimentation was faster and more convenient, 
affinity chromatography allowed better control of elution conditions (Kellogg 1989).  
Here I have used only microtubule co-sedimentation for the purification of MAPs.  
To further identify those proteins that associated with microtubules specifically 
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during mitosis, it would be advantageous to use multiple methods of purification.  
Affinity chromatography purification may uncover less abundant MAPs. 
A further possibility that may play a role in reducing the number of mitotic-
specific MAPs identified was the partial loss of phosphorylation.  Throughout the 
experiments I aimed to maintain phosphorylation, however in both experiments, 
although phosphorylation was still present it was not fully maintained.  This 
reduction in phosphorylation may result in the loss of cell-cycle regulation of some 
microtubule associated proteins.  The loss of regulation will most likely result in the 
equal association of proteins with microtubules from interphase and mitotic extracts.  
This then leads to the failure to identify proteins which are cell cycle regulated.  To 
prevent a reduction in phosphorylation, the phosphatase inhibitor mixture needs to be 
improved further.  However, simply increasing the concentration of phosphatase 
inhibitors poses a problem in the purification of MAPs.  I found that a high 
concentration of phosphatase inhibitors reduces the binding ability of MAPs.  The 
reason for the reduction in binding appeared to be from a high concentration of 
sodium ions present within the phosphatase inhibitor mixture.  Increasing the 
concentration of phosphatase inhibitors would result in an increase of the sodium ion 
concentration, and a reduction in MAP purification.  Therefore there is a fine balance 
between the maintenance of phosphorylation and the purification of MAPs and 
therefore further testing of various combinations of phosphatase inhibitors will 
maximise the number of quantifiable MAPs. 
 Another aspect that may impair the identification of mitotic-specific MAPs is 
a failure to maintain other cellular post-translational modifications.  I hypothesised 
that phosphorylation was the major post-translational modification used to regulate 
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protein association with microtubules.  However, there are other post-translational 
modifications which may also be used, such as methylation and acetylation.  These 
reversible post-translational modifications are more commonly known to act on 
nuclear proteins.  Acetylation however, has been shown to be present on cytoplasmic 
proteins such as tubulin.  The acetylation of tubulin at lysine 40, located on the 
luminal side of the microtubule, is thought to direct the formation of a docking site 
for motor proteins (Yang and Seto, 2008).  Stabilisation of microtubules is also 
thought to be affected by this acetylation (Matthias et al., 2008).  Interestingly 
however, acetylation has also been shown to be involved in the polymerisation and 
branching of actin filaments.  The protein cortactin interacts with F-actin to promote 
polymerisation and branching.  The acetylation of cortactin prevents actin binding, 
affecting the formation of the actin cytoskeleton, resulting in a reduction in cell 
mobility (Zhang et al., 2007).  It is therefore a possibility that this form of 
cytoskeletal regulation is also used within the microtubule network.  Therefore, the 
maintenance of other post-translational modifications may aid the identification of 
mitotic-specific MAPs. 
The protocol used here only identifies those proteins regulated by 
phosphorylation or by cell-cycle degradation.  Other post-translational modifications 
were not maintained during co-sedimentation.  Proteins regulated by these 
modifications would therefore not have differentiated binding when purified from 
interphase and mitotic extract.  To address this further and identify more MAPs 
which specifically bind microtubules during mitosis, it would be advantageous to 
perform multiple experiments, each maintaining a set of major post-translational 
modifications. 
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There are also a number of proteomic aspects that could be altered to increase 
the number of quantifiable proteins.  The first aspect is the preparation of the sample.  
To fractionate the proteins, I ran a short 1D denaturing gel.  This primarily separated 
tubulin from MAPs.  However, had a larger quantity of MAPs been purified, it would 
have been advantageous to fractionate the proteins further.  Different fractionation 
methods are used to prepare samples for mass spectrometric analysis.  Predominantly 
proteins are fractioned using 1D and 2D PAGE.  2D PAGE creates single protein 
spots, which can then be individually analysed by mass spectrometry for protein 
identification.  Mass spectrometry from 1D and 2D PAGE has been shown to 
identify significantly different set of MAPs (Hughes et al., 2008).  However, 2D 
PAGE needs significant protein quantities and proteins can be ‘lost’ within the gel.  
Therefore had a larger quantity of MAPs been purified, 2D PAGE may have been of 
benefit. 
Mass exclusion is another aspect that could be introduced during data 
collection.  The mass spectrometer can be programmed to exclude specific masses 
from peptide fragmentation analysis, which provides the information for protein 
identification.  Excluding specific masses leaves the mass spectrometer available to 
fragment other peptides.  Microtubule co-sedimentation samples contain large 
quantities of tubulin and although I have optimised the protocol to use the minimal 
amount of tubulin, mass exclusion could reduce masking further.  A sample of 
tubulin would first need to be analysed alone, resulting in a list of peptide masses 
being produced.  Those peptides which are high in intensity could be put together to 
formulate an exclusion list.  The mass spectrometer could be programmed to exclude 
peptides within narrow ranges surrounding these high intensity peptides.  This would 
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result in the mass spectrometer no longer continuously sequencing tubulin peptides 
but only peptides resulting from MAPs within the sample.  This would increase the 
number of proteins able to be identified.  However, although this excludes specific 
peptides, it may also be excluding other interesting peptides whose masses lie within 
the exclusion zones.  Therefore it is a fine balance between selecting the number of 
mass regions to exclude and the masking of high intensity peptides. 
Another aspect of mass spectrometry that could be adapted is that of charge 
exclusion.  Similar to mass exclusion, it excludes specific peptides from 
fragmentation analysis.  Most protein peptides become doubly charged in the mass 
spectrometer, they can however be more highly charged.  Noise within the mass 
spectrometer is more commonly singly charged, unlike protein peptides.  It could 
therefore be advantageous to exclude singly charged proteins from fragmentation 
analysis thus mainly noise would be excluded.  A drawback however is that as 
phosphopeptides are often singly charged, charge exclusion will exclude many 
phosphopeptides from analysis.  However, as phosphopeptides are in the minority, 
single charge exclusion could increase the number of quantifiable MAPs. 
 
3.4.2 Identification of MAPs that bind microtubules specifically in interphase 
Although I set out to identify those proteins that showed association with 
microtubules specifically during mitosis, the experimental design should have also 
allowed the identification of interphase-specific proteins.  However, the cell cycle 
arrest of S2 cells limited protein identification to mitotic specific binders.  
Drosophila culture cells, including S2 cells, do not efficiently arrest in mitosis when 
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using microtubule poisons.  The majority of cells in both populations were therefore 
interphase cells.  Any increase in protein microtubule affinity in interphase would not 
be detectable at peptide level in the mass spectrometer.  This therefore prevented the 
identification of proteins whose affinity for microtubules increased during 
interphase. 
To improve this, various cell cycle arrests could be used alone or in 
combination thus eliminating the dependence on arrest using microtubule poisons.  
For example, RNA interference (RNAi) could be used to deplete proteins such as 
cdc27, which has previously been shown to increase the mitotic index.  The extent to 
which the RNAi of these proteins enriches for mitotic cells is still low (cdc27 ≈ 10 
%) (Goshima et al., 2007) but in combination with microtubule poisons an effective 
arrest could be obtained.  However, the depletion of such proteins can have knock-on 
effects on the cell.  Directly depleting known MAPs may affect other protein 
regulation and therefore cause changes to their microtubule association.  The use of 
RNAi arrest-based methods alone or in combination with microtubule poisons would 
therefore need to be monitored closely for secondary effects.  
Another way to address the issue of cell cycle arrest may be to change model 
organism.  Cell cycle arrest in other organisms such as yeast and human cell lines 
can be achieved close to 100%.  Ozlu et al (2010) were able to obtain synchronies of 
more than 90 % for mitosis in HeLa S3 cells.  An arrest of this extent would enable 
the identification of more MAPs that associated with microtubules specifically 
during interphase or mitosis (Ozlu et al., 2010).   
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The use of Hela cell types however has its limitations compared to S2 cells.  
Drosophila melanogaster has been used in laboratories for more than a hundred 
years, with the availability of working with a complex, multi cellular organism with a 
short generation time being taken advantage of.  There are a large array of genetic 
and molecular tools, which have evolved to enable the analysis of genes.  The 
creation of mutants, using tools such as P elements, has allowed the investigation of 
gene function within the multicellular organism.  Aspects of Drosophila 
development and behaviour have been shown to parallel that of the human, and 
therefore the creation of mutants within Drosophila allows the study of these 
complex processes.  A wide base of knowledge and communication within the field 
gives Drosophila an advantage over other model organisms.  There are numerous 
available resources, such as Flybase, for sharing information and reagents.  Working 
with S2 cells gives the advantage to move directly into the multicellular organism 
and investigate the function of identified genes. 
However, the use of alternative model organisms may be useful within the 
screening process.  For example, HeLa cells have previously been used with SILAC 
and therefore are suitable for the experiment.  Due to a relatively high level of 
homology between Drosophila and human, the use of HeLa cells for screening MAP 
cell cycle binding may be advantageous.  A high cell-cycle synchronisation would 
enable the identification of not only mitotic specific MAPs but also interphase 
specific ones.  Once key proteins have been recognized, using homology, individual 
genes could be studied more closely in Drosophila, taking advantage of its multi-
disciplinary tools. 
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In summary, I have developed a method for the systematic identification of 
MAPs that associate with microtubules specifically during mitosis and using this 

















4. Characterisation of CG11120 – A new mitotic microtubule associated 
protein 
 
Using microtubule co-sedimentation coupled with SILAC and mass spectrometry, I 
identified CG11120 to bind microtubules specifically during mitosis.  I next wanted 
to confirm this cell cycle related microtubule association and investigate the 
mechanism of its regulation, as well as uncover the function of CG11120.   
 
4.1 Analysis of protein localisation 
To confirm the association of CG11120 with microtubules specifically during 
mitosis, I decided to analyse the localisation of the protein in S2 cells and developing 
flies.  For this purpose, I created green fluorescent protein (GFP) tagged CG11120 
and peptide antibodies.   
 
4.1.1 Localisation analysis of CG11120 protein in S2 cells 
I first used green GFP-tagged CG11120 to visualise its localisation in S2 cells.  To 
create GFP-tagged protein, CG11120 cDNA was used in the Gateway cloning 
system to create N- and C-terminal GFP-tagged protein under the control of the actin 
promoter.  S2 cells were transfected with N- or C-terminal GFP-tagged CG11120 
using a non-liposomal lipid formulation with DNA-condensing enhancer.  A sample 
of transfected cells was fixed and immunostained for GFP, DNA and α-tubulin.  
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Both the N- and C-terminal GFP-tagged protein showed identical localisation.  
During mitosis, GFP immunostaining showed a uniform signal which localised along 
the entire length of all spindle microtubules.  In interphase a distinct GFP 
immunostaining signal was distributed evenly throughout the nucleus, with no 
obvious specific point of localisation.  This indicated that the localisation of 
CG11120 is regulated through the cell cycle (Figure 4.1).  Interestingly, in interphase 
cells expressing high levels of GFP-tagged protein, the GFP signal was often 
associated with bundled microtubules (Figure 4.1).  As seen in mitosis, this 
localisation of CG11120 was uniform and associated with the full length of the 
bundled microtubules.  
 To confirm the localisation of endogenous protein, peptide antibodies were 
used in immunostaining of S2 cells.  Peptide antibodies were generated by 
Eurogentec using peptides corresponding to regions which are likely to lie on the 
exterior of the protein.  The peptides chosen by Eurogentec were as follows:  Peptide 
1 (QNTETPRRSCRKSVR) and Peptide 2 (EVGKNSRKRGRKSKR).  Both of these 
sequences are close to the N-terminus of the protein.  Both peptides were synthesised 
and a mixture of the two peptides was used to inoculate two rabbits.  Peptide 
antibodies were then purified from rabbit serum using affinity chromatography with 
the above peptides.  Each peptide was used separately resulting in two individual 
peptide antibodies, peptide antibody 1 and 2. 
A sample of wild-type S2 cells was taken and cells adhered to Concanavalin-
A coated coverslips.  Cells were fixed using -20 C methanol and immunostained 
with peptide antibody 1 or 2, anti α-tubulin antibody and DAPI.  Peptide antibody 1 












Figure 4.1 CG11120 localisation is cell cycle regulated. S2 cells were
fixed with cold methanol 48 hours after transfection with GFP-CG11120.
Fixed cells were immunostained using antibodies specific for GFP (to
visualise CG11120 localisation) and α-tubulin (to visualise microtubules).  
DNA was stained using DAPI.  GFP-CG11120 localised to the nucleus 
during interphase and spindle microtubules during mitosis.  Some
interphase cells showed GFP-CG11120 localisation to microtubules.
Exposures of these cells are roughly equivalent and therefore
images can be compared.
BAR=10µm
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uniformly associated with the mitotic spindle (Figure 4.2), but did not show any 
distinct signal in interphase cells. 
 To test whether the fixation method affected staining, cells were fixed using 
paraformaldehyde at room temperature.  Peptide antibody 1 again showed no 
significant signal.  Although the staining was less prominent with paraformaldehyde 
fix, peptide antibody 2 did show staining of the mitotic spindle, with a lack of 
distinct staining in interphase.  This indicated that staining of the spindle is 
independent of fixation method.  For the following experiments, peptide antibody 2 
with methanol fixation was used. 
 Although antibody 2 gave staining on the mitotic spindle, I needed to confirm 
this staining was derived from CG11120 protein and not from other proteins which 
the antibody cross-reacts with.  To address this I performed RNA interference 
(RNAi) in S2 cells followed by immunostaining.  Cells were treated for 5 days with 
double-stranded RNA (dsRNA) against CG11120.  As a control, a culture was 
treated in parallel with dsRNA against β-lactamase (a bacterial enzyme which is not 
found in the S2 cell genome).  A sample of each RNAi culture was adhered and fixed 
to Concanavalin A coverslips.  Both CG11120 and control knock-down cells were 
stained with peptide antibody 2, anti α-tubulin antibody and DAPI.  Control cells 
showed a signal uniformly associated with the mitotic spindle.  CG11120 RNAi 
cells, those lacking CG11120 protein, showed no localised signal in interphase or 
mitosis (Figure 4.2).  These results confirmed that the staining seen in control RNAi 
cells was specific to CG11120.  I therefore concluded that endogenous CG11120 


















DNA CG11120 Alpha tubulin
Figure 4.2  CG11120 localisation in Schneider 2 cells.  Cells were fixed
with cold methanol 5 days after treatment with dsRNA corresponding to 
β-lactamase (control) or CG11120.  Fixed cells were immunostained with 
peptide antibody 2 for CG11120 and an antibody specific for α-tubulin (to
visualise microtubules).  DNA was stained with DAPI.  CG11120 localises 
to spindle microtubules.  Exposure lengths are roughly equivalent
and therefore these images can be fairly compared.
BAR=10µm
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From localisation analysis in S2 cells, I determined that CG11120 was 
localised to the nucleus during interphase and as cells progress into mitosis CG11120 
associates with spindle microtubules.  From these results I named CG11120 Nuclear 
microtubule associated protein (NuMAP). 
  
4.1.2 Localisation analysis of NuMAP in Drosophila melanogaster 
To analyse the localisation of NuMAP in the fly, I decided to make use of the Gal4-
UAS system to express GFP-NuMAP in Drosophila oocytes.  The Gal4-UAS system 
is a commonly used method of ectopic expression of genes within Drosophila (Brand 
and Perrimon, 1993).  There are two elements to this system: the Gal4 gene, which 
encodes the Gal4 transcriptional activator protein and the upstream activation 
sequence (UAS), to which Gal4 protein binds and activates gene transcription.  The 
gene of interest is placed downstream of a UAS and when crossed with a Gal4 
containing line, the gene of interest is therefore expressed.  Expression can be 
restricted to specific cell types by placing the expression of Gal4 protein under an 
endogenous tissue-specific promoter. 
 I first generated transgenic flies in which GFP-NuMAP or NuMAP-GFP was 
downstream of a Gal4-UAS.  To do this I used the gateway system to clone NuMAP 
cDNA into a vector containing N- or C-terminal GFP tags and a UASp promoter.  
The UASp promoter and 3’ UTR allows Gal4 driven expression of a transgene in the 
Drosophila germline (Rorth, 1998).  Transgenic flies were then created by the 
injection of UASp-GFP-NuMAP or UASp-NuMAP-GFP into pre-blastoderm 
embryos with a helper plasmid containing the transposase coding sequence.  The 
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helper plasmid enables the insertion of the construct into the Drosophila genome in a 
P-element mediated manner.  The injection and selection of transgenic flies was 
performed by the Genetic services Inc, Cambridge.  The insertion sites of transgenes 
were genetically mapped to specific chromosomes.  GFP-NuMAP and NuMAP-GFP 
were expressed by crossing transgenic fly lines with a line containing the maternal 
Gal4 driver, driven by the nanos promoter (nanosGal4:VP16).  This fly strain also 
carried the transgene RCC1-mCherry, a chromatin associated protein, enabling the 
visualisation of chromosomes as well as NuMAP.  The nanos-Gal4:VP16 gives high 
levels of transgene expression in the germline from the germarium to the mature egg 
with products loaded into the embryo (Rorth, 1998). 
 To analyse the localisation of GFP-NuMAP and NuMAP-GFP in oocytes, 
live imaging analysis was carried out using confocal spinning disc microscopy.  
Oocytes were dissected in halocarbon oil from female flies expressing the transgenes 
and the metaphase-I meiotic spindle was examined.  Preliminary results showed that 
both constructs, GFP-NuMAP and NuMAP-GFP, appeared to localise to spindle 
microtubules with higher accumulation to the central spindle (Figure 4.3a).  
Dissection of oocytes also allowed examination of NuMAP localisation in the 
karyosome.  The karyosome is a discrete mass of chromosomes which forms during 
prophase of meiosis I.  NuMAP localised in the nucleoplasm, but was excluded from 
the karyosome (Figure 4.3b).   
 To analyse the localisation of NuMAP during mitosis in early development, I 
examined syncytial embryos.   At cycle 8 of embryonic development, multiplying 
nuclei migrate to the surface of the embryo and divide in synchrony through cycle 9 




Figure 4.3  NuMAP localisation in Drosophila oocytes.    Oocytes from 
GFP-NuMAP (green) and RCC1-cherry (to mark DNA, red) expressing 
females were analysed by confocal microscopy.  (A) NuMAP localises to the 
meiotic spindle, with enrichment at the central spindle.  (B)  NuMAP localises




dividing nuclei, which lay at the periphery of the embryo.  Embryos (0-4 hrs old) 
were collected from flies expressing GFP-NuMAP or NuMAP-GFP on grape 
juice/agar plates.  Embryos were dechorionated by dissection, mounted onto 
coverslips and covered with halocarbon oil.   Mitotic spindles were then examined 
using confocal spinning disc microscopy.  Imaging of the mitotic spindle was 
difficult due to the embryo depth and spindle movement, resulting in blurred images.  
However, a general localisation of NuMAP could be distinguished.   During 
prophase NuMAP is localised to centrosomes.  As the mitotic spindle is formed, 
NuMAP becomes localised to spindle microtubules and remains localised to spindle 
microtubules through anaphase and into telophase.  During telophase NuMAP is 
localised to a structure that appears to be the central spindle, though it is restricted to 
specific parts of this structure (Figure 4.4). 
 The above preliminary analysis of NuMAP localisation in Drosophila 
melanogaster shows NuMAP localises to spindle microtubules in female meiosis I 
and during mitotic divisions in the embryo.  At early stages of oogenesis, NuMAP 
appears to localise in the nucleoplasm with exclusion from chromatin.  From this I 
concluded that NuMAP can associate with spindle microtubules at different 
developmental stages.   
 
4.2 Domain structure of NuMAP 
To investigate NuMAP protein structure and function, I first used a basic local 
alignment search tool to identify any closely related proteins or possible homologues.  























Figure 4.4  NuMAP localisation in embryonic mitosis.  0-4 hour old embryos
laid by females expressing GFP-NuMAP (green) and RCC1-cherry (red) at 25 °C
and analysed with confocal microscopy.  NuMAP localises to centrosomes in
prophase and the mitotic spindle in metaphase and anaphase.  In telophase
NuMAP appears to localise to remaining spindle microtubules and central
spindle, though is excluded from the central midbody region. 
BAR=10µm
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closely related proteins were from other Drosophila species.  More limited 
similarities are found with Aedes aegypti and Anopheles gambiae (mosquito) 
proteins (Figure 4.5a).  Interestingly, the region (573-750) showed similarity to the 
Lepeophtheirus salmonisi protein nucleolar and spindle associated protein 1.  By 
reducing the region of protein alignment to this area, 40 % homology with the human 
protein Nucleolar and spindle-associated protein (NuSAP) was identified for a 50aa 
region (Figure 4.5b).  NuSAP is a 55 kDa protein with selective expression in 
proliferating cells.  Its localisation is predominantly nucleolar during interphase and 
on the central spindle during mitosis (Raemaekers et al., 2003). 
 Due to the localisation of NuMAP to the nucleus, I analysed the NuMAP 
protein sequence for the presence of a nuclear localisation signal (NLS).  The NLS 
has been identified on multiple nuclear proteins.  It has been shown that a short 
amino acid sequence can alone determine the localisation of a protein to the nucleus 
(Kalderon et al., 1984).  NLSs are usually rich in positively charged amino acids 
such as lysine and arginine (Alberts, 2002), although other signals have been 
identified but not yet characterised.  Automated tools have been developed for the 
analysis and determination of NLS sequences.  Using PredictNLS, no NLS was 
identified in the NuMAP protein.  Two coiled-coil structures were predicted using 
Coils, a program which calculates the probability that the sequence will adopt a 
coiled-coil conformation (Lupas et al., 1991) shown in Figure 4.5c. 
Further sequence analysis using an internet based motif prediction tool 
(http://bioweb.pasteur.fr/protein/intro-en.html) predicted three potential PEST motifs 
at (324-364), (154-172) and (154-172).  PEST motifs are hydrophilic polypeptide 




NuMAP   549    SRIPKPNRGVIPLNKTITPSKVNKRTKM--PNFAAMHERQFAKMESLVDHVERK  600  
               S++P   +  +  +++  P K NKRT +  PNF  +HE  F +MES+  ++ERK
NuSAP   154    SKVPSEGKKSLYTDESSKPGK-NKRTAITTPNFKKLHEAHFKEMESIDQYIERK  206
C
Figure 4.5  NuMAP homology and predicted secondary structure.  
(A)  Schematic representation of homology regions in NuMAP identified using the 
basic local alignment search tool.  (B)  Identified region of homolgy to human NuSAP
using NuMAP amino acid sequence 541-754 and a basic local alignment search 
tool.  Substitutions are marked by (+).    Identical matches are displayed
in letter code.  (C)  Prediction of coiled-coil secondary structures in NuMAP.
Coloured lines show different window sizes used for coil prediction by prediction 
software Coils.










which targets proteins for rapid degradation.  Proteins containing PEST motifs often 
have a half life of less than 2 hours, suggesting that NuMAP may also have a short 
half life. 
 
4.3 Identification of localisation domains 
Localisation analysis in S2 cells showed that NuMAP localises to the nucleus during 
interphase and spindle microtubules during mitosis.  The nuclear localisation of 
NuMAP precludes its interaction with microtubules and therefore prevents analysis 
the microtubule binding capabilities during interphase in cells.  The identification 
and separation of the microtubule binding and nuclear localisation domains will 
enable us to mis-localise NuMAP protein to the interphase cytoplasm and analyse the 
microtubules binding of NuMAP during interphase. 
To identify the regions of the protein responsible for nuclear and microtubule 
localisation of NuMAP, I created several GFP-NuMAP truncations and examined 
their localisation by immunostaining after transfection.  As described earlier, there 
are 4 main regions of homology with Drosophila and mosquito proteins.  I therefore 
first created C-terminal truncations, removing each major region of homology.  
These truncations were created by introducing premature stops into the NuMAP 
coding sequence by site-directed mutagenesis.  All truncations created no longer 
associated with microtubules during mitosis.  All except the smallest protein 
fragment, NuMAP(0-44), localised to the nucleus (Figure 4.6a).  These results 
indicated that the C-terminus is required for microtubule binding and a nuclear 

























Sufficent but not essential Sufficent but not essential
Microtubule binding
Essential
Figure 4.6  NuMAP truncation analysis.  (A)  Schematic represenation of 
created truncations and their localisation in interphase and mitosis.
(Nuc) indicates protein localisation to the nucleus.  (MT) indicates protein 
localisation to microtubules.    (Chromo) indicates localisation to mitotic 
chromosomes.  (-) indicates diffuse protein, no localisation.  (B)  Schematic 
representation of regions identified for NuMAP localisation.  NuMAP 
contains 2 NLS sequences, a microtubule binding region and a region that
shows localisation to mitotic chromosomes.












NuMAP with affinity for chromosomes.  NuMAP(0-171) showed association to the 
chromosomes during mitosis, as NuMAP(0-404) did not.  These results suggest that 
there is a region of NuMAP capable of chromosome association which is negatively 
regulated by an adjacent region (Figure 4.6b). 
To confirm that the microtubule binding domain is at the C-terminal and to 
narrow down the protein region, I created N-terminal truncations (Figure 4.6a).  All 
C-terminal fragments including the smallest, NuMAP(623-754), showed nuclear 
localisation during interphase and localisation to microtubules during mitosis.  This 
confirmed that the microtubule binding region and a nuclear localisation signal lies at 
the C-terminal end of the protein.  It also indicated that NuMAP contains two nuclear 
localisation signals, both sufficient but not essential to localise NuMAP to the 
interphase nucleus (Figure 4.6b).  To further focus in on the microtubule binding 
domain, I truncated NuMAP(623-754) further.  NuMAP(623-693) and NuMAP(623-
718) were diffuse and did not localise to microtubules (Figure 4.7a).  Truncations 
(623-729) and (623-632/713-754) showed nuclear and mitotic microtubule 
localisation (Figure 4.7a).  These results indicate the C-terminal nuclear and 
microtubule localisation domains are very close together, if not overlapping, in the 
protein region of 713-729 (Figure 4.7c).  However, NuMAP(623-729) and 
NuMAP(623-630/713-754) localisation was not as pronounced as full length 
NuMAP (Figure 4.7b).  There are two regions of homology in this section of 
NuMAP.  NuMAP(623-729) and NuMAP(623-630/713-754) each disrupt one of 
these regions suggesting they may collaborate to ensure effective localisation to the 
microtubules and the nucleus (Figure 4.7c).  Table 4.1 shows quantified localisation 
analysis of created truncations. 
128
NLS NLS
Sufficent but not essential Sufficent but not essential
Microtubule binding
Essential
44 109 713 729
Interphase Mitosis
Nuc MTNuMAP
NuMAP 623-729 nuc mt
NuMAP 623-630/
             713-754
nuc mt
NuMAP 623-718 - -
NuMAP 623-693 - -
A
B
Figure 4.7 Identification of NuMAP nuclear and microtubule localisation
domains.  (A)  Schematic representation of truncations created and their
protein localisation in interphase and mitosis.  (Nuc) indicates localisastion to
the nucleus.  (MT) indicates localisation to microtubules.  (nuc) indicates
reduced localisation to the nucleus.  (mt)  indicates reduced localisation to
microtubules.  (-) indicates diffuse protein, no localisation.  (B) S2 cell images 
showing observed decrease in localisation of NuMAP(623-729) and NuMAP
(623-630/713-754) .  Exposure times of tuncations were similar enabling their
comparison. (C) Schematic representation of regions identified for NuMAP
localisation.  Grey box represents two homology regions which may
come together to regulate microtubule binding.
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 Table 4.1 Analysis of the localisation of NuMAP truncations in S2 cells.  S2 cells were transfected with various NuMAP 
truncations and cultured for 48 hours.  Protein localisation was observed in immunostained fixed samples.  A total of 500 
















Cytoplasm Chromosomes Spindle 
microtubules 




1.4 100     1 26 3  
0-44 0.79     100    9 
0-109 0.99 106        7 
0-171 1.4 97 2    8   5 
0-404 0.9 99 1    4   11 
548-754 0.6 80  19 1   3   
623-754 2.4 74  23 2   19   
623-729 1.2 4 71   38  6 + 
cytoplasm 
 1 
623-693 2.3   1  99 4   17 
623-718 1.8     100    19 
623-630/ 
713-754 
2.2  77 28  4  3   
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4.4 Analysis of NuMAP microtubule binding in interphase 
Although I had narrowed down the regions of NuMAP which regulate its 
localisation, I had not managed to separate nuclear and microtubule localisation.  
This prevented me from investigating whether NuMAP can bind to microtubules 
during interphase by mutating the NLSs.  To overcome nuclear localisation of 
NuMAP during interphase, I decided to generate NuMAP fused to a nuclear export 
signal (NES).  The short hydrophobic signal of PKI, a heat stable inhibitor of the 
catalytic subunit of cAMP-dependent protein kinase, is sufficient to induce nuclear 
export (Roth et al., 2003; Wen et al., 1995).  Therefore to create an interphase 
cytoplasmic pool of NuMAP, I fused the PKI NES to GFP-NuMAP.  PKI NES was 
inserted at either side of NuMAP to create GFP-NES-NuMAP and GFP-NuMAP-
NES (Figure 4.8a).  After transfection in S2 cells, the microtubule binding of 
NuMAP in interphase was analysed by immunostaining.  Both constructs showed 
increased localisation to the cytoplasm, though the nucleus remained the 
predominant region of localisation.  The pool of NuMAP in the cytoplasm did not 
associate with interphase microtubules (Figure 4.8b).  In mitosis both constructs still 
showed association with spindle microtubules, confirming the ability of fusion 
proteins to associate with microtubules.  This confirms that the interphase form of 
NuMAP has low affinity to microtubules. 
I also fused an NES to the microtubule binding domain of NuMAP to create 
GFP-NES-NuMAP(623-754) (Figure 4.8a).  This construct showed greater 
localisation to the cytoplasm during interphase than full length NES fused protein.  
In contrast to the full length protein construct, it showed association with interphase 
microtubules (Figure 4.8b).  However, microtubules associated with NuMAP were 
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Figure 4.8 Localisation of NuMAP fused with an NES  (A)  Schematic 
representation of NuMAP constructs containing an NES.  (B)   Images
representing localisation observed of NuMAP containing an NES.  S2 cells 
were fixed with cold methanol 48 hours after transfection with plasmid for 
expression of specific NuMAP constructs, NuMAP (no NES), (NES)NuMAP 
and (NES)NuMAP(623-754).  Fixed cells were immunostained with
antibodies for GFP (to visualise NuMAP) and α-tubulin (to visualise 
microtubules).  DNA was stained with DAPI.  (NES)NuMAP showed an
increased cytoplasmic pool that did not co-localise with microtubules.  
(NES)NuMAP(623-754) showed an increased cytoplasmic pool and 
co-localised with microtubules and induces their bundling.  Exposure times

































bundled and showed a circular interphase microtubule array.  These results show the 
microtubule binding domain alone has a high affinity to microtubules even in 
interphase, indicating that the cell cycle regulation is mediated by a region other than 
this domain.  This also suggests that the nuclear localisation of NuMAP and the 
regulation of its microtubule binding ability are crucial to prevent bundling of 
interphase microtubules. 
 
4.5 Analysis of NuMAP function 
Although I had identified the localisation of NuMAP, no clear function had been 
determined.  Next I therefore decided to address the function of NuMAP using two 
approaches, in cultured cells and developing flies. 
 
4.5.1 Analysis of NuMAP function in S2 cells using RNAi 
To analyse NuMAP function in S2 cells during mitosis, I used RNAi to deplete 
NuMAP protein and analysed spindle morphology by immunofluorescence.  As 
previously described, S2 cells were treated for 5 days with either dsRNA against 
NuMAP or β-lactamase.  Cells were adhered to Concanavalin A coverslips and 
immunostained for α-tubulin, DNA and phospho-H3 (to identify mitotic cells) and 
examined for microtubule organisation in mitosis.  Spindle abnormalities were 
classified into the following categories: monopolar, bipolar with no asters, bipolar 
with one aster, tripolar, multipolar and other abnormalities.  Chromosome alignment 
was also examined and categorised as follows: misaligned, lagging and chromosome 
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bridges.  A minimum of 100 mitotic cells were examined from both NuMAP and 
control RNAi samples.  There was an increase in the number of bipolar spindles with 
only one aster after NuMAP RNAi compared with the control (Table 4.2).  There 
was also an increase in other abnormalities in the NuMAP knock down cells. 
As a lack of aster is likely to be caused by a lack of centrosome at spindle 
poles, I co-stained for γ-tubulin.  In addition, to enhance any defects I decided to 
perform 8-day RNAi.  Again 100 mitotic spindles were examined.  Spindles were 
classified to be bipolar with one centrosome if γ-tubulin staining was absent from 
one pole (Figure 4.9a).  Compared to the control, NuMAP RNAi showed an increase 
in the number of bipolar spindles with one centrosome.  The Fisher exact test showed 
this to be a statistically significant difference, with a p-value of 0.02 (Figure 4.9b). 
 
4.5.2 Analysis of NuMAP function in Drosophila melanogaster 
I took advantage of a fly strain that has a transposable element, the P-element, which 
is close to the NuMAP gene.  P-elements are transposable elements which tend to 
insert into the genome 5’ to the transcriptional start regions of genes and can be 
stimulated to ‘jump’ when a source of transposase is provided.  When excision 
occurs, it is not always precise and often removes surrounding chromosomal regions.  
In the strain EY05585, there is a P-element approximately 550 bp downstream of the 
NuMAP stop codon.  I therefore decided to mobilise this P-element to create a 
deletion mutant of NuMAP.  The P-element, however, is within the downstream 
gene, Trf4-2.  Previous analysis of a Trf4-2 disruption resulted in viable flies 
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5 Day           
β-lactamase 103 54 1 1 9 17 12 6  3 
NuMAP 102 37 1 2 14 16 6 19 1 6 
8 Day           
β-lactamase 207 145 3  4 18 16 20  1 
NuMAP 200 117 4  14 36 13 15  1 
 
Table 4.2  Table of RNAi phenotypes in S2 cells.  S2 cells were treated with dsRNA targeting NuMAP for a period of 5 or 8 
days.  Mitotic phenotypes observed in fixed samples are shown, with mitotic indices. 
RNAi target Number 
Mitotic/Interphase 
Mitotic index (%) 
   
5 Day   
β-lactamase 18/482 3.6 
NuMAP 14/486 2.8 
8 Day   
β-lactamase 31/971 3.1 
NuMAP 12/993 1.2 
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Figure 4.9  NuMAP RNAi induces monoastral spindles.  (A)  Typical spindle
morphologies of control and NuMAP depleted S2 cells.  S2 cells were fixed
with cold methanol 8 days after treatment with dsRNA against β-lactase
(control) or NuMAP.  Fixed cells were immunostained with antibodies for
gamma tubulin (to identify spindle poles, white), α-tubulin (to visualise 
spindle microtubules, red) and H3P (to identify mitotic cells, green).  DNA was
stained using DAPI (blue).  Depletion of NuMAP increased the number of cells
lacking gamma tubulin staining at one end of the spindle.   
(B)  Increase in the number of cells lacking gamma tubulin staining at pole of
















remobilisation of the P-element must be tested with reference to the disruption of 
Trf4-2.   
Following P-element mobilisation, flies which had lost the P-element were 
selected by eye colour and chromosome marker and were then analysed by PCR to 
determine if the P-element remobilisation had deleted any region of the NuMAP 
coding sequence.  Among 115 successful crosses, 7 strains had between 10-800 bp of 
NuMAP coding sequence excised.  In one strain the entire NuMAP coding region 
was deleted.  This strain is viable and indicates that the NuMAP gene is not essential 
for viability.  Although preliminary results show the gene upstream from NuMAP, 
CG11168, is disrupted, the extent of the deletion is not yet fully determined.  Initial 
analysis of the homozygotes of this deletion shows them to have reduced viability 
and to be female sterile.  Of seven female homozygotes analysed, only two of many 
embryos laid by them developed to third instar lava but no further.  Further analysis 
is required to test whether these phenotypes are due to the deletion of NuMAP. 
 
4.6 Analysis of NuMAP binding proteins 
I next wanted to identify NuMAP-interacting proteins.  The identification of NuMAP 
binding proteins may uncover regulating proteins and give further insight into the 
function of NuMAP in the cell. 
 To identify interacting proteins, I first made a stable cell line expressing GFP 
tagged NuMAP.  S2 cells were transfected with two plasmids; the first containing 
GFP-NuMAP sequence under the actin promoter, the second plasmid contained a 
gene conferring blasticidin resistance.  The concentration of this plasmid was lower 
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than that encoding GFP-NuMAP to ensure the majority of cells which took up the 
resistance plasmid also obtained GFP-NuMAP.  After transfection, cells were treated 
with blasticidin for six weeks, this resulted in a blasticidin resistant population in 
which most cells expressed GFP-NuMAP.  
 The stable cell line was next used for the purification of GFP-NuMAP and 
interacting proteins.  Cell lysate was incubated with beads coated with an anti-GFP 
antibody, allowing GFP-NuMAP and interacting proteins to bind.  Beads were then 
repeatedly washed using lysis buffer and finally boiled in SDS-PAGE sample buffer, 
dissociating all proteins.  As a control, the pull down was performed in parallel using 
cells that did not contain any GFP construct.   Protein samples were analysed by 
western blot using anti-GFP and silver staining after SDS-PAGE.  Western blot 
showed a 175 kDa band in the pull down sample from cells expressing GFP-
NuMAP. This band was absent from the control, which confirmed GFP-NuMAP had 
been successfully pulled down.  Silver staining showed a number of proteins had 
been pulled down from both cells with and without GFP-NuMAP.  There was no 
significant difference between the two samples, showing that although GFP-NuMAP 
was specifically pulled down, the majority of proteins were not specifically bound to 
NuMAP.   
I next decided to analyse the sample by mass spectrometry.  Although GFP-
NuMAP had been pulled down, I wanted to determine if the total quantity purified 
protein was sufficient to identify interacting proteins.  I therefore first analysed the 
section of the gel containing GFP-NuMAP, to assess if NuMAP could be identified 
by mass spectrometry.  Following in-gel trypsin digestion and peptide analysis, mass 
spectrometry data was processed using DTAsupercharge and Mascot.  However, 
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NuMAP was not identified, nor was the GFP tag.  This indicated that a significantly 
larger quantity of NuMAP needed to be purified before the sample could be used to 
identify interacting proteins. 
 
4.7 Discussion 
4.7.1 Regulation of NuMAP during interphase 
To investigate the microtubule binding ability of NuMAP during interphase, I mis-
localised NuMAP to the cytoplasm by fusing it with the PKI NES motif.  Analysis of 
this construct in S2 cells showed increased protein localisation to the cytoplasm 
though its localisation to the nucleus remained predominant.  This cytoplasmic pool 
of NuMAP did not associate with interphase microtubules indicating that the 
interphase form of NuMAP has low affinity for microtubules.  In contrast to the NES 
fused full length protein, the NES fused microtubule binding domain showed a more 
pronounced cytoplasmic localisation which associated with bundled interphase 
microtubules. 
 Although the fusion of an NES increases the interphase cytoplasmic pool of 
full length NuMAP, the immunofluorescent signal is weak.  Therefore to confirm no 
microtubule association of NuMAP during interphase, the cytoplasmic pool of 
NuMAP needs to be increased. 
As described previously, the NES microtubule binding domain construct 
showed a greater localisation to the cytoplasm than the NES full length protein.  
Interestingly, full length protein contains two NLS sequences as the NES 
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microtubule binding domain only contains one.  Wen et al (1995) observed that the 
NLS is slightly stronger than an NES.  Therefore the weaker cytoplasmic signal of 
NES full length protein may result from the presence of two NLS and only one NES.  
To increase the interphase cytoplasmic pool of NuMAP further, multiple NES motifs 
could be fused to NuMAP.  This may enhance the export of protein from the nucleus 
and result in a more prominent cytoplasmic localisation of NuMAP. 
 
4.7.2 NuMAP: a potential Drosophila homologue of human NuSAP 
From BLAST similarity search, I identified that NuMAP has a small region of 
homology with human nucleolar spindle associated protein (NuSAP).  Similar cell-
cycle localisation of NuSAP and NuMAP, interphase nuclear localisation and mitotic 
spindle localisation, raises the possibility that these proteins are functional 
homologues.  NuSAP was originally identified in proliferating and differentiating 
mouse MCSTSE1 oseteoblasts.  Gene expression patterns identified a cDNA which 
was enhanced during proliferation and the protein product was later called NuSAP 
(Raemaekers et al., 2003).  It was shown to be highly conserved in vertebrates, with 
little homology found to invertebrate proteins.  This current study may have 
uncovered a new invertebrate homologue. 
There are a number of similarities between human NuSAP and Drosophila 
NuMAP.  Firstly, both proteins have similar domain and secondary structures.  
NuSAP contains potential PEST and SAP motifs.  PEST motifs are hydrophilic 
sequences which target proteins for rapid degradation and SAP motifs are putative 
DNA-binding motifs involved in chromosomal organisation (Aravind and Koonin, 
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2000).  NuMAP contains three potential PEST sequences at (324-364), (154-172) 
and (154-172), with no SAP motif being identified at present.  NuSAP has two 
domains which are sufficient for its nuclear targeting during interphase, a bipartite 
NLS sequence and a charged helical domain.  Although no NLS sequence has been 
predicted in NuMAP, it too has two domains which can direct its localisation to the 
nucleus during interphase.  Both NuSAP and NuMAP have domains at their C-
terminus which enables their association with microtubules.  The interaction of 
NuSAP with microtubules has been shown to be direct, however this is yet to be 
confirmed with NuMAP.  However, a significant difference between the protein 
structures is their size.  NuMAP is almost double the size of NuSAP, with NuMAP’s 
754 amino acids to NuSAP’s 427 amino acids. 
Another similarity is that both NuSAP and NuMAP behave in a similar 
manner when analysed by SDS-PAGE.  The mouse NuSAP cDNA was predicted to 
encode a protein of 427 amino acids with a molecular mass of 48.6 kDa.  However, 
during SDS-PAGE analysis NuSAP shows a significant band shift which suggests its 
apparent molecular mass is slightly higher at 55 kDa.  This decrease in protein 
mobilisation can be partially accounted for by protein phosphorylation, but appears 
to be primarily due to the protein’s high basic amino acid content (Raemaekers et al., 
2003).  NuMAP also shows a decrease in protein mobilisation when analysed by 
SDS-PAGE.  NuMAP cDNA encodes a 754 kDa amino acid protein with a predicted 
molecular weight of 84.5 kDa.  When NuMAP is tagged with GFP, the predicted 
molecular weight is 112 kDa.  However, SDS-PAGE followed by western blot 
showed an apparent molecular weight of approximately 175 kDa.  Multiple 
phosphorylation sites have previously been identified throughout NuMAP protein by 
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genome wide phosphoproteomics in Drosophila melanogaster Kc167 cells 
(Bodenmiller et al., 2007). 
A further similarity between NuSAP and NuMAP is their ability to bundle 
microtubules.  Over-expression of NuSAP in Cos1 cells resulted in the localisation of 
NuSAP to long, curved, thick microtubule bundles in the cytoplasm.  These bundles 
were characterised to be extremely stable and remained polymerised in the presence 
of high doses of nocodazole (Raemaekers et al., 2003).  The expression of GFP-
NuMAP showed a population of cells with GFP-NuMAP localised to bundled 
microtubules.  This population of cells appeared to be those where GFP-NuMAP was 
heavily over-expressed.  When the cytoplasmic pool of NuMAP(623-754) is 
increased by the expression of NuMAP(623-754)+NES, interphase microtubules are 
bundled.  These comparable phenotypes suggest NuMAP and NuSAP may have 
similar functions in the cell. 
 Another common feature of NuSAP and NuMAP is that they both show 
localisation to mitotic chromosomes.  Immunostaining revealed that NuSAP 
localised to microtubules in the vicinity of chromosomes during metaphase and early 
anaphase.  In later anaphase, the intensity of this staining increases (Raemaekers et 
al., 2003).  Interestingly, Raemakers et al (2003) showed that the localisation of 
NuSAP to the vicinity of the chromosomes is independent of microtubule integrity.  
Furthermore, NuSAP has been shown to have the ability to bind DNA directly 
(Ribbeck et al., 2007).  This localisation and direct binding to both DNA and 
microtubules, has led to the hypothesis that NuSAP may play a role in linking 
microtubules to the mitotic chromosomes (Ribbeck et al., 2007).  In this study 
immunostaining and expression of GFP-NuMAP showed NuMAP localisation to the 
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entire mitotic spindle in S2 cells and Drosophila syncyial embryos.  Interestingly, 
two NuMAP truncations, NuMAP(0-171) and NuMAP(0-404), showed 
chromosomal localisation during mitosis.   
Although NuSAP and NuMAP have similar protein structure, possible 
function and potential chromosome binding, they do not localise to the exact same 
region of the mitotic spindle.  Yet NuSAP and NuMAP localisation in meiotic 
spindles is comparable.  By indirect immunofluorescence in Xenopus laevis, NuSAP 
was detected on the entire metaphase I spindle, showing enrichment at microtubules 
in the immediate vicinity of chromosomes (Ribbeck et al., 2006).  Preliminary live 
imaging results of GFP-NuMAP suggest that NuMAP also localises to the entire 
meiotic spindle with enrichment at microtubules surrounding the chromosomes. 
 There are a number of similarities between NuSAP and NuMAP and there are 
also some significant differences.  The phenotypes seen after protein knockdown are 
notably different.  Depletion of NuSAP using siRNA in HeLa cells showed a number 
of different mitotic phenotypes.  Microtubule organisation of the prometaphase 
spindle was abnormal and frequently coupled with an abnormal chromosome 
condensation pattern.  Metaphase cells also show disorganised microtubules, with 
less dense arrays of spindle microtubules and misaligned chromosomes (Raemaekers 
et al., 2003).  However, depletion of NuMAP by RNAi in S2 cells does not result in 
disorganisation of microtubules, but an increase in the number of monoastral 
spindles.  Monoastral spindles are generally created by the lack of centrosome 
duplication/separation during S phase (Wilson et al., 1997).  The increase in 
monoastral spindles in cells treated with dsRNA against NuMAP is not consistent 
with protein localisation.  As I have said previously, NuMAP is localised in the 
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nucleus during interphase and no localisation in the cytoplasm is seen.  Localisation 
of NuMAP to the centrosomes was seen in the embryo.  However this occurs after 
centrosomes have been duplicated/separated.  The increase in the number of 
monoastral spindles in cells treated with dsRNA against NuMAP is statistically 
significant, but not dramatic.  The phenotype was not penetrant and the loss of asters 
is common in S2 cells.  I therefore do not think this result reflects the primary 
function of NuMAP and further study of NuMAP function in the null mutant should 
be carried out to assess its central function. 
 Another aspect of NuMAP and NuSAP which differs is their behaviour when 
present in the cytoplasm during interphase.  By permeabilizing the nuclear envelope 
of MC3T3E1 cells with detergent, NuSAP was seen to pass into the cytoplasm and 
localise to the perinuclear microtubule network during interphase.  Raemakers et al 
(2003) showed that this localisation was dependent on microtubule integrity. 
However, when an NES sequence is coupled to NuMAP, thereby increasing its 
cytoplasmic pool during interphase, no localisation to the microtubule network is 
seen.  These results suggest that NuMAP may undergo a post-translational 
modification which NuSAP does not, preventing its association with microtubules 
during interphase. 
 
4.7.3 Mechanism of NuMAP cell cycle regulation 
I identified NuMAP biochemically by its ability to associate with microtubules 
specifically during mitosis.  NuMAP localises to the nucleus during interphase but 
when it is mis-localised to the cytoplasm by fusion to an NES, it does not associate 
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with the microtubule network.  Both biochemical and cytological studies show that 
NuMAP has a mechanism present during interphase that prevents its association with 
microtubules.  There are multiple ways of protein regulation which may control 
NuMAP function independently or together.   
Firstly, a post-translational modification might be present during interphase. 
This modification may be on the NuMAP protein itself, but it could equally be likely 
present on a NuMAP-binding protein.  Phosphorylation is a key post-translational 
modification and has been shown to play a role in the regulation of multiple proteins 
through the cell cycle.  Thus it is likely that phosphorylation plays a role in the 
regulation of MAPs through the cell cycle.  In addition, in this study phosphorylation 
was maintained during MAP purification from interphase and mitotic cell extracts.  
This supports the possibility that the regulation of NuMAP may be through 
phosphorylation.  
Secondly, NuMAP may undergo rapid protein degradation in a cell cycle 
dependent manner.  NuMAP is predicted to contain a PEST sequence.  PEST 
sequences are hydrophobic stretches involved in the rapid degradation of proteins.  
These sequences are often conditional proteolytic sites, but it has also been suggested 
that phosphorylation of PEST sequences may direct the attachment of multiple 
ubiquitin chains (Rechsteiner and Rogers, 1996).  SDS-PAGE followed by western 
blot of GFP-NuMAP showed reduced mobility of NuMAP.  Ubiquitination of 
potential PEST sequences in NuMAP may contribute to this decrease in protein 
mobility during SDS-PAGE.  This could be investigated by western blot using an 
anti-ubiquitination antibody. 
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Protein and mRNA levels of NuSAP peak at G2 to mitosis and decline 
rapidly after cytokinesis, reducing the quantity of NuSAP during interphase.  NuSAP 
degradation is proposed to be carried out by the ubiquitin/proteasome pathway using 
its KEN box and PEST sequences and is important for accurate spindle formation 
(Song and Rape, 2010).  During this study, high over-expression of GFP-NuMAP 
resulted in the bundling of interphase microtubules.  Therefore to remove excess 
protein during interphase, endogenous NuMAP may be regulated using its potential 
PEST sequence.  It would be interesting to monitor the degradation of NuMAP 
protein through the cell cycle to observe if it is degraded at specific stages similar to 
its potential homologue NuSAP. 
 Lastly, a number of MAPs which localise to the nucleus during interphase 
and to the spindle during mitosis have been shown to be regulated by the RanGTP 
pathway.  NuMAP may fall within this group.  Ran is a member of the Ras GTPase 
family which regulates intracellular processes such as spindle assembly at the start of 
mitosis and nuclear envelope reassembly after mitosis.  The activity of Ran is 
activated by the GTPase activating protein RanGAP1, which stimulates the 
hydrolysis of Ran bound GTP to GDP.  The non-catalytic protein Ran binding 
protein 1 (RanBP1) also plays a role in this process.  In isolation RanBP1 stabilises 
RanGTP and in the presence of regulators increases the activity of the RanGAP1 
protein.  GDP bound to Ran is next exchanged for GTP.  This exchange is instigated 
by the nucleotide exchange factor RCC1 (regulator of chromosome condensation 1).  
RCC1 is chromosomal associated, binding to chromatin through an interaction with 
histones H2A and H2B.  Therefore a pool of RanGTP is created in the vicinity of 
chromatin.  During interphase RCC1 associates with chromatin within the nucleus 
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and RanGAP1 is located in the cytoplasm.  Therefore a high concentration of 
RanGTP is present in the nucleus and RanGDP in the cytoplasm. 
 The Importin (Imp) β family of proteins, known to be transport receptors, are 
effectors of the RanGTP pathway.  The Imp family are normally classified as the 
importins and the exportins.  Importins bind their cargo in low RanGTP 
environments and release this cargo upon the binding of RanGTP.  Exportins work in 
the opposite way; they bind their cargo in a high RanGTP environment and unload 
their cargo upon the hydrolysis of GTP.  The binding of importins and exportins not 
only regulates the localisation of their cargo but also the cargo’s activity. 
 The RanGTP pathway has been shown to regulate the key proteins involved 
in the formation of the mitotic spindle such as TPX2, NuMA and also NuSAP.  The 
binding of importin-α and -β to NuSAP was shown to inhibit protein activity, 
preventing its binding to microtubules.  Data also suggested that the importin-α and 
importin-β heterodimers may mediate NuSAP localisation to the nucleus (Ribbeck et 
al., 2006).  The RanGTP pathway regulation of spindle factors, specifically NuSAP, 
suggests that NuMAP might be regulated in a similar way.  Two features of NuMAP 
which also hint that NuMAP might be a component of the RanGTP network are 
NuMAP is imported into the nucleus during interphase and NuMAP localises to the 
mitotic spindle.  I therefore believe that NuMAP is regulated in the same manner as 
NuSAP, by the RanGTP pathway. 
I hypothesise that during interphase the importin proteins, importin-α and 
importin-β, associate with NuMAP and mediate its localisation to the nucleus.  As 
cells progress into mitosis the nuclear envelope is broken down and NuMAP is 
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released into the cytoplasm.  Importin-α and importin-β proteins are likely to remain 
associated with NuMAP restricting its activity.  However, in the vicinity of the 
spindle, NuMAP is released from the importin proteins by RanGTP and is able to 
associate with microtubules.  This proposed model is illustrated in Figure 4.10.  
If Ran and the importin proteins only regulated NuMAP association with 
microtubules then the protein would be localised to microtubules in the vicinity of 
the chromosomes.  However, NuMAP is distributed evenly over the entire spindle.  
Therefore I propose that though Ran regulation may play a role in determining 
NuMAP association with microtubules, it may more importantly regulate the activity 
of NuMAP and therefore its function thus restricting NuMAP activity to the vicinity 
of the chromosomes.  Two truncations of NuMAP showed it to have the ability to 
associate with the chromosomes during mitosis.  It is therefore possible that like 

















































Figure 4.10 Proposed model of NuMAP cell cycle regulation.  Schematic
representation of proposed mechanism of the cell-cycle regulation of 
NuMAP.  During interphase, cytoplasmic NuMAP is bound by the importin 
proteins (α and β), and imported into the nucleus.  The high concentration
of RanGTP in the nucleus releases this binding, leaving NuMAP free in the
nucleus.  During mitosis, the importin proteins are likely to remain 
associated with NuMAP restricting its activity.  However, in the vicinity of the
chromosomes, NuMAP is released from the importin proteins by a high
concentration of RanGTP and is able to associate with microtubules.
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5 Summary and future direction 
 
5.1 Background 
The microtubule cytoskeletal network functions as a central framework of diverse 
cellular processes such as cell division, migration and morphogenesis (Valiron et al., 
2001).  One of the most remarkable structures formed by microtubules is the mitotic 
spindle, which is crucial for correct chromosome segregation during cell division.  
As cells progress through the cell cycle, the microtubule array changes dramatically 
from interphase to mitosis.  During interphase, microtubules emanate from the 
microtubule organising centres located at the centre of the cell towards the cell 
periphery.  At the onset of mitosis, the interphase array is reorganised into the 
dynamic mitotic spindle. 
This crucial re-organisation of microtubules is dependent on an abundance of 
proteins that interact with microtubules.  This group of proteins are called 
microtubule-associated proteins (MAPs).  Together these proteins use diverse 
mechanisms to regulate the organisation and function of microtubules through the 
cell cycle. 
As MAPs play a central role in the regulation of microtubule organisation, I 
hypothesised that there are distinct groups of MAPs which associate and regulate 
microtubules at specific times during the cell cycle.  Specifically, I proposed that as a 
cell progresses from interphase to mitosis, an interphase group of MAPs will 
dissociate and a mitotic-specific group of MAPs will associate with microtubules.  
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This group of mitotic MAPs will be important for the formation and function of the 
mitotic spindle. 
Although MAPs play an essential role in the regulation of microtubules and 
the formation of the mitotic spindle, only a handful of proteins are known to 
associate with microtubules specifically during mitosis.  The aim of this study was to 
identify more of those MAPs that associate with microtubules specifically during 
mitosis and to understand their regulation and function.  To fulfil this aim, I 
developed a method to determine the profiles and relative quantities of MAPs 
purified from mitotic and interphase Drosophila culture cells. 
 
5.2 A new method for the identification of MAPs 
The developed method utilises mass spectrometry combined with stable isotope 
labelling by amino acids in cell culture (SILAC) for protein quantification.  In brief, 
two populations of Schneider 2 (S2) cells were cultured, one in media containing 
‘heavy’(
13
C) amino acids and the other in media containing ‘light’ (
12
C) amino acids.  
Using these cultures as sources of interphase and mitotic proteins, MAPs were 
purified by microtubule co-sedimentation from mixed extracts (‘heavy’ interphase 
and ‘light’ mitotic) and analysed by mass spectrometry to determine their protein 
ratios.  These ratios represent the microtubule affinity of individual MAPs in 
interphase and mitosis, allowing the identification of those MAPs whose microtubule 
affinity increases in mitosis.  The advantage of using SILAC is that the proteins from 
both cell populations can be combined and analysed together by microtubule binding 
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assay and mass spectrometry.  This reduces the possibility of experimental variance 
and enables an accurate comparison of interphase and mitotic MAPs. 
Three major aspects of the method were optimised during this study.  Firstly, 
microtubule co-sedimentation in S2 cells was established.  For microtubule co-
sedimentation in S2 cells the addition of exogenous tubulin is required for 
microtubule polymerisation.  I identified that 7.5µg of exogenous tubulin to 1 x 10
8
 
cells was the optimal ratio of tubulin to cell number in order to quantitate a 
significant number of MAPs using mass spectrometry. 
Secondly, to identify MAPs which are cell cycle regulated, major post-
translational modifications were maintained.  Phosphorylation is a key post-
translational modification and regulates multiple proteins through the cell cycle and 
is probably significant in MAP regulation.  I therefore identified a combination of 
phosphatase inhibitors which was compatible with microtubule co-sedimentation and 
maintained cellular phosphorylation.  Using the MPM2 antibody to monitor extract 
phosphorylation, I identified the combination of 15 mM NaVO4, 10 mM p-
nitrophenyl phosphate and 1 µM okadaic acid to be suitable. 
Lastly, previous to this study SILAC had not been carried out using S2 cells, 
I therefore identified suitable SILAC culture conditions for S2 cell growth.  Although 
cell morphology was normal, S2 cell doubling time increased two-fold in dialysed 
FBS and yeast extract.  Mass spectrometry analysis revealed minimal arginine 
conversion in S2 cells, allowing the use of standard media concentrations (3.4 mM) 
of arginine. 
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The use of the optimised protocol identified 4 proteins (KLP61F, laminin A 
and two uncharacterised proteins CG11120 and CG3902) which showed increased 
microtubule affinity during mitosis.  CG11120 consistently gained a significant ratio 
which in both experiments lay close to that of KLP61F, a previously characterised 
cell cycle-regulated MAP.  I therefore studied CG11120 more closely, naming it 
nuclear microtubule associated protein (NuMAP). 
The identification of KLP61F confirms that the developed method is effective 
and appropriate for the identification of mitotic specific MAPs.  However, the 
number of proteins identified to associate with microtubules in mitosis was smaller 
than expected.  In the future, the sensitivity of the screen and hence its application on 
a larger scale may be improved by the measures discussed in chapter 3 in order to 
further dissect and identify the molecular mechanism of spindle formation in mitosis. 
The design of the method also allows for its application to a large range of 
microtubule processes other than its use in this present study.  Although microtubule 
reorganisation from interphase to mitosis is crucial, other changes in microtubule 
organisation occur during the cell cycle and development.  This described method 
could therefore be utilised as a tool for the rapid identification of MAPs regulating 
these other transitions in future studies. 
The method described here can be broken down into individual, specific tools 
which can be used separately.  Importantly, I have developed the use of SILAC in S2 
cells, a strategy which makes it possible to monitor quantitative differences at the 
protein level between different cell conditions.  Although the Drosophila 
melanogaster genome is among the best annotated, proteomic studies in Drosophila 
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are uncommon, with quantitative proteomics being very few.  In parallel to this 
study, was demonstrated that SILAC in Drosophila cells in combination with RNAi 
can be used to study gene function at the protein level (Bonaldi et al., 2008).  On the 
other hand, I have demonstrated that using SILAC in S2 cells can identify genes 
involved in specific cellular processes.  Therefore the developed tool when applied to 
future studies can give greater insight and understanding into the cellular 
mechanisms of Drosophila in top down and bottom up approaches. 
 
5.3 NuMAP: A new mitotic-specific MAP 
5.3.1 Localisation of NuMAP 
I next characterised the localisation of the identified protein NuMAP.  In S2 cells and 
early embryonic divisions, GFP-tagged NuMAP localised to the nucleus during 
interphase and to microtubules only during mitosis, confirming NuMAP to be a cell 
cycle regulated MAP.  The localisation to the spindle was confirmed for endogenous 
NuMAP by immunostaining with anti-NuMAP peptide antibodies coupled with 
RNAi.  Live imaging analysis in the syncytial embryo shows that NuMAP localises 
to duplicated centrosomes during prophase and as the mitotic spindle is formed, 
localises uniformly to the length of spindle microtubules.  NuMAP protein remains 
localised to spindle microtubules through anaphase and into telophase where it 
appears to localise to discrete regions of the central spindle. 
 Due to the distinctive cell cycle localisation of NuMAP, I identified its 
localisation domains and investigated the ability of NuMAP to associate with 
interphase microtubules.  Truncation analysis of NuMAP protein revealed that it 
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contains two domains that are sufficient but not essential for nuclear localisation and 
one C-terminal domain which is essential for microtubule association.  To overcome 
nuclear localisation of NuMAP during interphase and study its microtubule binding 
activity during interphase, I generated NuMAP protein fused to a nuclear export 
signal (NES).  Though nuclear localisation remained predominant, an increased 
cytoplasmic pool of NuMAP was generated.  This cytoplasmic pool of NuMAP 
fused NES protein did not associate with interphase microtubules, indicating that the 
interphase form of NuMAP has low affinity for microtubules.  In contrast, expression 
of the microtubule binding domain alone fused with an NES showed association with 
interphase microtubules.  Interestingly, microtubules were bundled and showed a 
circular interphase microtubule array.  This indicated that the microtubule binding 
domain of NuMAP alone has high affinity for microtubules even in interphase and 
that the cell cycle regulation of NuMAP is mediated by another region of the protein.  
The nuclear localisation and regulation of the microtubule binding ability of NuMAP 
is therefore critical to prevent the bundling of interphase microtubules. 
 The characterisation of NuMAP localisation and its regulation was carried 
out in S2 cells.  S2 cells are a non-clonal population which were originally derived 
from the Drosophila embryo and have been adapted for growth in suspension.  As a 
model system, cells are diverse and the cell population is not homogeneous.  
Therefore work in this model system must take this into consideration and 
quantitative analysis of phenotypes is essential.  During transfection cells can take up 
single copies of the plasmid construct resulting in average levels of over-expression.  
In contrast however, cells in the same transfected population can take up multiple 
copies of the plasmid.  This results in high levels of over-expression which may 
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affect protein localisation.  Therefore due to the variation in expression in S2 cells, 
the protein localisation of NuMAP constructs were counted and categorised.  
However, this was done by eye and therefore human error and opinion will have an 
effect on the results.  On drawing conclusion on NuMAP function and regulation this 
must be taken into consideration. 
 
5.3.2 NuMAP function 
To study the function of NuMAP, I used two approaches; the depletion of NuMAP in 
cultured cells and its deletion in developing flies.  The use of RNAi to deplete 
NuMAP protein in S2 cells resulted in an increase in the number of bipolar spindles 
with only one aster compared to control RNAi cells.  The lack of an aster at a spindle 
pole generally occurs due to the lack of centrosome duplication/separation during S 
phase.  This therefore suggests that NuMAP may somehow play a role in centrosome 
duplication.  However, this is not consistent with NuMAP localisation and therefore 
may not represent the primary function of NuMAP.  In parallel, the deletion of the 
NuMAP gene in flies, generated by P-element excision, indicated that NuMAP is not 
essential for fly viability.  However, preliminary results show that homozygotes of 
the NuMAP deletion mutant have reduced viability.  Also, only two of the many 
embryos laid by seven homozygote females developed to third instar larva but no 
further, suggesting the mutant to be female sterile.  Further analysis is needed to test 
whether these phenotypes are due to the deletion of NuMAP, as the extent of the 
deletion is yet to be determined.  
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5.4 Future directions 
The work summarised here advances our understanding of microtubule regulation 
through the cell cycle, proving my hypothesis that a group of MAPs associate with 
microtubules specifically during mitosis to be correct.  This study identified a new 
MAP which associates with microtubules specifically during mitosis, I named this 
protein NuMAP.  Although NuMAP has been shown to co-localise with 
microtubules, all microtubule association of NuMAP has been demonstrated in cell 
extract.  Therefore an in vitro microtubule binding assay is needed to distinguish if 
the association of NuMAP with microtubules is direct or if its association is 
dependent on a binding partner.  To determine this, I will incubate bacterially 
produced NuMAP protein with microtubules and then sediment the microtubules by 
centrifugation.  If NuMAP directly interacts with the microtubules, it will co-
sediment and be present in the microtubule pellet. 
Although NuMAP localisation and microtubule binding domains have been 
identified, little is known about its function.  To investigate the function of NuMAP 
in the developing fly, I will first examine the expression pattern of NuMAP during 
development by western blot.  Through development, proteins are often expressed at 
their time of function, therefore examination of their expression profile during 
development can suggest their role in development.  Due to the method used for the 
discovery of NuMAP, I propose that it plays a role in spindle formation and it would 
therefore be interesting to know if the expression of NuMAP is specific to 
developmental stages of increased cell division, such as the early embryo. 
157
 To understand the function of NuMAP in Drosophila development further, it 
is invaluable to analyse the NuMAP deletion mutant generated in this study.  Firstly I 
would like to define the region of genomic sequence removed during P-element 
excision.  Further analysis is therefore required to test whether phenotypes observed 
are due to the deletion of the NuMAP gene.  To achieve this, the NuMAP-GFP fly 
strain generated in this study can be used in rescue experiments to assess if 
expression of NuMAP protein can rescue the phenotypes observed.  Preliminary 
studies of the NuMAP deletion mutant have suggested that the removal of the 
NuMAP gene affects early development.  As NuMAP localises to the mitotic and 
meiotic spindle microtubules, it will therefore also be interesting to examine spindle 
microtubule organisation and function in mitosis and meiosis in the NuMAP deletion 
mutant. 
 During truncation analysis of NuMAP protein, I observed that NuMAP-GFP 
over-expression appeared to induce microtubule bundling, suggesting that NuMAP 
functions to bundle microtubules.  NuMAP shows homology to the human protein 
NuSAP which when over-expressed has been shown to bundle and stabilise 
microtubules making them resistant to colchicine treatment.  Therefore I will treat 
cells over-expressing NuMAP with colchicine to determine if NuMAP is also 
capable of stabilising these microtubule bundles, as does NuSAP.  This would also 
help to determine if NuMAP is a potential homologue of the human NuSAP protein. 
MAPs play an essential role in the regulation and formation of the mitotic 
spindle and it is likely that they themselves are under tight regulation.  However 
regulation of MAPs is poorly understood.  Biochemical and cytological studies show 
that NuMAP has a mechanism present during interphase which prevents its 
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association with microtubules.  Phosphorylation is a key cellular post-translational 
modification used to regulate proteins through the cell cycle and thus it is most likely 
to also regulate MAPs.  In this study, phosphorylation was maintained during MAP 
purification and this supports the possibility that the regulation of NuMAP may be 
through phosphorylation.  NuMAP has been identified to be phosphorylated in a 
previous phosphoproteome screen.  Systematic mutation of potential phosphorylation 
sites to alanine, an unphosphorylatable amino acid, may identify key residues in the 
regulation of the microtubule binding activity of NuMAP.  As cell phosphorylation 
levels increase in mitosis, I expect phosphorylation to enhance the association of 
NuMAP with microtubules.  Therefore I expect an unphosphorylatable mutant of key 
phosphorylation sites to show mis-localisation in mitosis. 
In parallel to systematic mutagenesis, I will use the SILAC tool developed 
here to identify the changes in the phosphorylation of NuMAP through the cell cycle.  
Two populations of cells will be cultured, one in ‘heavy’ media and one in ‘light’ 
media.  Again these cultures will be used as sources of interphase and mitotic 
proteins.  NuMAP will be purified from mixed extracts and analysed by mass 
spectrometry to determine phosphorylation ratios.  The advantage of using SILAC is 
that it will identify those modifications which change through the cell cycle and not 
those which are constitutively phosphorylated.  This will provide potential sites 
which will be subsequently mutated to identify their roles in the localisation and 
function of NuMAP. 
If phosphorylation is shown to regulate NuMAP, it will next be important to 
identify the kinase responsible.  At this point, key phosphorylation sites will be 
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known and therefore the sequence surrounding the site can be compared to known 
kinase consensus sequences. 
Lastly, the organisation and function of the microtubule network is regulated 
by the co-ordination of multiple MAPs.  The identification of NuMAP interacting 
proteins and how they function together to regulate microtubule behaviour will 
indicate the mechanism in which NuMAP functions.  I therefore will use immuno-
precipitation with mass spectrometry to identify NuMAP-interacting proteins.  The 
mapping of these interactions through truncation analysis or cross linking followed 















During the development of the method for identification of MAPs which associate 
with microtubules specifically during mitosis, three other side projects arose which 
resulted in potentially interesting data.  In this appendix I will briefly describe these 
projects. 
 
A.1 Identification of microtubule associated proteins from embryonic 
extract 
Microtubule co-sedimentation using Drosophila embryonic extract is a common and 
effective method for the isolation of MAPs (Kellogg et al., 1989).  Before I 
established microtubule co-sedimentation in Schneider 2 (S2) cells I tested a 
previous method used by Kellogg et al (1989) using embryonic extract.   
Embryonic tissue (0-4hrs) from w
1118
 flies was homogenised from frozen 
using a Dounce homogeniser using identical buffers as described for S2 cell co-
sedimentation.  The homogenised product was cleared of debris by centrifugation at 
20 krpm for 10 minutes at 4 C in a Beckman Avanti J-25 with JA-25.50 rotor.  The 
pellet was discarded and centrifugation repeated at 20 krpm.  The extract was then 
centrifuged repeatedly at 55 krpm (100 000g ) for 10 min until there was negligible 
pellet remaining.  Latrunculin A and B were added to 2 µg/ml, DTT to 0.1 mM and 
GTP to 1 mM.  The extract was then split into two halves, the control and the 
sample.  Embryonic extract has high tubulin content and enables the polymerisation 
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of endogenous tubulin in the presence of taxol.  To the sample, taxol was added 
stepwise to achieve a final concentration of 20 µM in order to polymerise 
microtubules.  To the control, colchicine was added to achieve a final concentration 
of 10 µg/ml.  Both the sample and control were then incubated at room temperature 
for 1 hour.  The incubation time allowed for proteins from the extract to bind 
microtubules.  The microtubules were then pelleted through a sucrose cushion twice, 
bringing with them any associated proteins. 
Protein pellets from the sample and control were analysed by SDS-PAGE and 
coomassie blue staining (Figure A1a).  Coomassie blue staining showed a number of 
proteins in sample pellet.  In contrast, the control pellet contained less protein.  This 
indicated that those proteins in the sample pellet were most likely to be microtubule 
binding proteins and were analysed by mass spectrometry.  An SDS-PAGE of the 
microtubule pellet was cut into two and trypsin digestion was carried out.  Both 
sections were cleaned using a C18 stage tip and run on an LC MS/MS Orbitrap.  The 
data was processed using DTAsupercharge and Mascot software.  In total 137 
proteins were identified from this process. 
To assess the purity of the sample, I compared those proteins identified with a 
previous microtubule mass spectrometry based screen by Hughes et al (2008).  
Hughes et al (2008) considered proteins significant if they scored above 30.  
Therefore I too only considered those proteins with scores above 30.  Of those 
proteins identified in this present study, 32 % were also identified by Hughes et al 
(2008).  Interestingly, 46.5% of those proteins not identified by Hughes et al (2008) 










Figure A1  Microtubule co-sedimentation in Drosophila embryonic 
extract.  (A) Coomassie blue staining analysis of microtubule 
co-sedimentation in embryonic extract.  The sample (S) pellet shows
significant protein and control (C) minimal protein.  (B) Silver stain 
analysis of sample and control protein pellets from microtubule 
co-sedimentation in the presence and absence of phosphorylation (P).  
The control pellet,which contained no microtubules, contains minimal protein,















analysis of my sample was in depth and identified proteins present at low levels 
different from those identified by Hughes et al. 
In summary, the microtubule co-sedimentation method tested here is effective 
for the isolation of MAPs and the mass spectrometry method used is thorough and a 
suitable tool for the identification of MAPs. 
 
A.2 Identification of MAPs whose microtubule binding is regulated 
through phosphorylation 
To identify MAPs that are cell cycle regulated, major post-translational 
modifications need to be maintained.  Phosphorylation is an abundant reversible 
post-translational modification that has been shown to affect protein stability, 
localisation and protein-protein interactions (Pinkse et al., 2004).  This tightly 
controlled modification is recognised to play an essential role in a number of cellular 
processes such as signal transduction, metabolic maintenance and most importantly 
the cell cycle (Reinders and Sickmann, 2005).  Therefore it is likely that 
phosphorylation plays a role in regulating MAPs and should be maintained during 
MAP purification.  I therefore identified a combination of phosphatase inhibitors 
which was compatible with microtubule co-sedimentation and maintained cellular 
phosphorylation.  Using MPM2 antibody to monitor extract phosphorylation, I 
identified the combination of 15 mM NaVO4, 10 mM p-nitrophenyl phosphate and 1 
µM okadaic acid to be suitable. 
 Although this protocol was developed to specifically identify MAPs which 
are cell cycle regulated, it also enabled the identification of any MAPs whose 
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microtubule association is affected by phosphorylation.  Therefore as a secondary 
project I aimed to identify those MAPs regulated by phosphorylation.  To achieve 
this aim I carried out microtubule co-sedimentation in Drosophila embryonic extract 
in both the presence and absence of phosphorylation.   
Previously I had noticed that phosphatase inhibitors chemically decrease the 
association of MAPs with microtubules.  This would influence the identification of 
MAPs regulated by phosphorylation and may result in false positives.  To ensure that 
there was no chemical effect of phosphatase inhibitors, other than the maintenance of 
phosphorylation, embryonic extract was prepared in the absence of phosphatase 
inhibitors.  This allowed for phosphorylation to be removed by active endogenous 
phosphatases.  Phosphatase inhibitors were then added and co-sedimentation was 
carried out.  In parallel, co-sedimentation was carried out with the addition of 
phosphatase inhibitors during extract preparation thus maintaining phosphorylation.  
The two sets of identified MAPs, those purified in the presence of phosphorylation 
and those purified in the absence of phosphorylation, could then be fairly compared. 
Microtubule pellets obtained in the presence and absence of phosphorylation 
were analysed by silver stain (Figure A1b).  Silver staining showed that both pellets 
contained a similar number of proteins.  To identify specific changes in protein 
profiles between co-sedimentation with and without phosphorylation, LC MS/MS 
analysis was carried out on microtubule pellets.  In total 329 proteins were identified 
in the microtubule pellet obtained in the absence of phosphorylation and 274 proteins 
were identified in the microtubule pellet obtained in the presence of phosphorylation.  
To identify those MAPs whose microtubule association is effected by 
phosphorylation, I compared the protein profiles of the microtubule pellets.  This 
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comparison showed that 109 proteins were purified only in the absence of 
phosphorylation and 55 proteins purified only in the presence of phosphorylation. 
To confirm that those proteins identified to be affected by phosphorylation, I 
decided to repeat the experiment and microtubule co-sedimentation was performed 
as previously described.  In total, 420 proteins were identified in the microtubule 
pellet obtained in the absence of phosphorylation and 390 proteins were identified in 
the microtubule pellet obtained in the presence of phosphorylation.  103 proteins 
were purified only in the absence of phosphorylation and 71 proteins were only 
purified only in the presence of phosphorylation.  The two experiments were 
compared in order to identify those MAPs whose microtubules binding is affected by 
phosphorylation.  23 proteins were identified to associate with microtubules only in 
the absence of phosphorylation, suggesting that phosphorylation inhibits their 
association with microtubules.  Only 10 proteins were identified to associate with 
microtubules only in the presence of phosphorylation, suggesting that 
phosphorylation enhances their association with microtubules (Table A1). 
Using microtubule co-sedimentation I have identified MAPs whose 
microtubule association is potentially regulated by phosphorylation.  However, the 
purification and analysis of samples was done separately.  No single mass 
spectrometry analysis results in full sample coverage and variance between the 
qualities of mass spectrum can be large.  Therefore comparison of MAPs purified in 
the presence and absence of phosphorylation is not conclusive evidence that 
phosphorylation effects their microtubule association.  This method of identification 
could be improved by the use of post-purification labelling mechanism such as 
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Synonym Number of 
peptides 
Protein score 
  Exp 1 Exp 2   
CG9042 Glycerol 3 phosphate dehydrogenase 5 3 258 111 
CG14792 Stubarista 4 4 177 180 
CG16817  4 3 148 157 
CG5266 Proteasome 25kD subunit 2 2 115 110 
CG5784 Mapmodulin 3 1 111 38 
CG5289 Proteasome 26S subunit subunit 4 ATPase 2 1 100 96 
CG7003 Msh6 3 2 98 67 
CG10480 Bj1 protein 1 3 89 133 
CG6339 Rad50 1 2 84 102 
CG16935  2 3 80 177 
CG7414  1 2 76 93 
CG2945 Cinnamon 2 3 74 91 
CG6625 Soluble NSF attachment protein 1 1 74 77 
CG3917 Gamma-tubulin ring protein 84 1 3 69 164 
CG3820 Nucleoporin 214 1 1 64 28 
CG32858 Singed 1 2 58 83 
CG1799 Raspberry 1 6 40 356 
CG33106 Multiple ankyrin repeats single KH domain 1 2 36 123 
CG11654 Adenosylhomocysteinase at 13 1 5 34 228 
CG6535 Telomere fusion 1 1 28 26 
CG8491 Kohtalo 1 1 28 31 
CG5581 Otefin 1 2 27 100 
CG4063 Ebi 1 1 25 42 
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isostope-coded affinity tags (ICAT) and iTRAQ chemical labelling to enable the 
analysis of combined samples. 
 
A.3 Optimisation of phosphopeptide enrichment for the identification of 
phosphorylation sites on MAPs 
It is thought that approximately 30 % of mammalian cell content is at one point in its 
life span phosphorylated.  Therefore, great effort has been focused on the 
development of suitable methods for the identification and characterisation of 
phosphorylated proteins (McLachlin and Chait, 2001).  Mass spectrometry has 
become one of the most widely used and powerful techniques for proteome-wide 
experiments and therefore the use of mass spectrometry in the identification of 
phosphorylation sites would be of great value. 
 However, there are still limitations to mass spectrometry-based methods in 
the analysis of phosphorylation.  Firstly, no single mass spectrometry approach 
results in 100 % coverage and consequently regions of interest may be missed.  
Secondly, the addition of a phosphate group affects both proteolytic cleavage and the 
ionisation of the protein/peptide and therefore the mass spectrometry signal for 
phosphopeptides is reduced (Kuroda et al., 2004; Larsen et al., 2005; McLachlin and 
Chait, 2001).  Lastly and probably the most substantial limitation is the presence of 
non-phosphorylated peptides.  Phosphorylation is often sub-stoichiometric, giving a 
low abundance of phosphopeptides for analysis.  This results in the mass 
spectrometry signal for phosphopeptides being suppressed by the presence of non-
phosphopeptides.  It is therefore advantageous to enrich phosphopeptides, reducing 
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the complexity of the mixture and therefore suppression of the phosphopeptide 
signal. 
 A variety of methods have been developed to enhance the phosphopeptide 
sample for mass spectrometry.  The more widely applied strategies have been 
chemical tagging, immobilised metal affinity chromatography (IMAC) and metal 
oxide chromatography (MOC) (Sugiyama et al., 2007).  In recent years titanium 
dioxide (TiO2) has been demonstrated to be an effective reagent in the MOC method 
for phosphopeptide enrichment by the analysis of B.subtilis and E.coli 
phosphoproteomes (Macek et al., 2008; Macek et al., 2007). 
 Larsen et al (2005) showed that the inclusion of 2, 5 dihydroxybenzoic acid 
(DHB) during phosphopeptide enrichment using TiO2 was effective at removing 
acidic non-phosphopeptides.  However DHB is not compatible with LC-MS/MS 
analysis as it interferes with peptide detection and affects the LC MS/MS system 
(Larsen et al., 2005).  During this study, Sugiyama et al (2007) developed a new 
approach for phosphopeptide enrichment using TiO2 using aliphatic hydroxyl acids 
such as lactic acid (Sugiyama et al., 2007).  However, I further wanted to develop the 
method for use with S2 cells specifically. 
 I needed to optimise the concentration of lactic acid used during 
phosphopeptide enrichment.  To achieve this, I performed phosphopeptide 
enrichment using peptide mixtures from in-solution digested cycling S2 cell extract 
using different concentrations of lactic acid.  TiO2 beads were incubated in peptide 
mixtures and bound peptides eluted.  Each digestion was incubated sequentially with 
three batches of beads.  To observe the enrichment of phosphopeptides the 
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percentage of phosphopeptides identified by mass spectrometry after enrichment was 
calculated (Number of phosphopeptides/Total number of peptides X 100). 
Analysis of S2 cell extract without phosphopeptides results in 0-0.04 % of 
observed peptides being phosphorylated.  The number of phosphopeptides and non-
phosphopeptides was plotted against the concentration of lactic acid used (Figure 
A2).  The number of non-phosphopeptides decreases continuously as the 
concentration of lactic acid is increased.  However, the proportion of identified 
phosphopeptides remained approximately 30 % and rapidly decreased as the 
concentration of lactic acid was increased to 100 mg/ml.  I therefore determined the 
optimum concentration of lactic acid to be 85 mg/ml. 
Using this optimum concentration of 85 mg/ml lactic acid, phosphopeptide 
enrichment was carried out on in-gel digested Mad3 protein phosphorylated in vitro 
using Mph1 kinase.  These samples were provided by Judith Zich from the Hardwick 
Lab.  14 of the 19 unique peptides identified from Mad3 and Mph1were 
phosphopeptides.  Without phosphopeptide enrichment 68 unique peptides were 
identified with only being 5 phosphopeptides. 
In summary, I have identified a lactic acid concentration of 85 mg/ml to be 
effective in phosphopeptide enrichment from in-solution and in-gel digested proteins.  
However, the method needs further testing for its use on the identification of MAP 
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Figure A2.  Number of non-phospho and phosphopeptides 
observed with the use of varying lactic acid concentrations.  An 
increase in the lactic acid concentration used during phosphopeptide 
enrichment decreases the number of non-phosphopeptides observed.  
However the number of phosphopeptides also decreases when the 
concentration of lactic acid reaches 80-90 mg/ml.  This indicates the 
optimum concentration of lactic acid is 85 mg/ml.











A.4 Supplementary tables 
Table A2 
Table A2 shows proteins from the first relative quantification of MAPs purified from 
interphase and mitosis extracts.  The table lists the 270 proteins quantified in 
ascending order of ‘heavy’/ ‘light’ ratio.  Those proteins in red make it through the 




Table A3 shows proteins from the second relative quantification of MAPs purified 
from interphase and mitosis extracts.  The table lists the 156 proteins quantified in 
ascending order of ‘heavy’/ ‘light’ ratio.  Those proteins in red make it through the 









Table A2  Quantified proteins from the first relative quantification of 
MAPs from interphase and mitosis. 
CG 
Number 




CG2093 Vacuolar protein sorting 13 1 0.002979 
CG9359 β-Tubulin at 85D 16 0.025272 
CG9476 α-Tubulin at 85E 13 0.026871 
CG3401 β-Tubulin at 60D 13 0.033196 
CG10390 Meiosis I arrest 1 0.036992 
CG31315  1 0.038591 
CG2512 α-Tubulin at 84D 19 0.057841 
CG3836 Stonewall 2 0.065102 
CG9277 β-Tubulin at 56D 24 0.080957 
 Porcine Trypsin 8 0.10706 
 Bovine Albumin 14 0.18835 
CG9191 Kinesin-like protein at 61F 8 0.1886 
CG11120  6 0.19275 
CG4869 β-Tubulin at 97EF 12 0.1949 
CG4001 Phosphofructokinase 3 0.19811 
CG13345 Tumbleweed 2 0.27969 
CG10641  4 0.34193 
CG1258 Pavarotti 18 0.34382 
CG12065  2 0.37367 
CG11207 Fascetto 6 0.37713 
CG10691 Lethal (2) 37Cc 1 0.41397 
CG9193 Mutagen-sensitive 209 2 0.42167 
CG10160 Ecdysone-inducible gene L3 2 0.45315 








CG1681  3 0.48269 
CG3902  6 0.48675 
CG5099 Musashi 2 0.49585 
CG7831 Non-claret disjunctional 13 0.50489 
CG18076 Short stop 31 0.50812 
CG10236 Laminin A 1 0.52101 
CG2238 Elongation factor 2b 10 0.52976 
CG12165 Inner centromere protein 5 0.53705 
CG3415  2 0.53766 
CG6647 Porin 7 0.54296 
CG1782 Ubiquitin activating enzyme 1 7 0.54343 
CG2982  4 0.55765 
CG5787  2 0.55797 
CG9633 Replication Protein A 70 3 0.60835 
CG6756 Translocase of outer membrane 70 2 0.60921 
CG9412 Rasputin 2 0.61069 
CG14804 Vacuolar protein sorting 26 3 0.61441 
CG13387 Embargoed 5 0.62005 
CG12030  7 0.63089 
CG7438 Myosin 31DF 5 0.6322 
CG1616 Disc proliferation abnormal 6 0.63388 
CG8893 Glyceraldehyde 3 phosphate 
dehydrogenase 2 6 0.636 
CG12141 Lysyl-tRNA synthetase 3 0.63801 
CG9916 Cyclophilin 1 4 0.65189 
CG31716  4 0.65291 








CG12233 Lethal (1) G0156 4 0.65769 
CG10565  3 0.65895 
CG10701 Moesin 5 0.66012 
CG7008 Tudor-SN 9 0.66286 
CG5119 PolyA-binding protein 4 0.67501 
CG5108 Mitochondrial ribosomal protein S7 4 0.67572 
CG5353 Threonyl-tRNA synthetase 16 0.67811 
CG10523 Parkin 1 0.68438 
CG4800 Translationally controlled tumor 
protein 4 0.68553 
CG2064  2 0.68556 
CG9075 Eukaryotic initiation factor 4a 3 0.68593 
CG1591 REG 2 0.68734 
CG10161 Eukaryotic initiation factor 3 p66 
subunit 3 0.68758 
CG1009 Puromycin sensitive aminopeptidase 7 0.69725 
CG6944 Lamin 3 0.6973 
CG1458  1 0.69846 
CG7010 Lethal (1) G0334 2 0.70089 
CG10279 Rm62 3 0.70371 
CG5784 Mapmodulin 2 0.7056 
CG2331 TER94 12 0.70784 
CG5730 Annexin IX 5 0.71414 
CG8036  5 0.73023 
CG12306 Polo 2 0.73051 
CG8402 Protein phosphatase D3 2 0.73193 








CG14996 Chd64 4 0.73527 
CG8947 26-29kD-proteinase 4 0.7373 
CG4265 Ubiquitin carboxy-terminal hydrolase 3 0.74103 
CG10223 Topoisomerase 2 8 0.74178 
CG17064 Mars 3 0.75036 
CG3937 Cheerio 28 0.75535 
CG1548 CathD 4 0.76086 
CG13281 CAS/CSE1 segregation protein 2 0.76208 
CG3523  5 0.7637 
CG14648 Growl 2 0.76491 
CG18572 Rudimentary 5 0.76611 
CG11949 Coracle 4 0.76649 
CG7461  6 0.76927 
CG12163  2 0.77329 
CG4027 Actin 5C 9 0.77358 
CG15112 Enabled 2 0.78047 
CG4747  3 0.78239 
CG7113 Scully 3 0.78242 
CG16901 Squid 3 0.78389 
CG1721 Phosphoglyceromutase 4 0.79004 
CG8280 Elongation factor 1α48D 8 0.79892 
CG3696 Kismet 2 0.8057 
CG4600 Yippee interacting protein 2 4 0.81364 
CG1065 Succinyl coenzyme A synthetase α 
subunit 7 0.82218 
CG4466 Heat shock protein 27 2 0.82403 









aminotransferase 2 4 0.83285 
CG4389  6 0.83359 
CG6084  3 0.83485 
CG3821 Aspartyl-tRNA synthetase 7 0.83491 
CG2171 Triose phosphate isomerase 3 0.83808 
CG10363 Thiolester containing protein IV 5 0.84241 
CG5170 Dodeca-satellite-binding protein 1 3 0.8431 
CG7762 Rpn1 2 0.8446 
CG17530 Glutathione S transferase E6 2 0.85603 
CG9862 Rae1 2 0.85754 
CG6370  2 0.85954 
CG2720 Hsp70/Hsp90 organizing protein 
homolog 5 0.86559 
CG14813 δ-coatomer protein 2 0.86651 
CG8977 Cctγ 6 0.86652 
CG6692 Cysteine proteinase-1 2 0.87049 
CG4254 Twinstar 7 0.87323 
CG5374 Tcp1-like 3 0.87446 
CG12792 Lethal (2) 09851 2 0.87536 
CG10333  2 0.87666 
CG17259  8 0.88321 
CG7144 Lysine ketoglutarate reductase 2 0.88461 
CG4082 Minichromosome maintenance 5 2 0.88761 
CG3299 Vinculin 6 0.88848 
CG8231 T-cp1δ 10 0.8916 








CG2248 Rac1 2 0.91715 
CG13096  3 0.92144 
CG7765 Kinesin heavy chain 12 0.92347 
CG8715 Lingerer 5 0.92883 
CG6699 Β'-coatomer protein 4 0.92956 
CG8798  2 0.93269 
CG3895 Polyhomeotic distal 2 0.93466 
CG1633 Thioredoxin peroxidase 1 5 0.93745 
CG15100  7 0.94045 
CG10067 Actin 57B 6 0.94097 
CG2207 Decondensation factor 31 1 0.94493 
CG3725 Calcium ATPase at 60A 5 0.94501 
CG7070 Pyruvate kinase 4 0.94672 
CG17654 Enolase 3 0.9509 
CG5525  2 0.95736 
CG5642  2 0.95745 
CG6543  2 0.96031 
CG1242 Heat shock protein 83 8 0.9624 
CG1483 Microtubule-associated protein 205 18 0.96364 
CG30122  4 0.96728 
CG11963 SkpA associated protein 2 0.97514 
CG34417  5 0.97648 
CG3762 Vha68-2 3 0.98489 
CG13388 A kinase anchor protein 200 3 0.98533 
CG4634 Nucleosome remodeling factor - 
38kD 2 0.98822 








CG11471 Isoleucyl-tRNA synthetase 9 0.99095 
CG6341 Elongation factor 1 β 5 0.99261 
CG10600  3 0.99448 
CG10840 eIF5B 2 0.99801 
CG2050 Modulo 4 0.99932 
CG7033  3 0.99945 
CG1250 Sec23 2 0.99958 
CG17246 Succinate dehydrogenase A 2 1.0023 
CG1554 RNA polymerase II 215kD subunit 3 1.0064 
CG7261  3 1.0065 
CG9579 Annexin X 4 1.0076 
CG33130 Short spindle 4 5 1.0081 
CG6143 Protein on ecdysone puffs 10 1.0138 
CG4276 Arouser 3 1.0161 
CG12013 PHGPx 3 1.0311 
CG6964 Grunge 2 1.0313 
CG8472 Calmodulin 1 1.0388 
CG33123  5 1.0393 
CG8351 Tcp-1ε 7 1.0429 
CG3107  3 1.0434 
CG8996 Walrus 7 1.0447 
CG3186 eIF-5A 6 1.0462 
CG10302 Bicoid stability factor 6 1.0511 
CG6995  2 1.0531 
CG4598  3 1.0561 








CG4264 Heat shock protein cognate 4 12 1.058 
CG4494 Smt3 2 1.0609 
CG7823 RhoGDI 1 1.0636 
CG11143 Inos 4 1.0686 
CG5394 Glutamyl-prolyl-tRNA synthetase 22 1.0688 
CG1404 Ran 4 1.0817 
CG17255 No circadian temperature entrainment 3 1.0933 
CG12819 Slender lobes 6 1.0941 
CG1101 Aly 4 1.0993 
CG4147 Heat shock protein cognate 3 15 1.1043 
CG11027 ADP ribosylation factor 102F 1 1.1066 
CG8439 T-complex Chaperonin 5 3 1.1177 
CG5094 Small glutamine-rich tetratricopeptide 
containing protein 3 1.1383 
CG9302  5 1.1401 
CG13391 Alanyl-tRNA synthetase 9 1.1405 
CG7834  3 1.1419 
CG5728  3 1.1467 
CG2168 Ribosomal protein S3A 5 1.1512 
CG5355  8 1.1584 
CG7415 Dipeptidyl aminopeptidase III 4 1.1603 
CG5771 Rab-protein 11 3 1.1645 
CG7752 Putzig 2 1.1652 
CG31196 14-3-3ε 11 1.1683 
CG6226 FK506-binding protein 1 2 1.1692 
CG17870 14-3-3δ 5 1.1711 








CG8415 Ribosomal protein S23 2 1.1842 
CG7360 Nucleoporin 58 2 1.1851 
CG15792 Zipper 17 1.2075 
CG13849 Nop56 4 1.2152 
CG8542 Heat shock protein cognate 5 12 1.2219 
CG17611 eIF6 2 1.2255 
CG6871 Catalase 3 1.226 
CG6058 Aldolase 8 1.2299 
CG2852  5 1.2564 
CG5874 NELF-A 3 1.2656 
CG32031 Arginine kinase 6 1.2762 
CG18495 Proteasome α1 subunit 2 1.2969 
CG7145  2 1.3072 
CG10206 Nop5 9 1.3138 
CG3644 Bicaudal 2 1.3192 
CG4062 Valyl-tRNA synthetase 4 1.3295 
CG11276 Ribosomal protein S4 6 1.3604 
CG7421 Nopp140 2 1.3641 
CG9888 Fibrillarin 6 1.3721 
CG6988 Protein disulfide isomerase 9 1.3754 
CG6453  3 1.396 
CG7581 Bub3 3 1.4001 
CG8322 ATP citrate lyase 4 1.4005 
CG3152 Trap1 4 1.4269 
CG8983 ERp60 14 1.4297 








CG4900 Iron regulatory protein 1A 2 1.4489 
CG10315 eIF2B-δ 2 1.4807 
CG2210 Abnormal wing discs 2 1.4815 
CG4164  3 1.4833 
CG6603 Hsc70Cb 5 1.4963 
CG3001 Hexokinase A 2 1.517 
CG5174  3 1.5394 
CG4038  2 1.5828 
CG14066 La related protein 2 1.6217 
CG6459  2 1.6308 
CG10122 RNA polymerase I subunit 2 1.6384 
CG2918  6 1.6562 
CG7998  2 1.6685 
CG1883 Ribosomal protein S7 3 1.6983 
CG7917 Nucleoplasmin 5 1.7222 
CG5520 Glycoprotein 93 6 1.7404 
CG5258 NHP2 1 1.7813 
CG12101 Heat shock protein 60 8 1.7908 
CG6684 Ribosomal protein S25 2 1.8463 
CG4233 Glutamate oxaloacetate transaminase 
2 1 1.9097 
CG32549  2 1.9174 
CG33129  1 1.9368 
CG5809 CaBP1 2 1.9371 
CG6850 UDP-glucose-glycoprotein 
glucosyltransferase 5 2.0494 








CG14998 Ensconsin 9 2.0782 
CG17489 Ribosomal protein L5 2 2.0953 
CG9342 Microsomal triacylglycerol transfer 
protein 1 2.1017 
CG5020 Cytoplasmic linker protein 190 37 2.1905 
CG1112 α-Esterase-7 2 2.1922 
CG10687 Asparaginyl-tRNA synthetase 4 2.1981 
CG6287  4 2.2609 
CG4464 Ribosomal protein S19a 2 2.387 
CG4143 multiprotein bridging factor 1 1 2.4496 
CG7013 Mesencephalic astrocyte-derived 
neurotrophic factor 2 2.4551 
CG1516  4 2.58 
CG9244 Aconitase 5 2.9101 
CG4460 Heat shock protein 22 2 3.2741 
CG4463 Heat shock protein 23 2 3.3766 
CG4183 Heat shock protein 26 2 3.8974 
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Table A3  Quantified proteins from the second relative quantification of 
MAPs from interphase and mitosis. 
CG 
Number 




CG9476 α-Tubulin at 85E 10 0.007349 
CG3401 β-Tubulin at 60D 11 0.011363 
CG9359 β-Tubulin at 85D 14 0.014124 
 Porcine Trypsin 6 0.022402 
CG9277 β-Tubulin at 56D 19 0.036572 
CG2512 α-Tubulin at 84D 17 0.054269 
CG1399  1 0.064963 
CG4869 β-Tubulin at 97EF 10 0.1787 
CG9191 Kinesin-like protein at 61F 12 0.24925 
CG11120  5 0.30307 
CG10849 Sc2 1 0.36331 
CG11840 Signal peptide protease 1 0.40762 
CG2064  5 0.53082 
CG6214  5 0.53321 
CG6370  3 0.55058 
CG6455  2 0.55654 
CG10223 Topoisomerase 2 4 0.55816 
CG10236 Laminin A 4 0.56329 
CG10630  2 0.57865 
CG17064 mars 2 0.59691 
CG3902  3 0.61395 
CG6030 ATP synthase, subunit d 1 0.63072 








CG5020 Cytoplasmic linker protein 190 30 0.65623 
CG10882 stenosis 3 0.66675 
CG13387 embargoed 4 0.67608 
CG1371  4 0.67833 
CG3321  1 0.69523 
CG11856 Nucleoporin 358 2 0.71339 
CG8947 26-29kD-proteinase 1 0.7241 
CG8996 walrus 6 0.72644 
CG4389  4 0.74697 
CG6647 porin 5 0.75254 
CG4494 smt3 1 0.75495 
CG17856  1 0.7586 
CG6699 β'-coatomer protein 2 0.7676 
CG12819 slender lobes 7 0.76819 
CG1528 γ-coatomer protein 3 0.77387 
CG4817 Structure specific recognition protein 2 0.77863 
CG8798  5 0.78031 
CG15792 zipper 2 0.78047 
CG1258 pavarotti 9 0.78087 
CG14066 La related protein 3 0.78934 
CG10206 nop5 9 0.79366 
CG1828 dre4 2 0.79643 
CG7752 putzig 4 0.79769 
CG5991  2 0.798 








CG13345 tumbleweed 3 0.81321 
CG11958 Calnexin 99A 6 0.81516 
CG8479 optic atrophy 1-like 1 0.81677 
CG7834  1 0.81682 
CG10811 eukaryotic translation initiation factor 
4G 
2 0.8203 
CG7961 α-coatomer protein 6 0.83729 
CG1483 Microtubule-associated protein 205 12 0.84507 
CG1059 Karyopherin β 3 2 0.84843 
CG7765 Kinesin heavy chain 12 0.85004 
CG4169  4 0.85264 
CG11471 Isoleucyl-tRNA synthetase 10 0.85432 
CG10691 lethal (2) 37Cc 2 0.8558 
CG33129  7 0.85632 
CG13281 CAS/CSE1 segregation protein 4 0.85654 
CG12165 Inner centromere protein 2 0.85674 
CG5099 musashi 2 0.8571 
CG12276 Aos1 2 0.85713 
CG6223 β-coatomer protein 3 0.85879 
CG6815 belphegor 4 0.86303 
CG11624 Ubiquitin-63E 1 0.86467 
CG4276 arouser 4 0.86772 
CG3937 cheerio 3 0.86792 
CG5728  4 0.87119 
CG5394 Glutamyl-prolyl-tRNA synthetase 11 0.87227 








CG9012 Clathrin heavy chain 3 0.88279 
CG7113 scully 2 0.88549 
CG3333 Nucleolar protein at 60B 3 0.8894 
CG1065 Succinyl coenzyme A synthetase α 
subunit 
4 0.89237 
CG1404 ran 4 0.8947 
CG9805 eIF3-S10 4 0.8966 
CG2098 ferrochelatase 2 0.90307 
CG6453  3 0.9038 
CG6988 Protein disulfide isomerase 3 0.90959 
CG4769  1 0.91579 
CG11207 fascetto 2 0.9258 
CG5170 Dodeca-satellite-binding protein 1 6 0.93227 
CG7831 non-claret disjunctional 17 0.95124 
CG7261  3 0.95161 
CG7434 Ribosomal protein L22 2 0.95545 
CG33123  9 0.96168 
CG4307 Oligomycin sensitivity-conferring 
protein 
1 0.97106 
CG4254 twinstar 2 0.98271 
CG5258 NHP2 1 0.98375 
CG8402 Protein phosphatase D3 2 0.98473 
CG12008 karst 4 0.9901 
CG18076 short stop 42 0.99025 
CG6341 Elongation factor 1 β 4 0.99096 








CG5520 Glycoprotein 93 8 0.99749 
CG7490 Ribosomal protein LP0 4 1.0042 
CG4912 eEF1δ 4 1.01 
CG8542 Heat shock protein cognate 5 2 1.0154 
CG9302  2 1.0205 
CG9888 Fibrillarin 4 1.0236 
CG6684 Ribosomal protein S25 2 1.0249 
CG4046 Ribosomal protein S16 1 1.0271 
CG8732 Acyl-CoA synthetase long-chain 3 1.0311 
CG12306 polo 5 1.0318 
CG7070 Pyruvate kinase 2 1.037 
CG11876  1 1.0373 
CG8983 ERp60 2 1.0439 
CG6944 Lamin 3 1.0561 
CG5854  2 1.0665 
CG2918  2 1.0704 
CG12030  7 1.0765 
CG7421 Nopp140 2 1.0869 
CG10279 Rm62 2 1.0905 
CG12055 Glyceraldehyde 3 phosphate 
dehydrogenase 1 
3 1.0949 
CG4264 Heat shock protein cognate 4 11 1.0955 
CG6512  1 1.0974 
CG4147 Heat shock protein cognate 3 7 1.0997 
CG8280 Elongation factor 1α48D 2 1.0997 








CG11276 Ribosomal protein S4 1 1.1069 
CG8893 Glyceraldehyde 3 phosphate 
dehydrogenase 2 
3 1.107 
CG8274 Megator 7 1.1119 
CG17870 14-3-3δ 3 1.1175 
CG3373 Hemomucin 2 1.1178 
CG8258  5 1.1214 
CG6773 sec13 1 1.1223 
CG4463 Heat shock protein 23 3 1.1284 
CG13849 Nop56 6 1.1444 
CG4878 eIF3-S9 2 1.1507 




CG3821 Aspartyl-tRNA synthetase 5 1.1705 
CG15100  5 1.1742 
CG14897  3 1.1887 
CG8415 Ribosomal protein S23 1 1.1891 
CG8231 T-cp1δ 4 1.1894 
CG1101 Aly 2 1.1918 
CG2168 Ribosomal protein S3A 2 1.2248 
CG5353 Threonyl-tRNA synthetase 9 1.2253 
CG14648 growl 4 1.2287 
CG10712 Chromator 3 1.2334 
CG12101 Heat shock protein 60 3 1.2494 








CG7917 Nucleoplasmin 2 1.2667 
CG13391 Alanyl-tRNA synthetase 3 1.2712 
CG6143 Protein on ecdysone puffs 6 1.2951 
CG33910 His2B:CG33910 2 1.3004 
CG8977 Cctγ 6 1.3111 
CG1977 α Spectrin 8 1.345 
CG34417  3 1.4354 
CG13096  2 1.4881 
CG31196 14-3-3ε 1 1.5008 
CG4183 Heat shock protein 26 2 1.6029 
CG4460 Heat shock protein 22 2 1.666 
CG14998 ensconsin 16 1.8021 
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